MikeLigalig.com

Amidst the barrage of events profoundly affecting Americans in 2020, it can be difficult to envision what "normal" will look like when the crisis and election turmoil have passed. For healthcare, however, the signs are clear - and although the changes may not end up being as dramatic as some may have wanted (or feared), the economics of care delivery remain consumer-driven and decidedly nonpartisan.

LAFAYETTE, CALIF. (PRWEB) NOVEMBER 12, 2020
Unprecedented. Devastating. Deadly. Divisive. The words used to describe America's 2020 have predictably focused on the negatives. But through all of the surprises; all the adversity and seemingly insurmountable challenges, the resourcefulness and resilience of people who refuse to succumb to the difficulties stand out. This resolve was evident in last week's election, which saw the highest voter turnout in more than a century. And it can be seen in the historic achievements of scientists, researchers and caregivers in the healthcare industry.
As this article is being written, a hopeful nation is celebrating the news that a COVID-19 vaccine has been shown 90 percent effective in a global clinical trial with more than 40,000 participants. And although the process for final approval of the Pfizer/Biontech vaccine, along with production, distribution and public acceptance are likely months away, the event has given all of us cause for renewed optimism even as COVID-19 case counts in America are reaching new peaks since the public health crisis began. At last, it appears, there is some light at the end of this tunnel.
Just days before, the winner of the 2020 presidential race was projected with the election of the forty sixth President of the United States. The winner, former Vice President Joe Biden, has promised an aggressive healthcare agenda, but as of this writing it appears unlikely that he'll have the congressional majority he'll need for anything more than incremental change. Despite the diminished prospect for dramatic healthcare reform in the short-term future, there are several market-driven conditions that have and will likely continue to drive healthcare policy forward.
The noteworthy events listed above are apropos of an era defined by noteworthy events, especially in healthcare. As America has strived to regain some economic and operating equilibrium, healthcare providers have, again and again, been at the center of the effort. Think of it. Faced with a deadly new virus, grave public health concerns and a nervous patient population, healthcare providers suspended nonessential services, depriving themselves of hundreds of billions in planned revenue. At the same time, they invested millions to expand capacity and develop new channels and operating models to help ensure the delivery of care.
Examining the healthcare industry's health and well-being at this stage of 2020, the results of these unplanned disruptions in revenue and expenses are mixed. Some systems have modified their businesses to adapt to the industry's new reality. One, HCA Healthcare (a Loyale client) announced their intention to pay back $6 billion in federal stimulus funding because of improved operating performance in the third quarter; while other providers have been forced to lay off personnel or face closing their doors. On balance, however, the industry seems to be finding its footing.
According to research published by healthcare industry consulting firm Kaufman Hall titled, "National Hospital Flash Report October 2020", "The nation's hospitals continue to face an uncertain operating environment, with margins fluctuating from month to month." Somewhat encouragingly though, the report found that operating margins against the firm's industry index were up in September, rising 8.1% year over year. This growth, occurring despite "lower volumes for a seventh consecutive month... was attributable to longer lengths of stay (up 2.3% YTD and YOY)," and higher net patient service revenue (up 5.8% YTD and 10.7% YOY). Additionally, "Organizations also are benefiting from the 20% Medicare COVID-19 add-on, suspension of the -2% sequestration adjustment and lower bad debt, all of which are helping to drive revenue."
In our view, the favorable trend in net patient service revenue (NPSR) is particularly telling. It underscores our observation that, as the industry works to reconfigure itself for the post-COVID-19 marketplace, the prominence of the patient-as-payer cannot be overlooked. This may be especially true now, with millions of Americans out of work and no longer covered by employer-sponsored healthcare plans.
We published an analysis earlier this year titled, "4 Changes Healthcare Providers Must Embrace After COVID." In it, we shared the experiences of Loyale clients to illustrate the operating models and business practices that are proving themselves in the "trial by fire" forced on the industry by the COVID-19 crisis. Noting that "market-driven, government-supported changes have redefined healthcare delivery for patients from today on," we urged healthcare providers to recognize and respond to these important developments if they intend to remain relevant in a redefined marketplace:
1. Virtual Care Delivery will be a permanent part of the healthcare delivery landscape.
2. Providers will be expected to provide their patients and communities with reliable information about price and quality to empower their ability to choose.
3. Total system interoperability, the seamless integration of all systems affecting the patient care experience will become an operating standard.
4. Technology will be relied upon for the delivery of better, more personalized patient experiences at scale.
It is critically important to note that market economics are the driving force behind these developments. Though they are affected by regulatory policy, the industry's competitive and financial fundamentals are being driven by an increased dependence on patient-paid revenue, as confirmed in the year to date research from Kaufman Hall cited above. These dynamics are not partisan; they are not liberal or conservative. Policy makers have been and will be compelled by the interests of their constituents to promote rules, regulations and reimbursements to support continued advancement in the affordability of, and access to, care. The healthcare providers who plan for that reality will be the winners in the post-COVID-19 marketplace.
In Loyale analysis published this summer titled, "Healthcare's COVID-19 Response Is a Window to the Industry's Future," we described how the pandemic "has led to the accelerated adoption of new operating models that promise better, more accessible and more sustainable healthcare." Healthcare's operating performance through Q3 affirms the conviction of several notable healthcare industry executives cited in the analysis. These industry leaders envision a future for healthcare that is, 1) consumer-centered, 2) accessible and affordable, 3) virtual, 4) data-driven and interoperable and 5) dedicated to delivering well care, not just sick care.
The demand for healthcare that meets these new operating standards is coming not just from consumers. Employers, regulators and legislators are all speaking out, and potent new competitors like CVS Health, Walgreens and Walmart are entering into the primary care marketplace to fill the demand. The future for healthcare can – and should be – bright, but for traditional providers, getting back to normal is going to have to look a lot different than it did not too long ago.
America has lived through tragic events of a massive scale before. The World Wars, Great Depression and Dust Bowl are prominent examples. But along with those tragedies, there have always been – and always will be – stories that illuminate how ordinary people crossed boundaries, tempted fate and worked together to help one another. These stories, we believe, form the basis for the astonishing advancements achieved in spite, and because, of our collective responses to the challenges we face.
In the face of COVID-19, healthcare providers have continually distinguished themselves. Their dedication to their patients and their communities has continually sustained and supported us. And now, with healthcare researchers and scientists announcing the prospect of a COVID-19 vaccine in the months ahead, healthcare will be the sector that ultimately walks us out of this latest challenge.
Remember early in the pandemic, when New York City was at the crisis' epicenter? Each evening, the locked-down city residents would honk horns, clang pots and pans and shout praise and gratitude to the city's healthcare workers from their balconies and fire escapes. At Loyale, we're doing that by rededicating ourselves to helping ensure that American healthcare is strong and sustainable for the new generations and new challenges to come.
Kevin Fleming is the CEO of Loyale Healthcare
About Loyale
Loyale Patient Financial Manager is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.
Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale's industry leading technology at all HCA hospitals and Physician Groups.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

cbdMD announced today an expansion of its topical product line with the launch of 'Premium Relieve', a product that combines the pain-fighting power of Lidocaine with Superior Broad Spectrum CBD extracts – leading to total wellness in one unique topical formula.

CHARLOTTE, N.C. (PRWEB) NOVEMBER 12, 2020
cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the "Company"), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today an expansion of its topical product line with the launch of 'Premium Relieve', a product that combines the pain-fighting power of Lidocaine with Superior Broad Spectrum CBD extracts – leading to total wellness in one unique topical formula.
Available in a roll-on applicator or spray, Premium Relieve combines the proven powers of Lidocaine (4%) with cbdMD's Superior Broad Spectrum formula, providing temporary relief from minor muscle aches and pains.
Premium Relieve joins a diverse offering of topical products featuring high profile over-the-counter (OTC) pain relief ingredients fused with cbdMD's unique hemp extract blend, including:
Premium Freeze Pain Relieving Formula ('2020 Product of the Year' Winner: CBD Topical) - cbdMD's award-winning Freeze gel offers the proven pain-relief properties of menthol, blended with the power of domestically sourced CBD, to provide temporary pain relief while working to ease aching muscles and joints.
Premium Recover Pain Relieving Formula - cbdMD's Recover combines pain-relieving agent Histamine Dihydrochloride (0.05%) with the whole-body benefits of cbdMD's Superior Broad Spectrum CBD formula into a unique, richly moisturizing cream that's great for temporary relief of pain and muscle aches, without any of the smell.
cbdMD's release of Premium Relieve marks an advancement in the topical market as it is one of the few CBD topicals available in aerosol spray form, utilizing a unique Bag-on-Valve Technology that allows for spraying at any angle and covering difficult-to-reach areas. In addition, Premium Relieve contains the most abundant CBD content of any Lidocaine-infused topical currently on the market.
"Topicals have never been more popular for consumers, with more and more products adding CBD to their formulas these days," said Ken Cohn, Chief Marketing Officer at cbdMD. "At cbdMD, we're revolutionizing the topical market by introducing innovative products that continue to lead in each category. With 'Premium Relieve', we are proud to now offer an expanded topicals line that is well-rounded and balanced, with broad appeal to not only health-minded individuals, but anyone seeking to enhance their personal wellness."
To learn more about cbdMD and their comprehensive line of U.S. grown, non-THC1 CBD oil products, please visit: http://www.cbdmd.com.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of "Team cbdMD." To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, Non-THC[1] CBD products, please visit http://www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to the expansion of the consumer market for CBD products and our ability to increase our market share, our limited operating history, our ability to expand our business and significantly increase our revenues, our ability to effectively leverage our brand partnerships and sponsorships, our ability to effectively compete in our market, our ability to achieve our net sales guidance, and our ability to report profitable operations in the future. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2019 as filed with the Securities and Exchange Commission (the "SEC") and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 Non-THC is defined as below the level of detection using validated scientific analytical tools.
Contact:
PR:
cbdMD, Inc.
Lauren Greene
Communications Specialist
Lauren.Greene@cbdMD.com
(843) 743-9999
Investors:
cbdMD, Inc.
John Weston
Director of Investor Relations
John.Weston@cbdMD.com
(704) 249-9515




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Partnership will provide better outcomes for Medicare patients managing chronic liver diseases

FORT LAUDERDALE, FLA. (PRWEB) NOVEMBER 12, 2020
ChronWell, a digital health and technology-enabled remote care management company, today announced its strategic partnership with ModifyHealth, a nationwide provider of gut-friendly, fully prepared meals, and Echosens North America, a high-technology company offering the FibroScan family of products. This collaboration will create LIVErHEALTHY, a newly integrated program that provides better outcomes and best-in-class service for Medicare patients managing chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Providing a holistic, tailored and technology-enabled approach to managing chronic liver diseases, LIVErHEALTHY links ChronWell's Chronic Care Management (CCM) Program with ModifyHealth's intuitive food and diet regime, and Echosen's frequent non-invasive liver testing.
LIVErHEALTHY will utilize the tools and services provided by ChronWell's CCM Program. This will enable its experienced Care Navigators to extend services beyond the walls of a doctor's office, working closely with providers as well as ModifyHealth and Echosens to remotely manage patients in-between visits. This is done through care coordination, real-time monitoring and routine check-ins, ensuring adherence to tailored care plans.
"Liver diseases require continuous care and helping drive patient behavior once they leave the medical office is the only way to get optimal results," said Joe Rubinsztain, MD, CEO of ChronWell. "Bringing these three companies together allows us to deliver an integrated and continuous experience for both providers and patients to yield healthier lifestyles and habits that lead to better outcomes, lower system cost and higher patient satisfaction, leading to value-based care."
According to the American Liver Foundation, the first line of treatment for NAFLD/NASH is weight loss, done through a combination of calorie reduction, exercise and healthy eating. ModifyHealth makes medical nutrition therapy (MNT) simple and effective for healthcare providers and helps form the backbone of any treatment strategy or care plan. With the goal of bringing relief and making dietary management easier, ModifyHealth and its dieticians create catered regimens and send chef-inspired meals that are fully prepared, organic, gluten-free and follow a Low-FODMAP diet plan directly to the patient's home.
"We're excited to partner with both ChronWell and Echosens to provide a streamlined solution for GI practices and their NAFLD/NASH patients," said Hagan Jordan, Chief Commercial Officer at ModifyHealth. "MNT plays a critical role in the management and treatment of these diseases, and our mission is to provide a resource for health care and providers that makes these necessary lifestyle changes easier and more effective."
In order to more effectively manage patients with chronic diseases, Echosens' innovative tool, FibroScan, is used. FibroScan is an FDA-cleared, noninvasive and portable technology for the assessment of liver steatosis and fibrosis as an aid to the diagnosis and monitoring of liver health. FibroScan technology provides an effective platform for identification of patients with progressive fatty liver disease, including NAFLD/NASH. Additionally, longitudinal FibroScan testing can be used to monitor therapeutic response to care. FibroScan is used worldwide in over 6,500 clinics and validated in over 2,500 peer review publications.
"This strategic partnership is a powerful combination that reflects our collective commitment to ending the epidemic of fatty liver disease and halting the progression of NAFLD/NASH," said Jon Gingrich, CEO of Echosens North America. "FibroScan complements the LIVErHEALTHY program and its treatment strategies, proving to be an important tool for improving individual patient outcomes. Working collaboratively with our partners, we can also sharpen our focus on cost-containment for all self-funded employers and payers. With shared dedication and alignment to value-based care, we look forward to supporting the marketplace as it prepares for the entry of specialty pharmaceuticals."
To learn more about LIVErHEALTHY, click here.
###
About ChronWell
ChronWell improves outcomes and reduces the cost of health care by offering a digital health platform with remote care coordination services for targeted populations. ChronWell is redefining how value-based care is delivered to patients by pairing highly skilled care teams with advanced digital technologies. ChronWell aims to improve patients' lives beyond the walls of the physician's office and minimize the impact of chronic conditions on patients, providers, employers and insurers. For more information, follow us on LinkedIn or visit chronwell.com.
About ModifyHealth
ModifyHealth changes lives by making food as medicine simple and effective for providers and patients. ModifyHealth's provider-recommended, home-delivered, Low-FODMAP, and gluten-free meals are shipped nationwide to help bring relief to common GI conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), SIBO, and celiac disease where dietary modification is a recommended treatment. Meals are Monash University Low-FODMAP Certified, organic, non-GMO, delivered fully prepared and supported with expert dietitian consultations to ensure positive outcomes. For more information, please visit modifyhealth.com.
About Echosens North America
Echosens, the developer of FibroScan, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans. For more information, please visit https://echosens.us/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Acne Scarring Brand ,Banish, Launches Warrior Video, "What it your biggest regret with Acne?" That asks acne battlers what their biggest regret is

PASADENA, CALIF. (PRWEB) NOVEMBER 14, 2020
Banish, a skincare brand focused on removing acne scars, has launched its warrior campaign video, "What is your biggest regret with acne". This video asks Banish's brand ambassadors, or Warriors, how acne has impacted their lives. The effects of acne go beyond the physical appearance. Many of those with acne have experienced isolation and rejection in their most formative years, impacting their loss of self confidence for years to come. In this two minute video, Acne Sufferers share they didn't attend school functions, didn't pursue romantic relationships, or spent so much time focused on their acne when they could have focused on other aspects of their lives.
Acne is the most common skin condition in the United States. Those diagnosed with acne have
a 63% increase in developing depression for five years after diagnosis. As a skincare brand with over 195k Instagram followers, Banish seeks to empower its customers (or "Soldiers") to be confident, with or without acne. As an acne sufferer herself, CEO Daisy Jing wanted to showcase the inner struggles of those with acne. "When I had acne, over 15 years ago, there was no social media. The worst part of having acne was I felt so incredibly alone. The isolation was the worst part for me. With this video, hopefully we can make everyone feel they are not alone in their struggle"
https://www.youtube.com/watch?v=Du_49rvZB5U&feature=youtu.be
###
About Banish
Banish is an indie skincare brand focused on removing acne scars at home. Founded in 2013 in when YouTuber Daisy Jing of "The Acne Channel" accidentally created the secret formula to battling her own acne scars, Banish products are freshly made in small batches and shipped to customers within a day of ordering. Since then, Daisy Jing has been named to the Forbes "30 Under 30" and is a TEDx speaker.
Banish products treat and relieve a variety of skin ailments, such as acne, acne scars, eczema, flaky skin, redness, and more. Learn more at Banish.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Five sample types are added to CUSABIO Exosome Isolation Kits. Now researchers can use the kits to extract exosome from Cell Culture Supernatant, Serum, Plasma, Latex, Urine, and Saliva.

HOUSTON (PRWEB) NOVEMBER 13, 2020
In 2019, the team at CUSABIO developed the first commercial Exosome Isolation Kit by affinity purification. Researchers can obtain the High Purity exosomes and other Evs (Extracellular vesicles) from the cell culture medium and body fluid (high yield by normal microfiltration) easily by this method. The exosomes obtained from CUSABIO kits are suitable for many downstream experiments, including Transmission electron microscope analysis, Nanoparticle tracking analysis, NanoFCM analysis, Western Blot, Fluorescence quantitative (qPCR), High-Throughput Sequencing, etc. But it only could extract exosomes from the cell culture supernatant at that time. To meet the requirements of researchers, CUSABIO adds another 5 sample types for the kit in 2020.
About CUSABIO Exosome Isolation Kit
CUSABIO exosome isolation kit can extract exosome from various sample types and cells with high purity and yield. It is suitable for many downstream experiments. This kit is very simple and efficient to use. No ultracentrifugation or phenol/chloroform step required. No large-scale equipment required. And the exosomes extracted by CUSABIO Exosome Isolation Kit are comparable to ultracentrifugation with High Purity and High Yield.
More details, please visit https://www.cusabio.com/Exosome-Isolation-Kit.html
About Exosomes
Exosomes are small, single-membrane, secreted extracellular vesicles of ~30 to ~200 nm in diameter that contains any of various biomolecules, such as proteins or nucleic acids. They allow for cell-to-cell communication, transporting molecules, and act as shuttles for certain genetic information and proteins to other cells. Intercellular communication by exosomes plays a critical role in diverse pathological processes, such as cancer, infectious and neurodegenerative diseases.
Exosomes were first discovered in the maturing mammalian reticulocyte by Stahl and group in 1983 and Johnstone and group in 1983, further termed 'exosomes' by Johnstone and group in 1987. In 2007, Jan Lotvall and the group made a great breakthrough in exosome research. The variable RNA and miRNA contained in the exosomes, and non-coding long RNAs and mRNAs can be transported between cells. In 2010, three research groups demonstrated that miRNAs can be transferred to standby cells and function in cells.
Since then, the importance of exosome comes out conspicuously. In addition, the Nobel Prize in Physiology or Medicine 2013 was awarded jointly to James E. Rothman, Randy W. Schekman and Thomas C. Südhof "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells." More and more researchers start their study of the exosome. And exosomes are being explored as a tool for disease diagnosis and management.
Since exosomes are distributed in a broad range of biofluids, such as serum, plasma, ascites fluid, urine, saliva and tissue culture media, exosome isolation becomesthe first and the most important step in the research of exosome. There are many methods to isolate exosomes from the samples, such as Differential ultracentrifugation and Density gradient ultracentrifugation, Ultrafiltration method, Polypolymer precipitation method, Magnetic bead immunoassay, Aqueous two-phase system (ATPS) method, etc. They have their own pros and cons. Exosome isolation kit is the product that tries to develop the strong points and avoid the weak points. And it turns out the results are not bad. It is also one of the reasons why CUSABIO developed the Exosome isolation kit.
About CUSABIO
CUSABIO is a manufacturer of ELISA kits, Exosome isolation kits, antibodies, proteins, and related reagents, starting with a small lab. After 13 years of effort, CUSABIO has become a good partner to researchers worldwide. And thousands of products are used by the researchers and help them make more and more breakthroughs.
To know more about CUSABIO, please visit: https://www.cusabio.com/

CUSABIO Exosome Isolation Kits purify exosomes by affinity purification. The purity and yield are comparable to ultracentrifugation.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nashua's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

NASHUA, N.H. (PRWEB) NOVEMBER 14, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Nashua, NH for 2021. The informational guide recognizes the top 13 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Nashua, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Nashua with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Nashua. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Nashua, NH please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-nashua-nh
2021 Best Rehab Facilities in Nashua, NH (in alphabetical order)
Addiction Recovery Services (ARS)
23 Stiles Road, Suite 108
Salem, NH 03079
978-228-5853
Avenues Recovery Center
81 Hall Street
Concord, NH 03301
855-340-4016
Aware Recovery Care
15 Constitution Drive Suite 2N
Bedford, NH 03110
603-769-8462
Balance Recovery Center
60 Main Street, Suite 103
Nashua, NH 03060
888-701-5677
GateHouse Treatment
155 Main Dunstable Road, Suite 130
Nashua, NH 03060
855-448-3588
Granite Recovery Center
6 Manor Parkway
Salem, NH 03079
855-712-7784
Health Care Resource Center
323 Derry Road
Hudson, NH 03051
603-595-3399
New England Recovery and Wellness
81 Hall Street
Concord, NH 03301
855-500-0167
New Hampshire Comprehensive Treatment Center
20 Market Street
Manchester, NH 03101
844-262-6206
Oasis Recovery
280 Main Street, Suite 431
Nashua, NH 03060
603-627-4764
Process Recovery Center
41 Sagamore Park Road
Hudson, NH 03051
888-649-1149
ROAD To A Better Life
2 Mound Court
Merrimack, NH 03054
603-423-0207
Sobriety Centers of New Hampshire
55 Main Street
Antrim, NH 03440
603-494-7480
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Buffalo's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

BUFFALO, N.Y. (PRWEB) NOVEMBER 14, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Buffalo, NY for 2021. The informational guide recognizes the top 10 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Buffalo, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Buffalo with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Buffalo. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Buffalo, NY please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-buffalo-ny
2021 Best Rehab Facilities in Buffalo, NY (in alphabetical order)
Beacon Center
3354 Sheridan Drive
Amherst, NY 14226
315-366-4100
Buffalo Adult and Teen Challenge
124 Locust Street
Buffalo, NY 14204
716-855-0602
BryLin Behavioral Health System
1263 Delaware Avenue
Buffalo, NY 14209
716-886-8200
Cazenovia Recovery
2495 Main Street, Suite 417
Buffalo, NY 14214
716-852-4331
ECMC
462 Grider Street
Buffalo, NY 14215
716-898-3000
Horizon Health Services
55 Dodge Road
Getzville, NY 14068
716-831-1800
Kids Escaping Drugs, Inc.
920 Harlem Road
West Seneca, NY 14224
716-827-9462
Spectrum Health and Human Services
227 Thorne Avenue
Orchard Park, NY 14127
716-539-5500
St Vincent Health Center (Catholic Health)
1500 Broadway Street
Buffalo, NY 14212
716-923-7050
Sunrise House Treatment Center
95 Franklin Street
Buffalo, NY 14202
973-383-6300
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Northern Virginia's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

ARLINGTON, VA. (PRWEB) NOVEMBER 14, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Northern Virginia, VA for 2021. The informational guide recognizes the top 13 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Northern Virginia, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Northern Virginia with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Northern Virginia. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Northern Virginia, VA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-northern-virginia-va
2021 Best Rehab Facilities in Northern Virginia, VA (in alphabetical order)
Aquila Recovery of Virginia
425-B Carlisle Drive
Herdon, VA 20170
703-687-0935
Bridging the Gaps, Inc.
31 S. Braddock Street
Winchester, VA 22601
540-535-1111
Broad Highway Recovery
5706 Jasonwood Court
Richmond, VA 23225
877-487-1599
Encore Outpatient Services
4600 Fairfax Drive, Suite 906
Arlington, VA 22203
703-594-7418
Inova Behavioral Health Services
8110 Gatehouse Road
Falls Church, VA 22042
855-694-6682
Kolmac Outpatient Recovery
1701 Clarendon Boulevard, Unit 100
Arlington, VA 22209
888-328-3053
New Paradigm Recovery
8150 Leesburg Pike, Suite 740
Vienna, VA 22182
703-214-5888
Recovery Unplugged at Harrison House
5105Q Backlick Road
Annadale, VA 22003
844-889-9433
Recovery Unplugged Northern Virginia Treatment Center
5105Q Backlick Road
Annadale, VA 22003
888-294-5786
Regional Health Providers Addiction Treatment Center
3917 Old Lee Hwy, Suite 1D
Fairfax, VA 22030
703-691-4000
Sagebrush Treatment Center
7921 Jones Branch Drive, Suite 400
McLean, VA 22102
866-488-1156
Sandstone Care
11415 Isaac Newton Square South
Reston, VA 20190
703-260-9359
Virginia Hospital Center
1715 N. George Mason Drive Suite 101
Arlington, VA 22205
703-558-6750
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Wichita's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

WICHITA, KAN. (PRWEB) NOVEMBER 14, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Wichita, KS for 2020. The informational guide recognizes the top 19 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Wichita, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Wichita with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Wichita. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Wichita, KS, please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-wichita-ks
2020 Best Rehab Facilities in Wichita, KS (in alphabetical order)
A Clear Direction
345 South Hydraulic Street
Wichita, KS 67211
316-260-9101
A New Dimension, Inc.
2422 South Seneca Street
Wichita, KS, 67217
316-265-8600
ADAPT
9505 West Central, Suite 103
Wichita, KS 67212
316-721-0971
AppleCore Outpatient Treatment/Olathe
226 South Kansas Avenue
Olathe, KS 66061
913-706-4132
Atishwin Institute, Inc.
937 South Bluffview
Wichita, KS 67218
316-681-2533
Bel Aire Recovery Center
4969 North Tierra Lakes Parkway
Bel Aire, KS 67226
888-905-7430
Center For Change
933 North Topeka
Wichita, KS, 67214
316-201-1234
Higher Ground Tiyospaye
247 North Market
Wichita, KS 67202
316-262-2060
Holland Pathways
551 South Holland
Wichita, Kansas 67209
316-260-1435
Hunter Health Clinic, Inc.
527 North Grove Street
Wichita, KS 67214
316-262-2415
Matrix Center
9918 East Harry Street
Wichita, KS
316-260-3445
Metro Treatment, Inc.
630 North Saint Francis, Suite C
Wichita, KS 67214
316-263-1623
Miracles
1015 East 2nd Street North
Wichita, KS 67214
316-303-9520
Preferred Family Healthcare
830 South Hillside Street
Wichita, KS 67211
660-665-1962
Recovery Unlimited, Inc.
3835 West Douglas Avenue
Wichita, KS 67213
316-941-9948
Seventh Direction
212 North Hillside Street
Wichita, KS
316-558-3066
Substance Abuse Center of Kansas
940 North Waco
Wichita, KS 67203
316-267-3825
The Caring Center
714 South Hillside
Wichita, KS 67211
316-295-4800
Word of Life Counseling Center
3811 North Meridian Avenue
Wichita, KS 67204
316-677-7646
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New features help users view healthy-eating progress and share social support without social pressure

SILICON VALLEY, CALIF. (PRWEB) NOVEMBER 13, 2020
Users of Fresh Tri, a neuroscience-based habit-formation digital app, can now check in on their progress with a new tool that captures insights, reframes perceived failures, and celebrates effort. They can also share expressions of appreciation and love with others in the Fresh Tri community.
Fresh Tri is a rapidly growing digital health company whose app — co-developed with Walmart and available to users directly or through their employers, health plans, or health providers — is designed to help people improve their lives by changing their eating habits. Fresh Tri does this by:

Training people in the Iterative Mindset, a resilient way of thinking that empowers people to transform their lives without performance-centric goals and tracking.

Choose and practice science-backed healthy-eating behaviors until they become habits.

Participate with others in interactive video mindset training sessions led by nationally recognized clinical experts.

Fresh Tri's latest release includes a chat-based check-in system that prompts users to reflect on the specific habit, or "Tri" (pronounced "try"), they are practicing in the app. Whether users have taken action, hit a snag, or gained an insight that can help them make better choices, the app guides them to notice what is and isn't working and to acknowledge the personal qualities that are helping them progress.
"Traditional goals-and-tracking methods backfire because any perceived failure triggers an area in the brain that kills motivation to keep trying," explains Fresh Tri founder and CEO, Kyra Bobinet, MD, MPH. "By training people to iterate — to practice and tweak daily habits — we help them overcome barriers of long-term change such as relapse, weight regain, plateaus, and self-doubt."
Users also can now send and receive "hearts" in the Tri(be) section of the app — though the app doesn't tally these acknowledgements the way "likes" are tallied on social media platforms.
"People want to support each other and feel acceptance and belonging, not competitiveness and self-judgment that often is felt on social-media," explains Bobinet. "In our system, appreciation is freely exchanged, while qualities such as compassion, honesty, resilience, and self-awareness are celebrated."
Fresh Tri is available to individuals through the App Store and Google Play. Fresh Tri is customizable to employers and healthcare organizations seeking to support weight loss and various other types of healthy-habit changes.
About Fresh Tri
Fresh Tri is a behavior-change technology company with offerings focusing on mindset, practice, and iteration. Fresh Tri's digital app trains users in a unique mindset, called the Iterative Mindset, inviting users to test-drive healthy habits, thereby removing the guesswork and feelings of guilt and shame that can often accompany efforts to adopt a healthy lifestyle. Fresh Tri guides users in a simple, positive, fail-safe approach based on the brain science of habit formation.The Fresh Tri solution draws on the success of a study the company conducted with Walmart associates that demonstrated Fresh Tri's method led to statistically-significant weight loss, habit formation, and improved psychological factors. Find out more about Fresh Tri: freshtri.com, Instagram, Facebook

"In our system, appreciation is freely exchanged, while qualities such as compassion, honesty, resilience, and self-awareness are celebrated."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The 5th annual Patients as Partners Europe event is the global gathering of patient advocates, pharma leaders and technologists will focus on greater clinical trial access as well as ease and participation for patients throughout Europe.

NEW YORK (PRWEB) NOVEMBER 13, 2020
The Conference Forum today announced the launch of the 5th annual Patients as Partners Europe event to be held virtually January 25-26, 2021. This global gathering of patient advocates, pharma leaders and technologists will focus on greater clinical trial access as well as ease and participation for patients throughout Europe.
"Collaboration between industry, patients, clinicians and researchers has never been more important than during the pandemic," said Berkeley Phillips, Medical Director at Pfizer and conference presenter. "The rapid expansion of digital technology, telemedicine and remote monitoring is transforming the way we run clinical trials and is re-designing new pathways of care with patients. These are positive changes and herald a brighter post COVID future."
Key Sessions Focused on Pharma R&D and Patient Advocacy in Clinical Trials include:

Joint Pharma-Patient Initiative on How Best to Incorporate the Patient Voice in the Pre-Clinical Phase. Representation includes Servier, Ipsen, and Parkinson's UK

Leveraging Critical Insights from Patients in All Trial Protocols to Create More Patient-Friendly Studies, with representation by GSK

First-of-Its-Kind Collaborative Initiative: Scaling a Patient Engagement Training Program, with representation from Janssen and Novartis

Key Sessions Focused on Decentralized Clinical Trials include:

The Patient View on Designing Hybrid Decentralized Trials

Decentralized Clinical Trials: Learnings from the Pandemic and What's Next to Support Patients and Investigators. Representation includes Bayer Pharmaceuticals, Cystic Fibrosis Trust and PT&R

Insights into The First Virtual Trial in IBS in the UK with representation from the NIHR

Key Sessions Focused on Patient and Industry Solutions to Engage Underrepresented Communities in Clinical Research with:

Prostate Cancer Patient Advocate

Centre for BME Health

Type 1 Diabetes Patient Advocate

Rheumatoid Arthritis and Fibromyalgia Patient Advocate

African-Carribean Community

Biogen

GSK

NIHR CRN Coordinating Centre

Other Key Sessions include:

Understanding the Challenges Faced By Carers and Implementing Strategies to Support Them

How Pharma Adapted to Support Patient Groups During COVID-19

Addressing the Reality of Underrepresented Communities in Clinical Research

Leaders in R&D and patient advocacy also speaking include: Anthony Yanni of Astellas, Laura McKeaveney of Novartis, Katherine Capperella of Janssen and others from Merck, Pfizer, Biogen, Bayer, GSK, Servier, Ipsen, Norgine, Akcea Therapeutics, as well as patients and other stakeholders.
To learn more, please visit Patients as Partners EU.
About Patients as Partners Europe
Patients as Partners Europe focuses on how to involve patients throughout the entire medicines development life cycle, to drive and enhance efficiencies in clinical research. This annual event brings together pharma R&D leaders, patient advocacy groups and patients alike who are invested in advancing patient involvement and collaboration in medicines development.         
About the Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around getting therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.

"The rapid expansion of digital technology, telemedicine and remote monitoring is transforming the way we run clinical trials and is re-designing new pathways of care with patients. These are positive changes and herald a brighter post COVID future." - Berkeley Phillips, Pfizer



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The companies plan to further develop science-based SaaS offerings by forming a strategic partnership and signing a Letter of Intent for Acquisition

NEWPORT BEACH, CALIF. (PRWEB) NOVEMBER 13, 2020
PEAR Sports today announced a strategic partnership with Pilates Metrics. PEAR is the leader in smart digital coaching technology for the fitness, health and wellness markets. Pilates Metrics is the first digital platform in the Pilates industry that allows studios and teachers to track, chart and share client progress. This partnership is part of the company's strategy to further AI-based coaching and wellness offerings and ultimately make it possible for providers to offer efficacious recommendations for preventive care and predictive analytics for healthcare professionals and insurance providers.
Pilates Metrics has built a patented Instructor App that converts completed Pilates sessions into anatomical and biomechanical statistics and graphs, aggregating totals over time. The companies' powerful combined offerings will create robust tools that will deliver a complete digital coaching solution to the health and wellness markets.
Bob Allison, Co-Founder and CEO of PEAR Sports said, "Integrating modalities into PEAR's Health & Fitness Platform that emphasize functional movement, mobility and recovery such as Pilates are key to providing scientific recommendations that improve population health and wellness. We want to focus on important areas including breathwork, body alignment, balance, and posture. Pilates Metrics' patented assets, technologies and experiences will help bring measurable results to customers."
"I'm thrilled to join with the PEAR Team and include integrated video, wearables, and postural assessments in the Pilates Metrics App," said Joseph Quinn, Founder and CEO of Pilates Metrics. "In time, PEAR Training Intelligencewill know when, where, what type, and how many Pilates sequences should be added to one's regimen to facilitate the best outcomes for everything from athletic performance to managing musculoskeletal disorders."
With over 15,000 instructors located across 50 countries, Polestar Pilates is an international authority in Pilates education and a long-time Pilates Metrics customer. Brent Anderson, President and CEO of Polestar Pilates, stated, "Pilates Metrics provides the evidence-based data collection necessary to provide consistency between our teachers and the ability to document outcomes of our clients. This is a must if we are to advance our profession and to truly measure outcomes as a direct result of our teaching Pilates."
PEAR Sports and Pilates Metrics are located in Southern California. This proximity will facilitate a seamless integration and encourage future innovation.
About PEAR Sports
PEAR Sports is perfecting the personalized delivery of digital health, wellness and fitness programs. Our platform and solutions deliver on-demand customized coaching that creates great experiences for customers and enterprises.
About Pilates Metrics
Pilates Metrics provides digital solutions for the Pilates industry with a mobile app for instructors, integrated studio services, and app customization for teacher-training programs. Pilates Metrics was selected by Pfizer Healthcare for their "Innovations in Health and Wellness" Cohort in 2016, Google's "Google for Entrepreneur Program" in 2017, and ScaleHealth's "Engine Program" in 2019.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss protocols to refine inclusion/exclusion criteria and methods to utilize/analyze investigator performance in type 2 diabetes trials. Attendees will learn about real-world data analysis and its role in site selection as well as the methodology of site list development.

TORONTO (PRWEB) NOVEMBER 13, 2020
At Covance, they know that time is of the essence across their diabetes trials. Developing these trials in the most cost-efficient manner makes upfront planning crucial, but interrogating the best data resources to augment team expertise is a difficult task. Covance understands that delays to the development of a well-defined site list are costly, and that selection of the wrong investigators could cost a company crucial time to market. They use a variety of data sources to guide early site selection, honing in on the best possible sites and countries upfront to pre-identify the most effective sites for a trial. Their extensive data repositories allow them to create a master site list without the need for long, overly time-consuming feasibility questionnaires.
This webinar will discuss Covance's well-refined internal process of site selection, and lessons learned that would benefit their industry partners in site selection. Panelists will discuss using comprehensive protocol or concept analysis of internally available studies to identify similar trials, how to incorporate sites from investigator performance databases driven by trial expertise, using data to hone in on specific patient locations, and using all of this to develop strong site lists to save time and money in early study planning and site selection.
Join expert speakers from Covance, Kevin Melvin, Executive Director, Operational Strategy & Planning, Cardiovascular, Metabolic, Endocrine and Renal; Earl Seltzer, Sr. Director, Feasibility and Site Selection; and J.B. Flinders, MPH, MBA, Sr. Director, Operational Strategy & Planning in a live webinar on Thursday, December 3, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit The Value of Early Site Selection in Type 2 Diabetes Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The San Diego nonprofit releases their 2019-2020 Annual Impact Report, highlighting the immense influence in lives across the County.

SAN DIEGO (PRWEB) NOVEMBER 13, 2020
Serving Seniors, a San Diego-based nonprofit helping older adults in poverty live fulfilling lives through health-promoting services, today released its annual impact report. The report highlights the organization's steadfast dedication to the senior community throughout San Diego County by helping them live in health and happiness.
"From the beginning, we have identified and worked to help San Diego's most vulnerable population, our seniors," said Paul Downey, President/CEO of Serving Seniors. "I could not be prouder of our team for providing record-breaking levels of service under difficult circumstances caused by COVID-19."
Over the past five decades, Serving Seniors has grown from a single site in downtown San Diego with the mission of providing one meal a day, to having 15 locations across the county and bringing a wraparound support system of services. The 2019-2020 fiscal year marked several new milestones for the organization with a record number of clients and meals, to expanding their nutrition and housing programs into new areas of San Diego County.
The nonprofit organization brings a unique, whole-person approach to its mission and this approach is the cornerstone of their comprehensive offerings. From nutrition to large-scale advocacy for the community, Serving Seniors broke records across the board in their mission to ensuring that low-income seniors have their most basic needs met to live happy and healthy lives. The organization's 2019-2020 annual impact report highlights these achievements and puts tangible numbers to their commitment to the community:
Nutrition:
-- Surpassed 950,000 meals served in a single year
-- Fed over 7,300 San Diego County seniors
-- Increased food security for 92% of clients
-- Reduced healthcare costs for 39% of seniors
Housing:
-- Broke ground on its fourth affordable housing residence
-- Housed 500 seniors
-- Increased housing navigation services and transitional units for homeless seniors
-- Provided over 400 affordable housing units for financially insecure seniors
-- Had 83% of transitional housing graduates move into permanent housing
Health & Social Services:
-- Performed over 8,500 social service visits
-- Increased knowledge of chronic health conditions and how to prevent them for 90% of seniors
Enrichment & Activities:
-- Improved social health for 78% of seniors with over 900 activities during a pandemic
-- Increased social interaction and forging new friendships for 92% of seniors
The work of Serving Seniors would not be possible without the generosity of its donors and the help of more than 576 volunteers. Those volunteers serve meals, teach classes, host social activities, and so much more.
In addition to the compassion of volunteers, Serving Seniors staff bring the mission of the organization to life and are the heart of the organization. Serving Seniors was named a San Diego Union Tribune Top Workplaces in 2020. This award is determined solely through employee feedback and further shows that Serving Seniors mission is a thread that weaves through every employee and unifies the entire organization to continue doing great work.
To learn more about Serving Seniors mission and programs, please visit http://www.servingseniors.org.
About Serving Seniors
Founded in 1970, Serving Seniors is a 501(c)(3) nonprofit organization based in San Diego, California, dedicated to serving low-income adults aged 60 and over. A leader in senior advocacy and programming, Serving Seniors has created an innovative model of comprehensive services including nutritional meals, housing, health and social services and lifelong learning opportunities to hundreds of seniors in need. It is the largest provider of meals to seniors in the county, and one of the only organizations in the nation providing such a robust range of services to vulnerable, at-risk older adults.
Serving Seniors President and CEO Paul Downey has been instrumental in the organization's growth over the past 25 years. Since being appointed the role in 1995, Downey has guided the nonprofit's innovative efforts to provide supportive services focused on keeping low-income seniors healthy and independent.
Media Contact:
Lindsay Denietolis
lindsay@theforumpr.com
760-525-8857



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CallFinder, the market-leading provider of SaaS speech analytics technology and call center solutions, unveils a new release that empowers businesses to optimize conversational interactions and enhance the customer experience.

BURLINGTON, VT. (PRWEB) NOVEMBER 13, 2020
CallFinder, the market-leading provider of SaaS speech analytics technology and automated quality monitoring solutions, announced a new release that provides businesses with greater insights into customer interactions to improve CX and reduce customer churn.
This release marks the official launch of Insights, which includes sentiment analysis by agent, in conjunction with silence and overtalk, developed to help organizations meet the increasing demands of the modern contact center. CallFinder's Insights provides context and meaning to customer interactions for a broader understanding of how customers experience products, services, or brands, through the conversations they have with contact center agents.
The experts behind Insights understand that the customer experience is part of a multi-faceted approach to identifying the behaviors that result in positive outcomes and ensuring that agents have the right skills to reach those outcomes. With the release of Insights, CallFinder delivers on its commitment to offer an affordable, accessible, and flexible AQM solution that helps businesses of all sizes understand what ultimately drives revenue—their customers.
By measuring periods of silence and overtalk, along with sentiment analysis, Insights provides expanded agent performance information, identifying agent gaps in listening skills, unprepared employees who need refreshed training on scripts or other tools, and common customer pain points. Together, the sentiment and conversation metrics extracted from Insights help uncover dissatisfaction events to quickly reveal why customers are upset and proactively train call center employees accordingly to mitigate future occurrences.
Insights shows the percentage of silence within a call for both the customer and agent, and how often the caller and agent spoke at the same time (overtalk events). Additionally, silence and overtalk unlocks insights on how agents are trained and even the tools they use to assist customers.
Calls with longer periods of silence, for instance, may be symptomatic of gaps in agent training, such as the agent taking too long to provide an answer. Long silences can also indicate technical issues with the agent's software, or any number of snags that reduce operational efficiency and potentially leave the agent with an angry customer.
"We're continuing to evolve the CallFinder solution to meet the needs of our clients and empower them to efficiently enhance the customer experience. Our continued drive to transform customer operations has led us to develop this most recent CallFinder release. Insights provides deeper analytics and a viewpoint into the context and sentiment of interactions and does so quickly and automatically with our dynamic and AI-fueled solution," says Laura Noonan, SVP of Sales and Marketing for CallFinder.
Combined with CallFinder's automated scorecards, Insights will identify whether an agent simply needs help with basic skills (following or deviating from a script), if more nuanced training is needed to improve soft skills, or if other issues are at play. Ultimately, detecting silence and overtalk during conversations ensures that agents are supporting customers in the best way possible. This not only improves the customer experience that they deliver, but it also can drive business growth for their organization.
About CallFinder:
CallFinder is the leading provider of managed cloud-based SaaS speech analytics, automated call scoring, and speech-to-text transcription with conversational insights, such as sentiment analysis and emotion detection.
Our easy-to-use, affordable, and flexible solution helps small and medium-sized businesses with both contact center and remote agents automate quality monitoring to improve agent performance and provide a superior customer experience.
Learn more about CallFinder at http://www.mycallfinder.com and schedule a demo today



START your own Wordpress site, business or personal website, or online store at www.siteground.com

American Heart Association Award Recognizes Queen of the Valley Hospital and Foothill Presbyterian Hospital's commitment to quality stroke care.

COVINA, CALIF. (PRWEB) NOVEMBER 13, 2020
Emanate Health Queen of the Valley Hospital (QVH) and Emanate Health Foothill Presbyterian Hospital (FPH) have both received the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital's commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
QVH and FPH earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, get a follow-up visit scheduled, as well as other care transition interventions
"Emanate Health is dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association's Get With The Guidelines-Stroke initiative," said President & CEO Robert H. Curry. "We're proud to use these tools and resources to help us better track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes."
QVH also received the Association's Target: StrokeSM Honor Roll Elite Award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient's arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
In addition, QVH and FPH both received the Association's Target: Type 2 Diabetes Honor Roll Award. To qualify for this recognition, hospitals must meet quality measures developed with more than 90 % of compliance for 12 consecutive months for the "Overall Diabetes Cardiovascular Initiative Composite Score."
"We are pleased to recognize Emanate Health for their commitment to stroke care," said Lee H. Schwamm, M.D., national chairperson of the Quality Oversight Committee and Executive Vice Chair of Neurology, Director of Acute Stroke Services, Massachusetts General Hospital, Boston, Massachusetts. "Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates."
According to the American Heart Association/American Stroke Association, stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.
About Emanate Health
Emanate Health is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women's Health. Its family of hospitals and hospice include Emanate Health Inter-Community in Covina, Emanate Health Queen of the Valley in West Covina, Emanate Health Foothill Presbyterian in Glendora, Emanate Health Hospice and Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted "Best Hospital" and "Best Place to Work" and providers are consistently among the "Top Doctors" in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn │Twitter │ Instagram │ Facebook.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The University of Maryland (UMD) recently received a grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) to develop a next-generation food safety risk assessment model by combining emerging techniques in both food safety and machine learning. With this new funding, UMD is paving the way to a more robust food safety risk assessment model that combines computational techniques, genomic and microbial data, and machine learning to improve the management of foodborne illness and better protect public health.

COLLEGE PARK, MD. (PRWEB) NOVEMBER 13, 2020
The University of Maryland (UMD) recently received a grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) to develop a next-generation food safety risk assessment model by combining emerging techniques in both food safety and machine learning. With vast genomic data on foodborne pathogens such as Salmonella now available through whole genome sequencing, there exists the new potential to substantially improve public health through more specific food safety risk assessments that can better predict the risk of outbreaks and guide strong risk management decisions at the policy level. However, big data analytics approaches such as artificial intelligence (AI) and machine learning have yet to be leveraged in the field of food safety to integrate this genomic data with pathogen characteristics of interest to risk assessors. With this new funding, UMD is paving the way to a more robust food safety risk assessment model that combines computational techniques, genomic and microbial data, and machine learning to improve the management of foodborne illness and better protect public health.
"I am so excited about this grant award, as it gives us the resources to conduct cutting-edge research on food safety and risk assessment, which is very important in controlling foodborne diseases and protecting public health," says Abani Pradhan, associate professor in Nutrition and Food Science at UMD and lead investigator of this work. "AI as an emerging technology can take advantage of big data available in the agriculture and food sectors and has the potential to integrate food production, processing, food safety risk factors, and genomic data that can transform public health strategies to prevent foodborne diseases and rapidly respond to outbreaks."
The advancement and applications of big data analytic techniques like AI and machine learning have significantly gained momentum across various fields, including transportation, manufacturing, healthcare, and even finance. However, according to Pradhan, applications in agriculture and food are just starting to get attention with the simultaneous progress of bioinformatics and genomic data presenting a clear opportunity for the advancement of food safety risk assessment. Alongside the expertise of co-investigators Jianghong Meng, director of the UMD Joint Institute for Food Safety and Applied Nutrition (JIFSAN) and the Center for Food Safety and Security Systems (CFS3), Hector Corrada Bravo, associate professor in Computer Science at UMD, and Marc Allard as a collaborator from the U.S. Food and Drug Administration (FDA), Pradhan and his team are poised to lead the way in combining these tools to develop a next-generation quantitative microbial risk assessment (QMRA).
"Risk assessment is an important area that has great significance to food safety," explains Pradhan. "It is a holistic approach to food safety and is the umbrella under which all food safety information can be organized systematically to control the risk of foodborne diseases by providing a scientifically-sound basis for informed risk management and policy decisions."
Food safety risk assessment generally involves the scientific evaluation of adverse public health effects resulting from exposure to foodborne hazards. QMRA specifically uses mathematical and statistical models to understand, predict, and prevent risks presented by foodborne pathogens like Salmonella, E.coli, Listeria, and many more. According to the Centers for Disease Control and Prevention (CDC), foodborne illnesses affect an estimated 1 in 6 Americans every year and in extreme cases cause hospitalization and even death, making foodborne disease outbreaks a serious public health concern.
QMRA can be used to predict the behavior and transmission of pathogens across the food production, processing, and supply chain, identify areas in the chain that could lead to contamination, and estimate the probability and consequence of adverse public health effects in the event that tainted products are consumed. QMRA models incorporate uncertainties and variabilities in different steps of the farm-to-fork pathway in order to obtain an accurate indicator of the risk posed by the foodborne pathogen.
As Pradhan explains, this is why integrating genomic data using big data analytics techniques is so important. "The sheer abundance of information by including molecular and genomic data available should increase the robustness of disease risk estimates by reducing the sources of uncertainty and variability in the QMRA model. This is important because there are so many different species of each foodborne pathogen, and even within the same species, there are different variations or types called serovars."
Pradhan and his team are focusing on Salmonella with this particular work to develop the framework to be applied to other foodborne pathogens, particularly because Salmonella has so much available data and so many different variations to account for. Salmonella enterica specifically is a subspecies of this pathogen that causes about 1.2 million cases of foodborne illness each year and consists of over 2,500 serovars with highly variable characteristics. How resistant the pathogen is to heat stress or antimicrobials, how infectious it is, and how quickly it grows and spreads are all characteristics of the pathogen that can be partially explained by genomic data.
"The idea is to connect that genetic information with the characteristics of the pathogen to bridge the gap between the genes and the food safety aspects for consumers," says Pradhan. "If we can use machine learning tools to understand the linkages between genotypes [genetic information] and phenotypes [physical traits], based upon that we can determine which serovars are the most concerning so that we can focus our experimental work on those types and further strengthen our models to create a risk assessment that provides a more robust and complete picture of the risk for risk mitigation."
This cutting-edge work is just one of the ways that Pradhan and his lab, along with colleagues at JIFSAN and CFS3, focus on innovation for the future of food safety. "We have continued to conduct innovative and interdisciplinary research to improve the safety of the global food supply and public health by integrating experimental and field data with mathematical modeling, and developing predictive and risk models that will aid in guiding stakeholders like policy makers, government agencies, and the food industry. I always try to be innovative and focus on the future, and big data analytics and machine learning are the future of predictive modeling and food safety risk assessment. I'm super excited about this work because it ties together all these different components to improve public health."
This work is funded by the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA), Award #2020-67017-30785.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The new HandScanner from Datalogic is the smallest and lightest non-intrusive hands-free scanner that streamlines workers' daily operations. Using the HandScanner workers are faster, more efficient and improve the quality of their work saving 4 seconds per scan and cut reading errors by up to 33%. The HandScanner is designed to be always up and running delivering up to 15 hours of operation and 10,000 scans; it is fully recharged in only two hours using its 2-slot charging station.

EUGENE, ORE. (PRWEB) NOVEMBER 13, 2020
Datalogic, a global leader in automatic data capture and factory automation, is pleased to announce the launch of the new HandScanner, the smallest and lightest non-intrusive hands-free scanner designed to streamline workers' daily operations. This wearable device allows workers to use both hands for faster picking of goods or parcels, expanding their productivity dramatically.
Paired with Datalogic mobile computers, the HandScanner helps streamline processes to eliminate wasted time and steps. Using the HandScanner workers are faster, more efficient and improve the quality of their work saving 4 seconds per scan and cut reading errors by up to 33%.
The ergonomic design of the HandScanner delivers higher 1D and 2D barcode scanning accuracy, faster scanning tasks, and dramatic error reduction. Workers can easily interact with objects while wearing the HandScanner; it comfortably accommodates to the operators' natural motions. In addition, users are notified of each successful scan with optical, acoustic, and haptic technology feedback, so they can quickly proceed to the next step.
Compared to ring scanners, the HandScanner is thinner and has the unique advantage of being positioned on the back of the hand. Unlike a ring scanner that is held on the fingers of the worker, the HandScanner is not intrusive, more resistant, and is not exposed to bumps at every movement.
Many environments benefit from the HandScanner. Vertical markets such as Transportation and Logistics, Manufacturing, Retail, and Healthcare will benefit from its flexibility and versatility. With it, workers perform picking, packing, palletizing, receiving, sorting, shipping, store inventory, price checking, assembly, replenishment, finished product verification, pharmaceutical and laboratory warehouse management.
Customers can optimize the HandScanner's capabilities by choosing the model that best suits their requirements. The HandScanner is available in two versions: Standard Range is designed for close range scanning, between 10 to 80 cm / 3.9 to 31.4 inch, and fits well for Manufacturing, Retail and Healthcare applications. The Mid-range model has a 30 to 150 cm / 11.8 to 59 inch scanning range and is the perfect solution for Transportation & Logistics environments like warehouses, plant floors, docks, and stock yards.
The HandScanner is designed to be always up and running, delivering up to 15 hours of operation and 10,000 scans; it is fully recharged in only two hours using its 2-slot charging station.
When the device is in use, data transfers automatically to a connected smartphone, mobile or industrial computer, or tablet through Bluetooth Low Energy connectivity.
The HandScanner is easily paired with Datalogic handheld devices including the Memor 10 and Memor 20 and vehicle mount computers like the Rhino II, providing workers with a complete and top performing data collection solution.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Vinyl trade association recognized 36 facilities with 52 awards for outstanding performance and two individuals for their commitment and service to the vinyl industry.

WASHINGTON (PRWEB) NOVEMBER 13, 2020
The Vinyl Institute (VI), the U.S. trade association representing manufacturers of vinyl resin, vinyl chloride monomer (VCM), additives, and modifiers, announced recipients of its annual health, safety and environmental awards, which are given to companies in the vinyl industry for safeguarding workers and protecting the environment at manufacturing facilities throughout the United States and Canada. This year, VI recognized 36 facilities with 52 awards for outstanding performance.
These awards are based on facility performance according to Occupational Safety and Health Administration (OSHA) recordable incidents, the U.S. Environmental Protection Agency's (EPA) National Emissions Standards for Hazardous Air Pollutants (NESHAP), other regulatory permit performance, and the EPA's Toxic Release Inventory data for air and water during the 2019 calendar year.
"Our industry is fully committed to the safety of our workers and environmental practices, and this is evident by the large number of awards we're presenting this year," said VI President and CEO Ned Monroe. "Worker health and safety continues to be a long-term goal in our sustainability journey, and we're proud of the major investments our member companies have made and continue to make to ensure employee health and safety and in finding additional ways to reduce emissions. In fact, our resin and monomer producer members have an occupational injury and illness rate that is less than one third of the chemical industry. And since 1987, VCM emissions have reduced by 88 percent, while PVC resin production has increased by 100 percent."
Each year, VI proudly recognizes facilities in the PVC, EDM/VCM, plasticizer production, additive production and chlorinated PVC compounding categories that have achieved outstanding performance in four categories: Safety Excellence, Safety Performance, Environmental Excellence and Environmental Honor.
Safety Excellence Award
This award recognizes consistent adherence to OSHA safety regulations and recognizes plants with five or more consecutive years with no recordable incidents. This award was presented to:

Formosa Plastics Corporation, PVC Compounding plant, Point Comfort, TX (9 consecutive years of performance)

Oxy Vinyls LP, EDC/VCM plant, Deerpark, TX (7 consecutive years of performance)

Shintech Louisiana LLC, PVC plant, Plaquemine, LA (7 consecutive years of performance)

Westlake Vinyls Company LP, PVC plant, Geismar, LA (10 consecutive years of performance)

ExxonMobil Chemical Company, Plasticizer/Additive Manufacturing plant, Baton Rouge, LA (8 consecutive years of performance)

GEON Performance Solutions, PVC Compounding plant, Long Beach, CA (6 consecutive years of performance)

Teknor Apex Company, Plasticizer/Additive Manufacturing plant, Brownsville, TN (6 consecutive years of performance)

Safety Performance Award
This award recognizes efforts to improve worker safety based upon federal OSHA recordable incidents, which are defined as an occupational injury or illness resulting in medical treatment. This award, which recognizes plants with no recordable incidents for the reporting year, was presented to:

Formosa Plastics Corporation, EDC/VCM plant, Point Comfort, TX

Formosa Plastics Corporation, EDC-only plant, Point Comfort, TX

Formosa Plastics Corporation, PVC plant, Point Comfort, TX

Formosa Plastics Corporation, PVC Compounding plant, Point Comfort, TX

K-Bin Inc., PVC Compounding plant, Freeport, TX

Occidental Chemical Corporation, EDC-only plant, Convent, LA

Occidental Chemical Corporation, EDC-only plant, Geismar, LA

Occidental Chemical Corporation, EDC/VCM plant, Ingleside, TX

Oxy Vinyls LP, PVC plant, Pedricktown, NJ

Oxy Vinyls LP, EDC/VCM plant, Deerpark, TX

Shintech Inc., PVC plant, Freeport, TX

Shintech Louisiana, LLC, PVC plant, Plaquemine, LA

Westlake Chemical Corporation, PVC plant, Calvert City, KY

Westlake Chemical Corporation, Plasticizer/Additive Manufacturing plant, Aberdeen, MS

Westlake Chemical Corporation, PVC/CPVC Compounding plant, Aberdeen, MS

Westlake Chemical Corporation, Lake Charles North EDC/VCM plant, Westlake, LA

Westlake Chemical Corporation, Lake Charles South EDC-only plant, Westlake, LA

Westlake Chemical Corporation, Lake Charles South EDC/VCM plant, Westlake, LA

Westlake Compounds LLC, PVC Compounding plant, Prairie, MS

Westlake Vinyls Company LP, EDC/VCM plant, Geismar, LA

Westlake Vinyls Company LP, PVC plant, Geismar, LA

Dow Chemical Company, Plasticizer/Additive Manufacturing plant, Louisville, KY

Eastman Chemical Company, Plasticizer/Additive Manufacturing plant, Chestertown, MD

Eastman Chemical Company, Plasticizer/Additive Manufacturing plant, Kingsport, TN

ExxonMobil Chemical Company, Plasticizer/Additive Manufacturing plant, Baton Rouge, LA

Lubrizol Advanced Materials Inc., PVC plant, Louisville, KY

Lubrizol Advanced Materials Inc., CPVC Compounding plant, Louisville, KY

Vestolit USA, PVC plant, Henry, IL

GEON Performance Solutions, PVC Compounding plant, Long Beach, CA

GEON Performance Solutions, PVC Compounding plant, Pasadena, TX

GEON Performance Solutions, PVC Compounding plant, St. Remi, Quebec

GEON Performance Solutions, PVC Compounding plant, Terre Haute, IN

Teknor Apex Company, Plasticizer/Additive Manufacturing plant, Brownsville, TN

Environmental Excellence Award
This award is based on outstanding track record of performance for five or more consecutive years under EPA's NESHAPs, and other environmental permit requirements. The following facilities demonstrated continued outstanding performance in 2019:

Formosa Plastics Corporation, EDC-only plant, Point Comfort, TX (8 consecutive years of performance)

Formosa Plastics Corporation, PVC Compounding plant, Point Comfort, TX (9 consecutive years of performance)

Occidental Chemical Corporation, EDC-only plant, Convent, LA (8 consecutive years of performance)

Westlake Chemical Corporation, Plasticizer/Additive Manufacturing plant, Aberdeen, MS (7 consecutive years of performance)

Westlake Chemical Corporation, PVC/CPVC Compounding plant, Aberdeen, MS (7 consecutive years of performance)

GEON Performance Solutions, PVC Compounding plant, Avon Lake, OH (6 consecutive years of performance)

GEON Performance Solutions, PVC Compounding plant, Long Beach, CA (6 consecutive years of performance)

GEON Performance Solutions, PVC Compounding plant, Pasadena, TX (6 consecutive years of performance)

GEON Performance Solutions, PVC Compounding plant, Terre Haute, IN (6 consecutive years of performance)

Lubrizol Advanced Materials Inc., CPVC Compounding plant, Louisville, KY (5 consecutive years of performance)

Environmental Honor Award
The criteria for this award includes emissions reduction under the NEHSAP, the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), and EPA's Toxics Release Inventory (TRI) data for air and water. This award is presented to two plants, one in the PVC category and one in the EDC/VCM category. The facilities achieving this award for performance during 2019 were:

EDC/VCM category: Westlake Chemical Corporation, EDC/VCM plant, Calvert City, KY

PVC category: Formosa Plastics Corporation, SPVC plant, Point Comfort, TX

2020 Lifetime Achievement Award
In addition to the Health, Safety and Environmental Awards, the VI bestowed the Lifetime Achievement Award to an outstanding individual at Vinyl360. The Lifetime Achievement Award recognizes outstanding service to the vinyl industry during a person's career. This year's recipient was the T.T. Chao Family, of Westlake Chemical Corporation, for their lifelong commitment to innovation and growth of the U.S. vinyl industry.
2020 Partner of the Year Award
Finally, VI recognized Richard Church, Executive Director of the Plastic Pipe & Fittings Association, as Partner of the Year, for his continued contributions to the vinyl and PVC pipe industries, and advocacy for fair standards and regulations for industry members.
###
About the Vinyl Institute:
The Vinyl Institute (VI), founded in 1982, is a U.S. trade association representing the leading manufacturers of vinyl, vinyl chloride monomer, vinyl additives, and modifiers. The VI works on behalf of its members to promote the benefits of the world's most versatile plastic, used to make everything from PVC piping to flooring, roofing and vinyl siding. The vinyl industry in the United States employs over 350,000 highly skilled employees at nearly 3,000 facilities and generates an economic value of $54 billion. For more information, visit vinylinfo.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The partnership between technology innovators addresses an urgent need for contact tracing and safe distancing approaches in response to COVID-19 to ensure health and safety for essential workers and high-risk nursing home residents.

NEW YORK (PRWEB) NOVEMBER 13, 2020
According to the CDC, 42% of coronavirus-related deaths reported in the US were in senior living and nursing home facilities, with adults 65 years and older responsible for 8 out of 10 deaths.
Today, VivaTrace, a pioneer in senior community contact tracing solutions, announces its strategic partnership with Vantage, one of the world's leading technology innovators in real-time locating systems (RTLS).
The integration of VivaTrace's software and Vantage's RTLS technology creates a platform to quickly retrace the path of an infected individual, understand who they have come in contact with, and the duration for which they have been exposed. The platform automates the tracing process to be completed in seconds, without the arduous and imperfect method of interviewing individuals and relying on memory recall.
Challenges of Contact Tracing in Nursing Homes and Senior Living Communities
Nursing homes and senior living communities house a population highly vulnerable to the virus. Understanding each individual a person may have come in contact with and pinpointing a timeframe that could span from a few minutes to two weeks, is a formidable task. Further, relying on effectively tracing through the recollection from residents who, in certain cases, may unfortunately struggle with memory retention, adds another layer of complexity to contact tracing in nursing homes and senior living communities.
VivaTrace's contact tracing solution, powered by Vantage's RTLS technology, strengthens traditional, costly, manual efforts, while delivering unprecedented value in response time, visibility, and reporting at a fraction of the cost. Operators can leverage this unique capability to instantly identify every resident, employee and visitor who may have been exposed.
When a person is showing symptoms or has tested positive, facilities can now quickly sanitize and disinfect all of the areas the person has visited. VivaTrace provides immediate visibility into the areas visited by the carrier so that staff can use enhanced disinfection and testing protocols in these spaces.
Unlike popular contact tracing mobile phone applications, VivaTrace's solution relies on feather-light bracelets for the highest level of wearability, sanitization, and ease of use. This allows nursing home communities to seamlessly ensure compliance of all persons in their facilities, without the expense, sanitation risks, and complexities of managing mobile phones.
Senior living residents enjoy a greater quality of life when they are able to maintain social interactions, which is why VivaTrace and Vantage are working tirelessly to develop solutions that limit exposure and empower operators to confidently allow social engagement. "When we've spoken to these facilities, their biggest concern is obviously the safety of their staff, residents, and visitors. Beyond limiting outbreaks, they're looking to return to some form of social interaction that their residents once knew, whether that be small group activities, one on one programs, or a limited number of visitors," remarked Alex Margovsky, VivaTrace's CEO. He continued, "It is our mission to safely reunite residents with the activities and people that they love, which is why we've partnered with Vantage."
"In a time where personal relationships matter more than ever, it's critical that we equip the organizations that serve our most vulnerable populations with the quality care technology they desperately need," commented Philip Edgell, Vantage's President. "Our resident journey platform, combined with VivaTrace's intuitive software creates a powerful tool in the drive to keep senior living facilities safe while allowing them to continue supporting a wellness culture."
Head Administrator at Harbor House Assisted Living, Krystal Ross, commented:
"The peace of mind that VivaTrace has afforded our organization cannot be overstated. Being able to tell our resident families that we have an existing layer of security lends even more importance to the precautions that we have taken, and continue to take, to protect our communities."
Located in Long Island, the leading dementia care facility is currently piloting the platform, with subsequent facility rollouts scheduled for Q4 of 2020 and Q1 of 2021.
About VivaTrace
VivaTrace is a data driven contact tracing company headquartered in New York, NY. The privately held company was started by Health IT leaders with decades of experience as trusted business partners to some of the world's largest healthcare systems in a coordinated COVID-19 response.
VivaTrace supports local and regional customers with an extensive coverage footprint throughout North America. By providing digitally connected and automated contact tracing, IoT and a fully end-to-end solution, we are setting a new bar for infectious disease management and response.
To learn more, visit VivaTrace here: https://www.vivatrace.com, and follow us on LinkedIn at https://www.linkedin.com/company/vivatrace.
About Vantage
Headquartered in Vancouver, Canada, the Vantage platform has been designed to understand user behaviors, and by doing so, improve their experiences. Using a combination of real-time tracking technology and smart wearable devices, Vantage links this information to a user, creating invaluable insights that can be leveraged in real-time.
Vantage's contact tracing technology gives senior care residences and nursing homes the ability to see everyone an infected individual has come into contact with, within in seconds. When speed and accuracy are critical, our solution becomes an integral component of a facility's COVID-19 control measures.
Vantage is a subsidiary of WhiteWater, the world's leading water park manufacturer with a portfolio that includes many of the largest brands in the attractions industry.
To learn more, visit https://vantage.co/contact-tracing-for-senior-living-residences and follow us on LinkedIn at https://www.linkedin.com/company/vantage-technology-ltd/.
Media Contacts
Krista Kaszycki
VivaTrace
kkaszycki@vivatrace.com
Dawn Kirby
Vantage
dawn.kirby@vantage.co



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NJ Top Docs has reviewed and approved South Jersey doctor, Dr. Pooja Malik of Malik Medical Aesthetics for 2020.

SCOTCH PLAINS, N.J. (PRWEB) NOVEMBER 13, 2020
NJ Top Doc, Dr. Pooja Malik of South Jersey is a board-certified family medicine doctor specializing in aesthetic and cosmetic medicine. Dr. Malik has a special interest in anti-aging medicine and completed an Advanced Fellowship with the American Academy of Anti-Aging and Regenerative Medicine. She also completed a postdoctoral fellowship in International Health at Johns Hopkins University.
"At Malik Medical Aesthetics, your beauty, health, and wellness are our priority. We offer medical spa treatments and services so patients can look and feel their best," says Dr. Malik.
From Botox injections, dermal fillers, to laser resurfacing, body contouring and even customized weight loss programs, Dr. Malik's team is committed to offering a variety of medical spa treatments while providing excellent results.
"Patient safety has always been our top priority and we have implemented stringent safety COVID-19 protocols keeping up with the latest recommendations from the CDC," Dr. Malik adds.
Dr. Malik's quality of care is uncompromising and equaled only by her compassionate demeanor and bedside manner.
To learn more about this NJ Top Doc, please visit: https://njtopdocs.com/nj-doctors/pooja-malik/
---
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Winpak will continue to be the source of packaging materials used to create the finished products, designed with a specialized configuration to hold the liquid. Going forward, the collaboration provides more evidence of what can be accomplished when people work together for the common good. Congratulations to all three companies for their ability to get it done in an unprecedented time of need.

SAN BERNARDINO, CALIF. (PRWEB) NOVEMBER 13, 2020
When the phone rang one morning just before Labor Day at the offices of Winpak Lane in San Bernardino, Calif., the backlog of orders for their Vertical Form-Fill-Seal (VFFS) packaging machines was the largest in the company's history. Still, the customer who called was placing an order for a machine to support COVID vaccine shipment.
The global health community is racing to deliver as many doses as possible of coronavirus vaccine by the beginning of 2021. The vaccine will require specialized packaging and refrigerant mats designed to maintain the vaccine at a specific temperature range during shipping. The Winpak customer had already stepped up production to create the needed product, going from 40-hour work weeks to running their existing VFFS machines for 168 hours a week. Now they needed more; the distribution chain had upped its requirements.
"The only way to meet this customer's quicker-than-normal deadline for getting a third machine to produce more refrigerant mats was to get one of our other customers to accept a later delivery date on the machine we were building for them," said Mark Griffin, Winpak Lane Director of Sales. "I started making calls immediately."
One of the customers Griffin reached out to was Matt Miller, CEO of Branded Sanitizer Packets in Henrico, Va. His company makes customized, 1.5ml single-use gel sanitizer packets, producing more than a million a day. "Our Mission is to create a safe, sustainable solution to a problem our world faces in the coronavirus era. The new machine we were expecting from Winpak Lane would give us the ability to increase our capacity and offer key product enhancements." Miller said. "When I received the call from Mark Griffin, the decision to help by delaying delivery of our machine was easy. After all, our idea was born to support our world's growing need, and there is no greater need right now than a vaccine."
Shipping mats with phase-change technology
"The packaging material used to manufacture the shipping mats for the vaccine protection project needed a specifically blended sealant that would seal through the liquid inside to maintain optimal liquid distribution," Griffin said. "We had developed this technology for a customer six years ago when we sold them their first machine. The process was re-engineered to meet specific conditions relevant to the coronavirus vaccine. These refrigerant shippers are designed for a specific size, based on how many BTUs of cooling capability it needs to have."
In addition to manufacturing machinery for packaging, Winpak has four other divisions, one of which specializes in high performance laminated film. That Winnipeg, Canada location had to ramp up and find spots in its manufacturing schedule to produce the massive quantities of the high-barrier film that would be needed to support the shipping mat production.
Branded Sanitizer Packets stepping up by stepping back
Branded Sanitizer Packets (BSP) is currently providing customizable 1.5ml single use sanitizer gel packets to retail, food service, hospitality, government agencies, and nearly every other industry in today's world. To meet the growing demand, BSP had spent the previous six months customizing a new machine with Winpak engineers. This state-of-the-art machine was designed to enable more product features as well as to double their existing manufacturing capability.
"Our goal was to take a problem and turn it into an opportunity for brands in this new world," Miller said. BSP's focus is empowering brands to use these packets to connect to their customers in new ways, printing anything on them from custom messages, to QR codes that link to a menu, rewards program, or other customer engagement initiatives. "When you are in the business of helping people, you have to be able to walk the talk." Miller admitted. "Losing our spot in line was a big hit to our fourth quarter plans, but when Mark called, it was about being a part of something bigger."
A win-win-win effort
All three companies will benefit in different ways from the breakneck collaboration. "We were fortunate to be able to satisfy an urgent need for a Winpak Lane customer," Griffin admitted. "Likewise, as our thanks to Branded Sanitizer Packets for stepping up, we changed their payment terms, delaying most of the balance until just before the replacement machine is ready to ship."
In addition, Winpak will continue to be the source of packaging materials used to create the finished products, designed with a specialized configuration to hold the liquid. Going forward, the collaboration provides more evidence of what can be accomplished when people work together for the common good. Congratulations to all three companies for their ability to get it done in an unprecedented time of need.
About Winpak
Winpak Ltd. manufactures and distributes high-quality packaging materials and related packaging machines. The Company's products are used primarily for the protection of perishable foods, beverages, and in health-care applications.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

The collaboration helps further establish the two brands as household names in the California cannabis space

LOS ANGELES (PRWEB) NOVEMBER 13, 2020
El Blunto, California's top blunt producer, announced the release of four special edition product lines made with top-shelf flower from Glass House Farms. These special edition runs will include an El Bluntito single, crafted with the popular strain MAC1, an El Bluntito 4-Pack made with Purple Gelato, and two classic El Bluntos, one rolled with Triple Chocolate Chip and another rolled with Runtz.
"We have long admired the way Glass House does business. Their reputation precedes them; they deliver premium quality product and are a delight to deal with." said Q. Ladraa, CEO of Albert Einstone's, El Blunto's parent company. "We are both quality and community-driven brands that put our customers' wellbeing first, and we expect this is the first of many collaborations."
El Blunto's signature product, The World's Finest Cannabis Cigar, is a tobacco-free blunt that features 1.75 grams of top-shelf high-testing cannabis. The full flower used is hand-broken, never ground, then hand-rolled in an all-natural fiber wrap, cured for 72- hours, and finished with a glass filter.
Glass House Farms is founded on the belief that a cannabis brand can not only deliver a top quality product but do so while being both state-of-the-art and eco-friendly. Harnessing coastal California's sunshine and utilizing cutting-edge, sustainability minded environmental controls, they put true expertise to work in sourcing and cultivating the finest strains of cannabis flower, while cultivating a deep commitment to community and respect for cannabis' history.
"The Glass House Team puts an immense amount of love and care into what we grow and the El Blunto team brings that same care to the finest cannabis cigars. We couldn't be prouder to showcase the quality of our flower in these top-quality, super-enjoyable products. They're the perfect marriage of flower and format." said Graham Farrar, Founder of Glass House Farms.
The El Blunto and Glass House Farms collab will be available in dispensaries beginning November 13th, 2020.
About El Blunto
El Blunto is a California-based cannabis brand that offers 'The World's Finest Cannabis Experience'. Born from a passion for craftsmanship and quality, El Blunto is an evolution of historic cigar-making tradition. Borrowing age-old techniques from master cigar-rollers, we create products of the highest caliber with the highest level of finishing. Product design and development is approached like a true science, ensuring customers get the same, phenomenal experience every single time. The El Blunto line up includes El Blunto (cannabis cigar), El Bluntito (cannabis cigarillo), El Jointo and El Jointito (joints and mini-joints), as well as jars of full-flower and Roll Your Own Blunt Kits. El Blunto products are available in 200+ dispensaries across California. El Blunto is a subsidiary of Albert Einstone's LLC. For more information visit http://www.alberteinstones.com Follow us on instagram @Elblunto.ca @Alberteinstones
About Glass House Farms
As locals to the Central Coast, we take pride in the Santa Barbara area, and strive to make decisions that preserve, honor, and protect our beautiful community. Our farms help contribute to the local economy. We are always meticulous in our adherence to regulation and taxes. And most importantly, we take neighbors into consideration through odor and light control. We are the cannabis you can count on to go the extra mile for quality, every time. We begin by finding the finest strains of cannabis and cultivate them in sparkling clean greenhouses. Finally, each flower is trimmed and packaged with exceeding care to deliver a consistently premium product that we, as highly discerning consumers, are proud to sell.
For more information visit http://www.glasshousefarms.org.
Follow us on instagram @glasshousefarms



START your own Wordpress site, business or personal website, or online store at www.siteground.com

On Wednesday, November 25, 2020, be sure to wear purple warpaint to be an advocate for cystic fibrosis awareness. For the second year in a row, Piper's Angels Foundation is presenting Warpaint Wednesday, a global day of activism and giving for the cystic fibrosis community.

JUPITER, FLA. (PRWEB) NOVEMBER 14, 2020
On Wednesday, November 25, 2020, be sure to wear purple warpaint to be an advocate for cystic fibrosis awareness. For the second year in a row, Piper's Angels Foundation is presenting Warpaint Wednesday, a global day of activism and giving for the cystic fibrosis community fueled by the power of social media and community collaboration.
"Wearing warpaint has historical, traditional, and meaningful uses by cultures all over the world," said Travis Suit, Founder & Executive Director of Piper's Angels Foundation. "The reason why we encourage people to wear warpaint on this day is that you can derive a sense of strength, promote unity, and fight for what's important. Anyone, whether they're two years old or 80 years old, can wear warpaint."
Warpaint Wednesday takes place the day before Thanksgiving in the U.S. and before Giving Tuesday to kick off the giving season from a place of gratitude and purpose.
There are many ways to participate in Warpaint Wednesday. Wear purple warpaint to show your alignment to the cystic fibrosis community and post a photo to social media with the tag #WarpaintWednesday. Another way to participate is to rally your community to host a Warpaint-themed event or encourage your local businesses to donate a percentage of their sales on the day of in support of CF. You can also make a donation directly to any of the participating cystic fibrosis organizations with the online crowdfunding campaign through GoFundMe.
This year, Piper's Angels Foundation is forming a digital media partnership with The Digital Intellect, a full-stack marketing agency in West Palm Beach. TDI will help with marketing strategy and execution for the Warpaint Wednesday campaign. Piper's Angels Foundation and The Digital Intellect came together in March 2020 after realizing they had common goals of community engagement and bringing awareness to an important cause.
"When we met Travis and the team behind Warpaint Wednesday, we saw their passion and desire to have an impact on the greater good," said Robert Aycock, Co-Founder and Chief Executive Officer of The Digital Intellect. "After learning about last year's launch and its limited exposure, we knew we had to get behind this amazing cause for the CF community and do everything we can to push it forward."
Last year's inaugural Warpaint Wednesday was met with widespread enthusiasm from the cystic fibrosis community, even on an international level. It's a day of activism, awareness, and celebration that thrives online in the CF community, where cystic fibrosis patients communicate regularly through digital avenues because of the extreme isolation that the disease causes. Now, with COVID-19 running rampant in 2020, the isolation has reached all-time highs in the immunocompromised CF community.
Cystic fibrosis is a chronic genetic disorder that affects the lungs and digestive system, often resulting in difficulty breathing, severe lung infections, and digestive problems. About 30,000 people in the U.S. and 100,000 worldwide suffer from cystic fibrosis.
"We encourage everyone to show support for those who have cystic fibrosis on Warpaint Wednesday," Suit said. "We want cystic fibrosis warriors to know that they're not alone. Wearing warpaint is simple, fun, and a way to empower people to become their own advocates."
We are also very excited to see many more cystic fibrosis organizations jump on board and participate in Warpaint Wednesday. At this time, we have verbal commitments from CF nonprofits like Boomer Esiason Foundation, Claire's Place Foundation, The Bonnell Foundation, Vivian Lee Foundation, Singing At The Top Of My Lungs. We also have international CF social media influencers on board like Ben Mudge, Travis Flores, Julia Rae, Marc Cotterill and many others to make Warpaint Wednesday the biggest day of activism for cystic fibrosis in the world. Any CF nonprofit-related organizations that create a campaign and fundraise for Warpaint Wednesday will receive 100% of their fundraising dollars to support their missions to support the CF community.
For more information on Warpaint Wednesday and how you can show your support, visit http://www.warpaintwednesday.com​.
About Piper's Angels
Founded in 2017, Piper's Angels Foundation aims to support and enrich the lives of cystic fibrosis patients and their families. Based in Palm Beach County, Florida, the foundation raises awareness through education, provides assistance through four signature programs, produces a weekly podcast, and its flagship fundraiser, Crossing For Cystic Fibrosis, an 80-mile paddle event from the Bahamas to Florida. To learn more about Piper's Angels Foundation, visit https://pipersangels.org. You can also follow Piper's Angels Foundation on Facebook, Instagram, and YouTube.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In light of World Diabetes Day, Mediaplanet announces the launch of the November edition of its "Diabetes Awareness" campaign on November 25th, 2020.

NEW YORK (PRWEB) NOVEMBER 14, 2020
The cross-platform campaign, "Diabetes Awareness," launching November 25, 2020, advocates for an increased emphasis on how to manage the disease, especially in ways it has shifted due to the pandemic. By featuring the most prominent industry thought leaders, the included stories and interviews highlight the challenges of having a high-risk condition with a lack of resources amidst a global pandemic. The campaign aims to educate those with diabetes or prediabetes, healthcare providers, healthcare professionals, and those with loved ones that are diabetic on innovations in diabetes management.
The print component of "Diabetes Awareness" will be distributed in the November 25th edition of USA TODAY in New York; Los Angeles; San Francisco; Minneapolis; Chicago; Atlanta; Washington, D.C.; the Carolinas; Dallas; and Boston. The digital component is distributed nationally through a vast social media strategy and across a network of top news sites and partner outlets. The digital version of the campaign will launch on FutureofPersonalHealth.com, Mediaplanet's prominent online health content hub.
This campaign was made possible with the support of the American Diabetes Association, JDRF, American Podiatric Medical Association, American College of Preventive Medicine, Allergy & Asthma Network, Dr. Mark Hyman, Mary Ellen Phipps, Vanessa Rissetto, Rebecca Ditkoff, Medtronic, Medela, LifeScan, Companion Medical, and ExpressionMed.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit https://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Katie McNerney
katherine.mcnerney@mediaplanet.com
646-619-0195

The cross-platform campaign, "Diabetes Awareness," launching November 25, 2020, advocates for an increased emphasis on how to manage the disease, especially in ways it has shifted due to the pandemic.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Britten provides advanced periodontal surgical treatment and dental implant care for veterans in his Clearwater, Florida based periodontal practice. He offers sedation options and high-tech treatment, which can be very helpful to veterans that suffer from PTSD.

CLEARWATER, FLA. (PRWEB) NOVEMBER 15, 2020
On Friday November 13th, Dr. Todd M. Britten and the team at Britten Periodontics & Implant Dentistry held their 6th annual Day of Care for Veterans. Dr. Britten stated that that dental coverage for veterans for major dental surgery can be very hard to attain, so he and his team "hit the ground running" in 2015 trying to deliver periodontal care to as many veterans as they could.
Dr. Britten says he owes the success of the event for the last 6 years to the help of local dentists, Dr. Carey Bonham, Clearwater Dental Associates (Dr. Keith Kiskaddon, Dr. Nolan Allen, Dr. Matt Burton, and Dr. Jim Hayslett and Dr. Keith Kiskaddon), Dr. Jeffrey Ellenberg, Dr. Ira Berger, Dr. Michael Podlusky and the local Community Dental Clinic in Clearwater. Some of the dentists have done extensive restorative treatment such as fillings, crowns, and even implant dentures.
Dr. Britten provides advanced periodontal surgical treatment and dental implant care for veterans in his Clearwater, Florida based periodontal practice. He offers sedation options and high-tech treatment, which can be very helpful to veterans that suffer from PTSD.
For Britten and his team this event is something they look forward to all year long. They keep in touch with veterans from previous events and this year they were able to provide follow up exams, x-rays and periodontal maintenance procedures, which help prevent reinfection of the gums following treatment. "It is always great to see them again and the progress they have made in their oral health. It is touching to be a part of something that has changed someone's life in such a positive way," said one of Dr. Britten's volunteers. Another volunteer hygienist chimed in that her favorite part was "seeing patients return for periodontal maintenance from previous years' events to help maintain their new healthy smiles." Veteran David Kennedy of Largo said, "I appreciate what he is doing for me!"
Dr. Britten explained that local restorative dentists and their teams have volunteered each year to help provide comprehensive dental care to our veterans. As a periodontist, Dr. Britten's specialty is the surrounding structures of the teeth; roots, gum and bone; i.e., the foundation. The restorative specialists have done fillings, crowns, and even full sets of dentures for veterans at no cost each year. "Our practice alone has provided over $56,000 in periodontal procedures for patient," said a staff member at Britten Periodontics who has helped to coordinate the event each year.
Dr. Britten says he would like to continue this event for the entirety of his career. "I have always respected the sacrifices that our veterans and their whole families had to make to ensure our safety and freedom. The sacrifices are really innumerable."
Britten Periodontics is a periodontal practice offering patients personalized dental care in periodontics, laser therapy and implant dentistry for Clearwater, Florida. Dr. Todd Britten received his Bachelor of Science and Doctorate of Dental Medicine and Master's Degree and Certificate in Periodontology and Implant Dentistry at the University of Florida. He is a Diplomate of the American Board of Periodontology. He has completed extensive continuing education coursework, including training at the Pankey Institute, Pikos Institute for Advanced Bone Grafting, Misch International Implant Institute and LANAP Institute for advanced Laser Dentistry. His Professional Associations and Memberships include American Board of Periodontology, American Academy of Periodontology, American Dental Association, Florida Association of Periodontists, Academy of Osseointegration, Upper Pinellas County Dental Association, Pinellas County Dental Association, Top Dentist 2015, Florida West Coast Dental Association and he completed extensive training at the Institute of Advanced Laser Dentistry. Dr. Britten is part of the one percent of dental professionals offering the FDA cleared laser procedure for gum disease treatment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Remedium Pharmacy, an independent compounding, long-term care and retail pharmacy based in North Chelmsford, Massachusetts, is proud to announce a major donation of medical accessories and personal protective equipment to the Lowell Senior Center in neighboring Lowell.

NORTH CHELMSFORD, MASS. (PRWEB) NOVEMBER 15, 2020
Remedium Pharmacy, an independent compounding, long-term care and retail pharmacy based in North Chelmsford, Massachusetts, is proud to announce a major donation of medical accessories and personal protective equipment to the Lowell Senior Center in neighboring Lowell.
The assortment of PPE and medical accessories included procedural (surgical) masks and latex gloves, along with a sizable contingent of sanitary and diagnostic supplies, including individual-sized hand sanitizer dispensers, external thermometers, and pulse oximeters.
The donation is the most recent result of a fruitful collaboration between Lillian Hartman and Tara Donnelly of the Lowell Senior Center and Cristina Iepure, owner/pharmacist of Remedium Pharmacy. Organized by Iepure and David Palmerino, vice president of sales for Remedium Pharmacy, the equipment and accessories will enable the Lowell Senior Center's staff to continue to safely and comfortably provide essential services to the at-risk populations reliant on the center for fellowship and support.
The donation is large enough to offset looming shortages of PPE, oximeters, and external thermometers amid rising COVID-19 case volumes and increasing strain on hospitals across the United States. The allotment should enable the Lowell Senior Center to operate normally into the holiday season, when supply chain disruptions tend to become more frequent.
"This year has been challenging for us all, especially the seniors and other individuals most at risk from this deadly virus," said Iepure. "Remedium Pharmacy stands ready to support our most vulnerable populations in any way we can."
In the short term, the senior center plans to use the donated PPE to bolster existing supplies of masks and gloves for its community transportation drivers and onsite staff members. The thermometers and oximeters will be used or distributed by city nurses and EMTs as needed, and the hand sanitizer bottles will ensure a high standard of sanitation throughout the facility.
About Remedium Pharmacy
Based in North Chelmsford, Massachusetts, Remedium Pharmacy is an independent compounding, long term care and retail pharmacy that produces and delivers customized medications for a range of conditions and indications. With an experienced staff devoted to providing a "pharmacy experience with a personal touch," Remedium offers multilingual sales and support as well as free same-day delivery throughout greater Lowell. Visit https://www.remediumrx.net/ to learn more.
About Lowell Senior Center
Located in historic downtown Lowell, Massachusetts, the Lowell Senior Center is run by the city of Lowell and features a diverse lineup of programs and services for disabled adults and people over 60 years of age. For more information about current programming and open hours, visit the lowellma.gov/seniors or call (978) 674-4131.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A new service has been launched to support vulnerable people who need to access cash in a hurry

MANCHESTER, UNITED KINGDOM (PRWEB) NOVEMBER 15, 2020
A service has been launched to support vulnerable people who need to access cash in a hurry. Family members, carers, volunteers and others can withdraw cash instantly from ATM's without a Card or Bank Account.
The CashByText service is especially useful during lock-down when people are not able to travel. During the first lock-down many carers struggled to access finance in urgent circumstances on behalf of their vulnerable clients. The CashByText service helps to solve that problem.

An account can be set up for family members or organisations so that they can access cash from ATM's by text without a card or bank account.

The service can be operational within one day

The service is provided by The Money Carer Foundation, the national social enterprise that provides everyday money management services to thousands of people and their carers across the UK. CashByText can be used alongside the organisation's popular Carer's Shopping Card service.
The technology is provided by Pin4Cash, the innovative Fintech company who have developed the software that enables ATM operators to facilitate this service.
Simple To Use
Click here to view the video
To use the service, the 'Sender' simply logs in to the secure payments portal and adds the mobile phone number of the carer to send them funds instantly from their float account. The 'Receiver' (carer) can then withdraw a specified amount between £10 and £500 from one of the participating 17,000 ATMs.
The Key Benefits
1. Enables 'one-off' or reoccurring regular payments to carers.
2. Easy to change the 'Receivers' mobile phone numbers as carers change or are on holiday.
3. Secure, low cost and instant service.
Sean Tyrer, CEO of the Money Carer Foundation commented:
"Our aim is to find solutions to keep vulnerable people and their carers safe. We provide innovative money management services for vulnerable people and our CashByText service has proven to be immensely useful in urgent situations. It's easy to use and, most importantly, it's quick. In times like lock-down, when people are being encouraged not to travel, it can solve some very tricky situations."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Consulting Magazine revealed that Health Data Movers Inc. (HDM) is No. 9 on its annual The Best Small Firms to Work For list. This list measures such things as client engagement, culture, leadership, career development, work/life balance, and compensation.

NEW YORK (PRWEB) NOVEMBER 16, 2020
Consulting Magazine revealed on November 12, 2020, that Health Data Movers Inc. (HDM) is No. 9 on its annual The Best Small Firms to Work For list. This is the sister list to Consulting Magazine's Best Firms to Work For, a list which this year included such companies as Boston Consulting Group, EY, and KPMG. This list measures such things as client engagement, culture, leadership, career development, work/life balance, and compensation.
HDM proudly offers Application Development, Data Conversion and Integration, EHR, and Program and Project Management Services across all healthcare IT vendors. Founded in 2012 and actively managed by founding partners Brian Battistone, Greg Georgatos, and Tyler Smith, the firm has continued to build on their early reputation as the "must call" firm for the toughest healthcare IT projects.
"We could not be happier to be named one of Consulting Magazine's Best Small Firms to Work For in 2020," Georgatos said. "This win really hits home for us. We pride ourselves on creating an inclusive company culture that encourages grit, growth, independence, and a family vibe. Our consultants do top-shelf work, and we consider this honor to be a reflection of what they are able to accomplish as we work to move healthcare forward together."
"The Best Firms survey is the largest and most in depth employee satisfaction survey in the industry," said Editor-in-Chief, Chris Nesi. "This year we collected thousands of responses from hundreds of consulting firms to compile our list of 2020 Best Firms winners, on topics spanning culture, career development, client engagement, compensation, and benefits, and firm leadership. As always, we were inspired to hear the glowing praise employees had for their firms."
About Health Data Movers (HDM)
Health Data Movers' mission is to improve the lives of patients and providers by unleashing the potential of healthcare data and technology. HDM executes data conversions, EHR implementations, and development projects with the nation's top healthcare provider organizations, medical device firms, and digital health enterprises.
The company works with organizations that put their patients first and strive for the seamless and safe transfer of medical information.
For more information, visit http://www.healthdatamovers.com
Follow HDM on LinkedIn at http://www.linkedin.com/company/healthdatamovers
Follow HDM on Twitter at http://www.twitter.com/healthdatamover



START your own Wordpress site, business or personal website, or online store at www.siteground.com

TrialScope's Trial Results Summaries portal will more than triple its available user interface translations, rolling out an additional 35 languages over the next three months.

JERSEY CITY, N.J. (PRWEB) NOVEMBER 16, 2020
TrialScope's Trial Results Summaries portal (TrialSummaries.com), the world's largest digital library of clinical trial plain-language summaries (PLS), is expanding in functionality to help trial sponsors engage with a growing global audience. TrialScope has kicked off an ambitious project that will more than triple the portal's available user interface translations, rolling out an additional 35 languages over the next three months. AstraZeneca, the founding member of TrialSummaries.com and which has shared hundreds of clinical study results on the portal, has championed the expansion, supporting it as part of its longstanding commitment to clinical trial transparency and accessibility.
This enhancement comes on the heels of continued growth this year for the portal. TrialSummaries.com has added four new study sponsors, alongside AstraZeneca, that have made a commitment to trial transparency by sharing clinical study summary results via the platform.
As clinical trial transparency trends upward across the pharmaceutical industry, an increasing number of sponsors are implementing PLS programs. Plain-language summaries must not include any promotional content, which is why many sponsors now opt to post their clinical trial results on a non-branded portal such as Trial Results Summaries. The portal already hosts clinical trial results from more than 800 industry studies from 2015 to present. Sponsors who post study results on the portal are already able and encouraged to do so in as many languages as relevant to study participants. A 2020 patient insight report by the James Lind Institute reveals that, in non-English-speaking countries, 90 percent of participants want trial feedback in their own language.
Eighty-five percent of respondents say it's important to receive a summary of clinical research study results, according to the 2019 Perceptions & Insights Study from the Center for Information and Study on Clinical Research Participation (CISCRP). However, an alarming 61 percent of clinical trial participants did not receive any post-study reports or updates.
Posting trial results online is convenient for sponsors, reduces the burden on sites and enables easy access for the public. Through digital distribution, sponsors can avoid the cost and effort of printing and distributing PLS at trial sites, particularly when versions in multiple languages are needed. At TrialSummaries.com, visitors can subscribe by sharing only an email address, democratizing access while sharing very limited personal information. This solution expedites accessibility for trial participants, who often wait months or years for trial results to be made available.
"Throughout the industry, an increasing number of sponsors are realizing the value of clinical trial transparency beyond regulatory compliance," said Francine Lane, TrialScope Vice President for Global Transparency. "Sharing study results in plain language shows participating patients that their contribution to the study was valued and respected. And when sponsors share translations of complex medical information, participants and the public can easily comprehend results in their language of choice."
For more information on the Trial Results Summaries portal, contact TrialScope at trialsummaries@trialscope.com or +1 877-658-8310.
About TrialScope
TrialScope gives your clinical trial data superpowers. The TrialScope Transparency Cloud makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As the legal market for marijuana continues to grow, Cannabis Compliance Center stands ready to assist growers and retailers of marijuana in complying with the myriad state laws and regulations that apply to marijuana operations in these states.

ONTONAGON, MICH. (PRWEB) NOVEMBER 16, 2020
Cannabis Compliance Center LLC ("Can-Comply") salutes Arizona, Montana, New Jersey and South Dakota as this November they legalized, and will tax, recreational marijuana for adults, joining 11 other states: Alaska, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Nevada, Oregon, Vermont and Washington. In related news, The Gallup Organization announced this week that according to their polling, U.S. public support for legalized marijuana is at a new high of 68%.
As the legal market for marijuana continues to grow, Cannabis Compliance Center stands ready to assist growers and retailers of marijuana in complying with the myriad state laws and regulations that apply to marijuana operations in these states.
"Can-Comply is particularly focusing on assisting the small grower and the small retailer as they work their way through a new and potentially confusing regulatory framework," said Andres Velez, EVP at Can-Comply. "Can-Comply can help with initial licensing applications, setup and ongoing maintenance of agent ID cards, and establishment of best compliance practices to keep small growers and retailers abreast of State requirements and expectations."
Cannabis Compliance Center LLC offers specialized compliance solutions for cannabis growers and retailers. More information on Can-Comply can be found at http://www.can-comply.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Women's Heart Health & Prevention Specialist Brings Together Panel of Professionals from Across the U.S.

PHOENIX (PRWEB) NOVEMBER 16, 2020
The Second Annual Women's Heart & Vascular Symposium, hosted by Dignity Health's Women's Heart Health Program in Arizona, returns on Saturday, November 21 through CommonSpirit Health's initiative across the United States to improve heart health in women. Cardiovascular disease (CVD) is the number one cause of death in women in the United States and the developed world. Research has identified risk factors specific to women such as adverse pregnancy outcomes or conditions more prominent in women such as rheumatologic or mental health disorders. While public health initiatives have increased awareness in these areas, there is still confusion among health care clinicians about risk assessment and best practices with regards to management of women with heart disease.
"In the medical field, women are often treated as 'little men,' meaning that instead of understanding the unique symptoms women exhibit for various health issues like heart attacks and strokes, they are viewed through the lens of men's symptoms," said Course Director Rachel M. Bond, MD, FACC. "Our goal is to educate healthcare clinicians nationwide on the unique pathophysiology of women to ensure that women are receiving proper medical treatment."
WHO:    
Rachel M. Bond, MD, FACC brings together a panel of professionals from across the U.S. to discuss the most current issues concerning CVD in women. She is board certificated in cardiovascular disease, internal medicine, echocardiography and nuclear cardiology and is a registered physician in vascular interpretation.
WHAT:    
The Second Annual Women's Heart & Vascular Symposium hosted by Dignity Health's Women's Heart Health Program in Arizona. Attendees will virtually learn about the continuum of care from prevention to early diagnosis and treatment strategies for heart disease in women.    
WHEN:    
Saturday, November 21
7 a.m. to 4:30 p.m.
WHERE:
Virtual - Live and On-Demand - Video Conferencing
https://www.dignityhealth.org/arizona/locations/chandlerregional/health-care-professionals-medical-students/for-medical-students/cme/womens-heart-and-vascular-symposium-2020?hR4
COST:     
Free
CREDITS OFFERED:
ABIM MOC Points - 8.00
AMA PRA Category 1 Credit - 8.00
Attendance - 8.00
For more information on the Second Annual Women's Heart and Vascular Symposium or to register to attend, please visit https://www.dignityhealth.org/arizona/locations/chandlerregional/health-care-professionals-medical-students/for-medical-students/cme/womens-heart-and-vascular-symposium-2020?hR4
About Rachel M. Bond, MD, FACC
Rachel M Bond, MD, FACC, Women's Heart Health & Prevention Specialist is devoted to expert diagnosis and treatment for improved patient outcomes. Her expertise is in cardiovascular disease with special interest in women's heart health, prevention, lipid disorders, pregnancy-related heart disease, cardio-oncology and autoimmune-related heart disease. Dr. Bond is a board-certified attending cardiologist and the System Director of the Women's Heart Health Program at Dignity Health in Arizona. She is affiliated with Chandler Regional Medical Center & Mercy Gilbert Medical Center. She is board certificated in cardiovascular disease, internal medicine, echocardiography and nuclear cardiology and is a registered physician in vascular interpretation. Dr. Bond is a well-known spokesperson for the American Heart Association, Go Red for Women Campaign.
###

"In the medical field, women are often treated as 'little men,' meaning that instead of understanding the unique symptoms women exhibit for various health issues like heart attacks and strokes, they are viewed through the lens of men's symptoms," said Course Director Rachel M. Bond, MD, FACC.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Technology facilitates the automatic generation of virtual dental patient models.

CAMPBELL, CALIF. (PRWEB) NOVEMBER 16, 2020
Bellus3D, Inc. a Silicon Valley startup formed by leading computer vision experts, announced today that the U.S. Patent and Trademark Office granted the company a patent that describes the invention of an automatic process for aligning multiple 3D face models of a patient to their dental intraoral scans, eliminating the need to use external markers placed on the face or mouth. The resulting aligned 3D models are the foundation for creating a 3D virtual model of a dental patient which enables dentists to improve the speed and quality of treatment diagnostics and planning.
Recent advances in intraoral scanners, 3D face scanners, and 3D printers have transformed dentistry from traditional workflows using physical dental impressions to digital workflows using the latest 3D scanning technologies. The starting point of the new digital workflows consists of scanning a patient's upper and lower jaw with a 3D intraoral scanner. The patient's face is subsequently scanned with a 3D face scanning system that delivers a 3D face scan file which needs to be aligned to the 3D jaw scans. Previously the alignment of the jaw scans to the facial scans was accomplished through the use of external markers placed on the patient's jaws and face which were then used as common reference points for alignment with specialized dental or medical software.
The Bellus3D patent describes the company's automatic implementation of aligning the jaw and facial scans using the exposed teeth of a patient's smile as a common reference point. A second face in a resting pose can then be aligned with the first face scan that was captured in a smile expression. The result is a simple automatic system for aligning the 3D scans of the patient's jaw and face with multiple expressions.
By creating a 3D virtual model of a dental patient, dentists and dental labs can quickly collaborate remotely using the patient's 3D face for making contextual adjustments in dental treatment planning. This results in improved designs, reduction in expensive case rework and faster case turnarounds. The automatic alignment technology described in the newly issued patent is implemented in the Bellus3D Dental Pro App for Apple iOS compatible devices.
Issuance of US patent 10,810,738 reflects the importance of the company's growing intellectual property portfolio. This is the 19th patent issued to the company's co-founder Eric Chen.
About Bellus3D, Inc.
Bellus3D (http://www.bellus3d.com) is the innovative leader in high-resolution 3D face scanning designed for Apple and Windows platforms. The company recently introduced its ARC camera systems for Windows which capture the 3D scans of human faces in under 3 seconds. More information about Bellus3D: http://www.bellus3d.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NODE.Health brings Digital Experts and Renowned Faculty together to teach all day foundational course on digital medicine

NEW YORK (PRWEB) NOVEMBER 16, 2020
NODE.Health, the association for digital medicine, has announced a new offering for professionals interested in the field of digital medicine. The Digital Medicine Foundation Certificate Course, worth up to 12 AMA PRA Category 1 Credit(s), is targeted towards trainees, graduate students and clinicians in all specialties to learn the fundamentals of digital medicine.
To deliver the course, NODE.Health brought together a panel of digital medicine experts and renowned faculty from UCSF, Providence, New York Mount Sinai, M Health Fairview, Stony Brook, UCSF, ATA, and the White House. The course aims to help students define digital medicine, apply digital Technologies to specialities, deploy best-practices in digital adoption, and to calculate ROI for digital technologies.
The eight classes will include topics related to telemedicine, patient engagement, apps and digital therapeutics, wearables, machine learning and will feature workshops in designing clinical trials for digital. The class will conclude with a panel of experts from a wide range of specialties discussing applications of digital in their practice along with lesson's learning in implementing digital solutions.
In order to obtain the Digital Medicine Certificate, students will be required to attend the entire full day session on Sunday, December 6, along with 4 of 6 free keynote sessions throughout the complementary NODE.Health Digital Medicine Conference the following week.
In offering the course, NODE.Health hopes to help emerging professionals excel in the field of digital medicine and to accelerate the adoption of digital solutions throughout the industry.
About NODE.Health:
As the professional association for digital medicine, NODE.Health is a catalyst for digital transformation in healthcare. A registered 501c3 non-profit organization, we help health care organizations realize the benefits of digital medicine faster and with less risk by creating, gathering, and disseminating clinical evidence and best practices. We foster global connections among the world's top healthcare organizations, innovative technology companies, professional societies and motivated individuals to bridge the gap between the scientifically rigorous world of healthcare and the fast-paced, disruptive world of digital innovation. Our members participate in industry-wide events—including our annual NODE.Health Conference—as well as private learning sessions and work groups. They have access to exclusive content from peers and experts, and they have the chance to participate in rigorous validation studies that transform innovative technologies into viable, real-world solutions. Join us at http://www.nodehealth.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This critical role will help expand capacity to serve small businesses and underprivileged communities fighting the next wave of COVID-19.

SAN JOSE, CALIF. (PRWEB) NOVEMBER 16, 2020
HumankindNOW announced today the hiring of Fynn Rorris as Director of Development to lead the non-profit's sponsorship and fundraising efforts. Rorris' role will include securing foundation and corporate donations, growing partnerships, and driving fundraising campaigns. This critical role will help HumankindNOW meet the increasing demand for personal protective equipment, affordable COVID-19 testing, and mental health support services for front line healthcare workers in small businesses and underprivileged communities.
Fynn Rorris brings ten years of proven experience in fundraising and humanitarian relief. Most recently Rorris worked for the American Red Cross of Greater New York, building donor relationships, leading large fundraising campaigns, and organizing volunteer programs. Rorris has also held senior fundraising positions at LifeServe Blood Center and Stockton University.
"Since March 2020, HumankindNOW has protected 11,500 front line healthcare workers through the procurement and delivery of critical PPE; however, as the United States braces for a new wave of COVID-19 cases, supply chains remain constrained, leaving many healthcare workers with limited access to critical supplies and essential services," said Chi-Chao Chang, Chairperson and CEO of HumankindNOW. "Having someone of Fynn's caliber join our team will help us develop partnerships and drive fundraising campaigns to help us meet the increasing demand for our services."
"The plight of healthcare professionals in rehabilitation centers, retirement homes, and rural communities protecting the vulnerable from COVID-19 is tough enough. Having to fight this terrible disease with inadequate equipment is a tragedy," said Fynn Rorris, Director of Development at HumankindNOW. "I am excited to be joining HumankindNOW during this uncertain time in our country. I look forward to helping this passionate team of volunteers in their mission to protect healthcare workers in the face of the COVID-19 pandemic."
Those interested in supporting HumankindNOW can make a donation of any amount by visiting: https://charity.gofundme.com/o/en/campaign/humankindnow.
About HumankindNOW
HumankindNOW is a registered 501(c)(3) nonprofit in California dedicated to supporting front line health care workers fighting the COVID-19 pandemic. Formed by leaders of Silicon Valley startups and fueled by $750,000 in donations, HumankindNOW has supplied 503,000 pieces of high-quality PPE to 11,500 health care workers in small businesses and underprivileged communities since its founding in March 2020. To learn more, go to humankindnow.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Company to Focus on Improving Member Experience and Engagement for Health Insurers and Cost Sharing Communities.

AUSTIN, TEXAS (PRWEB) NOVEMBER 16, 2020
Point Health, a digital health startup in Austin,TX, announced today its plans to acquire The Karis Group, a 25-year old healthcare navigation and bill negotiation company. This acquisition will combine Point Health's team of experienced product, technology, and UX design experts with The Karis Groups' decades of pricing data, healthcare navigation, and bill negotiation experience. Together, the companies will develop a new, digital-first healthcare navigation platform that will make healthcare easy to find, easy to understand, and easier to afford for members of health plans.
Point Health's healthcare navigation platform will empower members to be engaged healthcare consumers, by combining one-stop shopping for healthcare needs with a medical marketplace offering price transparency. The typical health insurance company loses an average of one-third of their members each year, making member experience and engagement critical to increase retention. Point Health's initial platform is targeted towards health insurers with high-deductible plans, health sharing communities, third-party administrators, and employers.
"The consumer health experience needs an overhaul. This acquisition is very positive for both companies, but even better for our clients and their members who will use our new, digital-first healthcare navigation platform," said Matt Dale, CEO of Point Health and The Karis Group. "Our easy-to-use technology will continue to push healthcare towards transparency, affordability, and simplicity."
Tony Dale, M.D., founder of The Karis Group, sees his company's legacy of patient advocacy carried forward with Point Health, "When I started The Karis Group there was an utter lack of transparency in billing for healthcare services. We helped resolve some of those issues by navigating billions of dollars in medical bills, and we assisted millions of people by solving the complexities of healthcare bills. I am proud and excited by the opportunity this new venture represents."
Under this acquisition, The Karis Group and Point Health will come together as one company using the Point Health brand in Q1 2021.
The beta version of Point Health's platform is available by request to health insurers, health cost sharing communities, employers, and other groups by reaching out to Hello@pointhealth.com. The initial platform is set to be unveiled in early 2021.
Learn more at https://www.pointhealth.com/landing-page/karis-and-point-health
About Point Health
Point Health is an Austin, Texas-based digital health startup paving the way for major changes in the healthcare industry, primarily through a healthcare navigation platform and marketplace. The healthcare system in the U.S. is confusing to navigate, but Point Health is guiding patients towards healthcare that is easier to find, understand, and afford.

The consumer health experience needs an overhaul. This acquisition is very positive for both companies, but even better for our clients and their members who will use our new, digital-first healthcare navigation platform.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

New COVID-19 management features for the Entro access control system from Remsdaq Ltd include occupancy management, temperature & mask screening and contact tracing.

DEESIDE, WALES (PRWEB) NOVEMBER 17, 2020
The latest version of EntroWatch includes several new features to help make buildings COVID-19 Secure. EntroWatch is the award-winning access control software for Entro series door controllers and contactless card readers and keypads. The new COVID-19 management features include occupancy management, temperature & mask screening and contact tracing.
Occupancy management can be used to manage social distancing and prevent overcrowding in an EntroWatch controlled building. Occupancy levels can be set for rooms whose doors have access control readers. Examples include offices, meeting rooms, laboratories, tool rooms, canteens & rest areas. EntroWatch displays occupancy levels, supports 'one in and one out' access and can be set to alarm if someone tries to exceed the occupancy threshold level.
The temperature & mask screening feature makes use of compatible camera technologies placed strategically within a building. As people pass one of these cameras, they are screened for temperature and whether they are wearing a mask or not. Based on threshold levels and settings, a person is either allowed to enter or exit an EntroWatch access controlled door or not. A snapshot of their temperature is stored in EntroWatch.
Contact tracing is an enhanced report within EntroWatch 3.1 based on the access control principle of Who, Where and When. The report can be used to track and trace people within a building.
"We have responded rapidly to requests from our clients to extend EntroWatch features for pandemic management" commented David Ross, Remsdaq's UK Security Business Development Manager. "These new features are part of the ongoing development of the EntroWatch platform and can help building owners and managers to ensure safe social distancing and protection from the potential risk of a Coronavirus infection."
The Entro series utilises the native BACnet/IP protocol; the open communications standard for the building automation industry. Using BACnet provides the opportunity to integrate the Entro series into an intelligent building management system, for population and movement data for analytics and rule-based energy usage. The Entro series includes the EntroStar (two-door) and EntroNet (eight-door) access door controllers, EntroPad card readers, keypad and management kit and EntroPass secure credential. For UK government sites Remsdaq supplies a Certified Secure CPNI version of the Entro system.
More information:
Robin Koffler – Sales & Marketing Director
Mobile: 07788 720 979 | Email: rk@remsdaq.com | Social: @remsdaq
Website: https://www.remsdaq.com/entro-series
Photo Image Available - The Entro access control system
About Remsdaq Ltd
Remsdaq Ltd is a privately held company started in 1974, specialising in SCADA, integrated security and mobilisation systems. Routes to market include utilities and industrial end-users (SCADA), Blue Light Emergency Services (mobilisation software) and IT/Security distribution channels (access security products) via strategic regional partners, distributors and value-added resellers. The company operates from a 4,000m² facility on the Deeside Industrial Park (on the Cheshire/North Wales border) and provides a turnkey service including complete lifecycle support from concept to design, project management, installation, commissioning and maintenance.

These new features are part of the ongoing development of the EntroWatch platform and can help building owners and managers to ensure safe social distancing and protection from the potential risk of a Coronavirus infection



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Springfield's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

SPRINGFIELD, MO. (PRWEB) NOVEMBER 17, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Springfield, MO for 2021. The informational guide recognizes the top 7 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Springfield, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Springfield with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Springfield. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Springfield, MO please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-springfield-mo
2020 Best Rehab Facilities in Springfield, MO (in alphabetical order)
A&M Recovery
3322 South Campbell, Suite P&Q
Springfield, MO 65807
417-823-3808
BHG Springfield Treatment Center
404 East Battlefield Road
Springfield, MO 65807
417-865-8045
Burrell Behavioral Health
1350 East Bradford Parkway
Springfield, MO 65804
417-761-5000
CoxHealth
1423 North Jefferson Avenue
Springfield, MO 65802
417-269-2273
Higher Ground Recovery Center
2032 East Kearney Street, Suite 214
Springfield, MO 65803
417-869-0700
Preferred Family Healthcare
2626 West College Road
Springfield, MO 65802
660-665-1962
Synergy Counselling Center
1717 East Republic Road
Springfield, MO 65804
417-351-4282
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Rochester's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

ROCHESTER, N.Y. (PRWEB) NOVEMBER 17, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Rochester, NY for 2021. The informational guide recognizes the top 6 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Rochester, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Rochester with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Rochester. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Rochester, NY please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-rochester-ny
2020 Best Rehab Facilities in Rochester, NY (in alphabetical order)
Delphi Rise
835 West Main Street
Rochester, NY 14611
585-467-2230
Huther Doyle Memorial Institute
360 East Avenue
Rochester, NY 14604
585-325-5100
Rochester Evaluation Center
1350 University Avenue
Rochester, NY 14607
585-287-5622
Rochester Regional Health
1565 Long Pond Road
Rochester, NY 14624
585-922-9900
UR Medicine-Outpatient Chemical Dependency Services
2613 West Henrietta Road, Suites C & D
Rochester, NY 14623
585-275-5400
Westfall Associates Inc. Outpatient
919 Westfall Road
Rochester, NY 14618
585-473-1500
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Malibu's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

MALIBU, CALIF. (PRWEB) NOVEMBER 17, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Malibu, CA for 2021. The informational guide recognizes the top 15 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Malibu, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Malibu with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Malibu. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Malibu, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-malibu-ca
2020 Best Rehab Facilities in Malibu, CA (in alphabetical order)
Alo House Recovery Center
28955 Pacific Coast Highway #200
Malibu, CA 90265
888-409-1774
Avalon Malibu
32420 Pacific Coast Highway
Malibu, CA 90265
888-732-0463
Beach House Treatment Centers
22601 Pacific Coast Highway, Suite 250
Malibu, CA 90265
310-448-1413
Broad Beach Recovery Center
31217 Bailard Road
Malibu, CA 90265
310-263-8699
Cliffside Malibu
29160 Heathercliff Road #100
Malibu, CA 90265
855-335-0850
Inspire Malibu
30101 Agoura Court, Suite 103
Agoura Hills, CA 91301
800-444-1838
Journey Malibu
22516 Carbon Mesa Road
Malibu, CA 90265
877-673-4225
LifeSync Malibu
28632 Roadside Drive, Suite 235
Agoura Hills, CA 91301
866-491-4426
Malibu Hills Treatment Center
415 Westlake Boulevard
Malibu, CA 90265
888-415-3483
Milestones Ranch
327 Latigo Canyon Road
Malibu, CA 90265
866-874-9774
Oceanside Malibu Addiction Treatment Center
21022 Pacific Coast Highway
Malibu, CA 90265
866-738-6550
Passages Addiction Treatment Centers
6428 Meadows Court
Malibu, CA 90265
888-920-8849
Riviera Recovery
2827 South Barrington Avenue
Los Angeles, CA 90064
855-207-9708
Seasons In Malibu
31739 Pacific Coast Highway
Malibu, CA 90265
866-780-8539
Summit Malibu
27026 Sea Vista Drive
Malibu, CA 90265
310-742-1882
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Overdone Workouts Can Be Simply Back Breaking.

WEST ORANGE, N.J. (PRWEB) NOVEMBER 16, 2020
When it comes to exercise, too much of a good thing can be, well, back breaking, advises physical therapist Sridhar Yalamanchili of the New Jersey- and New York-based Atlantic Spine Center. Workouts overdone or performed with little advance preparation are among the leading causes of back pain, particularly pain in the lower back, says Yalamanchili, whose expertise includes biomechanical analysis and functional rehabilitation.
"Failure to stretch before a workout, over-exertion, improper technique, and exercising when fatigued are all risks for back sprains and strains, muscle and ligament tears, or just plain soreness." Strains occur when a tendon or muscle in the back are pulled. A stressed ligament/ligament is what doctors refer to as a back sprain. Strains and sprains most often occur due due to overload on the muscles and supporting tissues like ligaments.
Fortunately, most exercise-related back injuries are relatively common, acute, and likely to resolve themselves with rest and proper care within four weeks to six weeks. But a sudden twisting or rotational force during a workout or sports play can damage one of the spinal discs and require more extensive medical treatment, Yalamanchili says.
"Pay attention to what you are doing and how you are moving during your routine. Change direction with your feet – not your back and hips – especially if you are working out with weights," Yalamanchili says. "Even a seemingly minor, out-of-balance movement or pivot can cause post-workout lower-back pain." Often overlooked, returning your weights to the stand or floor after a work out without proper form can cause injury.
Most susceptible to back injury in the workout world is the "weekend warrior," the individual who engages in strenuous activity only on Saturday or Sunday, according to Yalamanchili. "Sitting behind a desk or in front of a computer screen during the week is no preparation for undertaking several hours of intensive exercise or competing in basketball, tennis or touch football on the weekend," he says. "Sports can be hard on the joints, put stress on the back, and require some level of fitness to play them safely." The extra few minutes of warming up the muscles helps in injury prevention. Elite athletes do it for that precise reason and that is a valuable lesson for all
Lower back pain is considered the most common musculoskeletal complaint globally and a major reason for disability. Approximately 80 percent of all Americans experience lower-back problems at some time in their lives. The lower back is defined as that area where the spine curves inward -- between discs L-1 through L-5. It is a complex of muscles, tendons, and ligaments that hold the spinal vertebrae in place and share space with an array of nerves emanating from the spinal column. "Any tweak that affects how all these parts work together can lead to back pain," says Yalamanchili.
While regular exercise is a necessary component of achieving overall good health, Yalamanchili says too many workout routines focus merely on slimming the waist and building arm and leg muscles rather than on strengthening the body's core.
Core muscles are located beneath the exterior musculature in the upper and lower torso and are crucial for stabilizing and controlling forces on the body's trunk, including spine, hips, abdomen, and pelvic floor, and for protecting the inner organs. Weak core muscles contribute to an increased risk for back injury during exercise and athletic activities, Yalamanchili says.
Experts agree, indicating that strong core muscles improve performance not only during intensive exercises like swinging a bat or a tennis racquet but even for the simplest of daily activities, such as reaching up and removing an item from a top shelf.
"Any exercise requiring coordination of abdominal and back muscles builds the core musculature," Yalamanchili says. He cites the "bridge" as just such a routine. In the "bridge," a person lies on his or her back, bends knees, tightens abdominal muscles, and then raises the hips from the floor until they are at the level of the bent knees. ( Exhale as you raise up the hips and Inhale while bringing them down). This is a simple starter exercise to get a feel for what core activation should feel like.
Other activities that can benefit the "core" are yoga and Pilates – both mind-body exercise regimens, Yalamanchili says. According to spine and physical medicine specialists writing in the journal Current Reviews in Musculoskeletal Medicine, "Pilates focuses on the [body's] 'powerhouse'...This includes the abdominal, gluteal and paraspinal muscles in particular."
"Research and clinical experience show that, by strengthening the core, one can limit – or avoid -- episodes of activity-related back and neck pain, reduce severity of pain should it occur, promote healing of back problems, and improve overall posture," Yalamanchili notes. He also recommends including regular, low-intensity, low-risk aerobic and cardio exercises like bicycling, jogging, brisk walking, and swimming into any activity regimen.
In addition to aerobics and core-enhancing exercises, Yalamanchili offers the following tips to prevent back injury from workouts:

Stay active; exercise regularly – daily if possible. "Too much sitting not only increases stress on the spine but contributes to weakened trunk muscles," he says.

Stretch muscles before a workout to warm them up and after a workout to loosen them.

Avoid exercises like the classic sit-ups that are hard on the back.

The old adage: "No pain, no gain." is only true if you feel post exercise soreness. Otherwise "If you experience pain, stop what you are doing, take a break, rest," Yalamanchili says. "Playing through pain could cause further injury."

"And, if your back pain does not resolve itself with time after exercise, becomes more intense, awakens you at night, or radiates below the waist to your buttocks and legs, contact an orthopedic spine specialist immediately. You have a condition that needs medical attention sooner than later Yalamanchili advises.
Sridhar Yalamanchili, PT, MSPT treats a variety of spinal and upper and lower body musculoskeletal disorders as lead clinician in outpatient physical therapy at the Atlantic Spine Center.
Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery and pain management with several locations in NJ and NYC. http://www.atlanticspinecenter.com, http://www.atlanticspinecenter.nyc.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Los Angeles-based board-certified physician comments on a recent article that at-home flu shots and COVID-19 testing are crucial for the health and safety of all this winter.

LOS ANGELES (PRWEB) NOVEMBER 16, 2020
A November 12 article on USA Today reports on health experts stressing the importance of flu shots this winter in particular. The article notes that health officials are worried about a "twindemic" as flu season begins amidst the surging coronavirus pandemic and they are urging the public to get their inoculations as soon as possible. The report says that, for individuals who come down with the flu this year, their chances of catching and exhibiting severe COVID-19 symptoms increase if they are saddled with a weakened immune system. Los Angeles-based board-certified internist Dr. Michael Farzam House Call Doctor Los Angeles echoes the sentiment, saying that COVID-19 and flu shots must be taken seriously for the health and safety of every individual and their community.
Dr. Farzam says that taking the proper precautions and advice of medical professionals is the first step in ensuring an individual's health. The Southern California physician debunks the myth that getting the flu shot will give people the flu, saying that this simply doesn't happen, though patients may experience some very mild and brief symptoms, such as soreness in the arm, in the hours immediately following the shot. It's a very small price to pay for avoiding or weakening a debilitating illness that can often take weeks to recover from, says Dr. Farzam. Especially for people at higher risk for COVID-19 complications as well as those who may be more susceptible to flu complications such as people over 65, Dr. Farzam says that getting the flu shot this year can easily be the difference between life and death, not only for the recipient but for people in the community.
The Los Angeles-based doctor notes that, while getting the flu shot or even COVID-19 testing might seem difficult or slightly risky due to social distancing and health concerns, there are at-home options available for everyone's safety and peace of mind. Dr. Farzam says that in the current climate, house call doctors are needed now more than ever as they can minimize the number of trips outside individuals requiring medical care need to take improving health care for their patients and reducing the strain on the overall health system.
The House Call Doctor Los Angeles physician says that he can provide his patients with flu shots, rapid coronavirus testing, and, for those already suffering early flu symptoms, Tamiflu, all in the comfort and safety of their homes. With the concurrent viruses, Dr. Farzam adds that it may be easy to mistake one illness for the other and vice versa, which is why getting tested and seeing a doctor sooner rather than later makes sense for people with symptoms, especially those in more vulnerable groups.
Readers interested in learning more about at-home coronavirus testing, flu shots, or all of the other services provided by Dr. Michael Farzam can call House Call Doctor Los Angeles at (310) 849-7991 or visit https://www.housecalldoctorla.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Down Syndrome Superhero, by Eugene Tossany, takes you on a literary adventure that is the perfect storm of Down Syndrome advocacy and science fiction splendor. Written as a fictional tale, from distinct points of view - Down Syndrome mother, disabled Veteran and child Advocate – this story is sure to resonate with a compassionate audience.

LOUDOUN COUNTY, VA. (PRWEB) NOVEMBER 16, 2020
The Down Syndrome Superhero, by Eugene Tossany, takes you on a literary adventure that is the perfect storm of Down Syndrome advocacy and science fiction splendor. Written as a fictional tale, from distinct points of view - Down Syndrome mother, disabled Veteran and child Advocate – this story is sure to resonate with a compassionate audience.
On International Day for Tolerance (11/16/2020), Eugene Tossany, is pleased to announce the release of her first book, The Down Syndrome Superhero.
An intriguing story encompassing a delicate topic, The Down Syndrome Superhero is a supernatural tale about a Down Syndrome teenager, her canine companion, a new best friend, and a talking hummingbird. In the story, the Down Syndrome teenager, Josie, activates a magic rock that reveals a portal above her hometown with access to an alternate dimension. Woven into the story is a cautionary description of how predators sometimes target special needs children. In this setting, a small hummingbird intervenes to save Josie's town, while Josie's parents step up as her ultimate protectors.
Using this captivating, creative tale, The Down Syndrome Superhero introduces parents of Down Syndrome children to a sensitive topic in a powerful way. According to Author Eugene Tossany, "There is no collective thought on how we should prepare our special needs children and young adults to fight against pedophiles. And yet, it is one of the most important conversations in a growing Down Syndrome child's life, as many of them have no sense of 'stranger danger'." The Down Syndrome Superhero helps parents present this topic by providing guidance using an imaginative tale, along with a descriptive dialogue about how to speak with their special needs child(ren) and resolve sensitive topics.
The Significance of the November 16 Release Date
November 16, 2020 was selected as the release date of The Down Syndrome Superhero, because of the significance of the United Nations' International Day for Tolerance and the nature of the delicate themes explored in the book. Much of the focus of the International Day for Tolerance has been on understanding how to move beyond conflict to a better, kinder future together. This day is significant to the Author, Ms. Tossany, who points out that included among the United Nations' (UN) preamble, is a declaration of principles on tolerance that align with her position as an Advocate for children's rights and Down Syndrome awareness. Most notably, the UN preamble emphasizes social and cultural rights, the convention on the rights of the child, and the convention against torture and other cruel, inhuman or degrading treatment or punishment, all of which tie into the underlying themes discussed in the book.
The Down Syndrome Superhero was recently endorsed by Mikayla Holmgren, the first person with Down Syndrome to compete in any state's Miss USA pageant. Ms. Holmgren included Eugene Tossany's book as part of the VIP packages for the 2020 Dream Big Fashion Without Limits fundraiser. The event featured Down Syndrome and Pageant models.
The Down Syndrome Superhero (Olympia Publishers) is available for purchase in the United States via Amazon.com and BarnesandNoble.com. The first book is also available in the United Kingdom via Amazon.co.uk and bookstores. The Down Syndrome Superhero 2 is in production and slated for 2021 release. For more information, visit https://downsyndromesuperhero.com/ in the US and https://dssuperhero.co.uk/ in the UK.
About Eugene Tossany
Eugene Tossany is the chosen pen name of a U.S. Author who started her editorial journey in third grade. In 2019, after pursuing life and achieving accolades, awards and an Army Commendation Medal, Eugene picked up the pen again. After the birth of her Down Syndrome daughter and after living in Israel, she crafted an inspirational manuscript, citing experiences, ancient research, and wisdom, as well as a creative perspective from her indirect literary mentor, Stephen King.
Ms. Tossany is very active in the Down Syndrome community and has participated in events including the Down Syndrome Association of Northern Virginia - 2020 Buddy Walk, the Rocky Mountain Down Syndrome Association - 2020 Step Up for Down Syndrome Walk, and the Minneapolis Best Buddies Fundraiser - 2020 Dream Big Without Limits fashion show. She is a member of the Society of Children's Book Writers and Illustrators (SCBWI) and is active on Facebook and Instagram.
For more information, please contact:
Josh Fertel, River City Marketing / 703-218-1750 or jf@rivercitymarketing.com.

There is no collective thought on how we should prepare our special needs children and young adults to fight against pedophiles. And yet, it is one of the most important conversations in a growing Down Syndrome child's life, as many of them have no sense of 'stranger danger'.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

GHX Polling Data Shines Light on Key Takeaways from Provider and Supplier Communities

LOUISVILLE, COLO. (PRWEB) NOVEMBER 16, 2020
Global Healthcare Exchange (GHX) today shared a recap of its Summit 20 Digital Connect conference, a digital reimagination of GHX's annual Summit conference, which for two decades has assembled hundreds of healthcare industry leaders from the provider, supplier, distributor and GPO communities to explore ways to create a more collaborative and resilient supply chain. During the event, which concluded on October 29, GHX also polled participants on their organizations' readiness on critical issues such as the continued response to COVID-19, the clinically integrated supply chain, data maturity and the shift to a cloud-based ERP.
Over the course of the two-part event, more than 1,000 attendees participated in 18 weekly Summit Satellite breakout sessions and five keynote sessions during the Summit LIVE event, featuring GHX executives and other industry thought leaders. One participant, Renée McIntyre, BA, CSCMP, Director, Supply Chain, TransForm Shared Service Organization, commented, "What a great virtual event! Definitely missed being in person this year – but your team certainly created a great virtual event!"
Summit 20 Attendees Share Perspectives on Timely Issues
Attendees responded to polling throughout the Summit 20 Digital Connect conference on a variety of healthcare trends. Six interesting data points included:
1. Organizations Prepare, Go Local to Create a More Resilient COVID-19 Supply Chain
When asked about their organization's level of readiness to tackle a second wave of COVID-19, nearly 36% of respondents say they're prepared to face the challenge. Another 57% report having a "pretty good" plan in place that still requires "some work" to finalize. A total of 63% of respondents also report they identified and vetted local suppliers during the height of the pandemic and will continue to purchase from these suppliers moving forward.
In fact, breakout session speaker Jeff Jochims, executive vice president and chief operating officer, Owens & Minor, remarked, "What I realized myself through our panel discussion is that COVID response remains very much alive – this is not a situation now left to history. A huge part of this response story remains to be written."
2. Still Work to Be Done in Building a Clinically Integrated Supply Chain
Even as the industry shifts toward a more clinically integrated supply chain, nearly 70% of respondents report they lack a system of action that links Clinical, Supply Chain and Financial operations.
3. Organizations Leverage Data to Engage Physicians in Supply Chain
On a scale of 1-5 (with 5 being the highest), nearly 67% of respondents reported their organization's approach to sourcing Physician Preference Items (PPI) was a 3, indicating there's still room for improvement as hospitals and health systems move up the Value Analysis maturity curve. When asked if organizations have a repeatable process for sourcing PPI, 60% of respondents said yes, suggesting the majority have worked to create an ongoing, well-defined process for PPI sourcing excellence.
4. Most Healthcare Organizations Still Developing Data Maturity
When asked what data maturity stage they'd estimate their organization falls in currently, nearly 36% of respondents reported they were "still developing." Only 5% of respondents responded they had "optimized" their organizational data maturity.
5. Progress with the Move to Cloud ERP, But More Work to be Done
When asked which best describes their organization in implementing a cloud ERP, 42% of respondents say they've selected a vendor but have not yet implemented a system and 26% of respondents say they are still evaluating a vendor. Additionally, more than 64% of respondents say their item master data needs to be cleaned before it's cloud-ready and nearly 67% say they've automated more than the basic purchasing transactions, but there's still more they'd like to do.
6. Room for Improvement in Payment Digitization, But COVID Hastens Focus
When asked how they would best describe their current ePayment strategy, 52% of respondents said they are still "planning to optimize" an ePay strategy. Further, nearly 58% said they're interested in "using a supplier portal to support payments."
GHX Summit 20 Digital Connect content is available on demand by visiting https://www.ghxsummit.com/.
About GHX
Building on decades of collaboration between providers, manufacturers, distributors and other industry stakeholders, Global Healthcare Exchange (GHX) is leading the charge in helping organizations run the new business of healthcare. By automating key business processes and translating evidence-based analytics and data into meaningful action, GHX is helping the healthcare ecosystem to move faster, operate more intelligently and achieve greater outcomes. With the support of GHX, healthcare organizations have removed billions of dollars of wasteful healthcare spend. For more information on GHX's suite of world-class, cloud-based supply chain and pharmacy solutions, visit http://www.ghx.com and The Healthcare Hub. GHX has also launched a COVID-19 Information Center that provides a wealth of free resources and access to data and information needed to help serve patients and protect staff during the pandemic.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With this new product, the company that's known for the SneakPeek Early Gender DNA Test provides a window into what a child will look like as an adult, predicted nutrition levels, and sleep behavior, as predicted by genetics.

LA JOLLA, CALIF. (PRWEB) NOVEMBER 16, 2020
Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, launches the SneakPeek Early Traits DNA Test for parents of young children to learn more about their unique child. The test offers fun insights on adult physical features as well as helpful tips and advice for predicted nutrition levels and sleep behavior as gleaned from the child's DNA.
"We're dedicated to developing leading-edge DNA technology that provides parents with the information they need to help their children live their best lives," says Gateway Genomics CEO, Chris Jacob. "Prior to this, we focused on making our prenatal gender DNA test as accurate, accessible, and easy as possible, as early in pregnancy as possible. The new traits DNA test helps parents with their child's next stage in life - baby and early childhood, providing actionable advice for nutrition and sleep that's tailored for the child's DNA."
SneakPeek Early Traits DNA Test focuses on three main categories of traits: 1) Physical Features such as height, eye color, and hair color, 2) Nutrition & Taste, providing predicted vitamin levels and BMI, and 3) Sleep Behavior, including night owl versus early bird tendencies, and how long a child takes to fall asleep, as indicated by genetics. The test is ordered online, and an easy swab of the child's mouth is taken from the comfort of home and mailed back to SneakPeek Labs in a prepaid envelope. Extensive results that include background information on each trait, and tips and advice for nutrition and sleep as tailored for the child's age and genes, are delivered through a secure portal within 2 to 3 weeks. Security and privacy are built into the entire process with data encryption and advanced server authentication.
"We're very excited to offer this new test that gives parents more insight into their future children," continues Mr. Jacob. "It provides answers to questions that could never be addressed before like how tall will my child be, with what color eyes? Will they sleep through the night or have multiple wakeups? At Gateway Genomics, we're always pushing the envelope and innovating to provide leading-edge DNA-based tests that use the most current, scientifically-validated genetic studies for results parents can trust."
SneakPeek Early Traits DNA Test is currently available through the SneakPeek website and the test kit will soon be launched in the company's participating clinical locations.
In 2020, Gateway Genomics ranked #296 in the Inc. 5000 list of fastest-growing private companies in the U.S., #22 in the Health sector. In this year's Inc. 5000 California list, the company was ranked the 17th fastest-growing private company in the state, and #1 in the Health sector. Gateway Genomics' principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.
About Gateway Genomics
Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 300,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With this new product, the company that's known for the SneakPeek Early Gender DNA Test provides a window into what a child will look like as an adult, predicted nutrition levels, and sleep behavior, as predicted by genetics.

LA JOLLA, CALIF. (PRWEB) NOVEMBER 16, 2020
Gateway Genomics, leading provider of direct-to-consumer genetic tests focused on prenatal and pediatric information, launches the SneakPeek Early Traits DNA Test for parents of young children to learn more about their unique child. The test offers fun insights on adult physical features as well as helpful tips and advice for predicted nutrition levels and sleep behavior as gleaned from the child's DNA.
"We're dedicated to developing leading-edge DNA technology that provides parents with the information they need to help their children live their best lives," says Gateway Genomics CEO, Chris Jacob. "Prior to this, we focused on making our prenatal gender DNA test as accurate, accessible, and easy as possible, as early in pregnancy as possible. The new traits DNA test helps parents with their child's next stage in life - baby and early childhood, providing actionable advice for nutrition and sleep that's tailored for the child's DNA."
SneakPeek Early Traits DNA Test focuses on three main categories of traits: 1) Physical Features such as height, eye color, and hair color, 2) Nutrition & Taste, providing predicted vitamin levels and BMI, and 3) Sleep Behavior, including night owl versus early bird tendencies, and how long a child takes to fall asleep, as indicated by genetics. The test is ordered online, and an easy swab of the child's mouth is taken from the comfort of home and mailed back to SneakPeek Labs in a prepaid envelope. Extensive results that include background information on each trait, and tips and advice for nutrition and sleep as tailored for the child's age and genes, are delivered through a secure portal within 2 to 3 weeks. Security and privacy are built into the entire process with data encryption and advanced server authentication.
"We're very excited to offer this new test that gives parents more insight into their future children," continues Mr. Jacob. "It provides answers to questions that could never be addressed before like how tall will my child be, with what color eyes? Will they sleep through the night or have multiple wakeups? At Gateway Genomics, we're always pushing the envelope and innovating to provide leading-edge DNA-based tests that use the most current, scientifically-validated genetic studies for results parents can trust."
SneakPeek Early Traits DNA Test is currently available through the SneakPeek website and the test kit will soon be launched in the company's participating clinical locations.
In 2020, Gateway Genomics ranked #296 in the Inc. 5000 list of fastest-growing private companies in the U.S., #22 in the Health sector. In this year's Inc. 5000 California list, the company was ranked the 17th fastest-growing private company in the state, and #1 in the Health sector. Gateway Genomics' principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.
About Gateway Genomics
Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 300,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

IPM Chirana accelerates U.S. manufacturing of ICU ventilators to combat the effects of COVID-19

RESEARCH TRIANGLE PARK, N.C. (PRWEB) NOVEMBER 16, 2020
IPM Chirana today announced the location of its U.S. headquarters in Research Triangle Park, NC, as well as the commencement of production of Aura V critical care ventilators at the SMTC facility in Boston, MA.
"These milestones are part of our mission to improve healthcare outcomes by providing clinicians around the world with cutting edge, patient-centric solutions like the Aura V ICU ventilator," said Bud Reeves, CEO. "We are very excited to establish our headquarters in the prestigious Research Triangle Park area. Furthermore, we are proud of SMTC's accomplishment of implementing our accelerated production plan and are proceeding to manufacture at least 300 Aura V ventilators by year-end."
The Aura V ventilator is designed for use in intensive care units to support and protect the patient's lungs while providing critical information to caregivers. Its ventilation support range is comprehensive for neonates to adults. It provides supportive breathing assistance to complete mechanical ventilation, all in one system.
"The Aura V ventilator is one of the most technologically advanced critical care ventilators in the world," said Mike Gentile, Vice President of Medical Affairs. "With the ongoing COVID-19 pandemic and a worldwide shortage, our contribution to the global production of ICU ventilators is crucial. Many more patients and clinicians will benefit from the Aura V ventilator's sophisticated, unique technology that optimizes patient care."
IPM Chirana was formed as a strategic partnership between Europe's leading infratech asset manager IPM Group and Slovak company Chirana Medical to rapidly accelerate global production of Aura V ventilators. The Aura V ventilator has been available for years in the EU and other parts of the world. Recently, the Aura V ventilator received emergency ANVISA marketing authorization in Brazil. Applications for use in the U.S. and Canada are currently in review.
"We believe the world does not need more cheap ventilators; the world needs better ventilators," said Peter Gajdos, IPM Chirana Executive Chairman and Head of Venture Capital at IPM Group. "IPM Chirana is composed of exceptionally knowledgeable leaders in their respective fields and together, we are committed to delivering the most advanced critical care ventilator to patients and caregivers."
For more information about IPM Chirana, visit their newly launched website at IPMChirana.com.
###
About IPM Chirana
IPM Chirana is a global provider of life-changing medical technologies based in Research Triangle Park, North Carolina, with a manufacturing facility in Boston, Massachusetts. Led by knowledgeable leaders in respiratory care, we are focused on offering the Aura V ventilator's unique capabilities globally. Through our unwavering commitment, we empower and guide healthcare providers in their quest to improve and protect the health, safety and quality of life for patients around the world. Through our collaboration and unified efforts, we invest our resources to nurture and advance knowledge and the adoption of evidence-based, reliable and robust innovation.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss how etectRx's ID-Cap System is at the forefront of remote patient monitoring and how the technology produces unequivocal adherence data. Attendees will learn how adherence data derived from digital pills is useful for clinical trials and clinicians as well as how digital pills can strengthen patient interactions and adherence.

TORONTO (PRWEB) NOVEMBER 16, 2020
Digital pills offer the potential to help researchers truly understand connections between medication adherence and patient outcomes. The use of digital pills in clinical trials can help researchers have more confidence in their data, and can provide data that links dose to time of ingestion, dose to medication levels, as well as real-time notifications of missed doses. This data allows for immediate intervention if a researcher sees that a patient has not taken their prescribed medication.
Join this webinar to learn about how an FDA cleared technology, the ID-Cap System, uniquely addresses patient adherence to oral medication.
This system provides real-time data that confirms ingestion events and enables tracking of oral medication use with a high rate of accuracy. The technology enables fast interventions for maintenance to a prescribed medication regimen for better patient outcomes.
Learn how these technologies have been used in trials and how they can address risks to the success of trials that are associated with poor adherence, suboptimal patient engagement and inaccurate adherence reporting.
Join Susan Baumgartner, PharmD, MBA, Vice President, Product Management & Regulatory Affairs, etectRx; Peter R. Chai, MD, MMS, Assistant Professor of Emergency Medicine, Harvard Medical School; and Stefanie Kuhner, Global Director for Clinical Technology & Patient Recruitment within Strategic Sourcing & Procurement, Bristol-Myers Squibb in a live webinar on Thursday, December 3, 2020 at 2pm EST.
For more information, or to register for this event, visit Better Connections with Patients Using Data from Digital Pills.
ABOUT ETECTRX
etectRx is a digital health company. Our FDA cleared ID-Cap System uniquely addresses the issue with patient adherence to (oral) medication. Accurate, flexible and elegant digital pill system allows pharmaceutical companies to rethink approaches to medication adherence, innovate with confidence, and accelerate patient outcomes.
To learn more about etectRx, visit etectrx.com
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss strategies for engaging diverse patient populations who have rare genetic diseases and effective collaborative strategies between industry and patient advocacy organizations. Attendees will also learn about ways to reduce economic and geographic barriers to clinical trial participation.

TORONTO (PRWEB) NOVEMBER 16, 2020
When targeting rare genetic diseases for clinical trials or research, patient engagement is critical. In this webinar, join a panel of experts who will address proven and emerging ways to empower a diverse group of patients as critical stakeholders in clinical trials, leading to improved participation and more meaningful outcomes.
There are more than 2,500 gene-based therapies in the biotech pipeline, many of which are targeted for rare diseases. Clinical trials for these emerging therapies typically target very small patient populations, leading to significant challenges in the identification and enrollment of qualified patient participants. Biotech and pharmaceutical companies routinely reach out to patient advocacy groups, but don't often know how best to support their efforts, or how to engage a diverse population of patients in the clinical trial development process.
In addition, the patient voice is often restricted to those who have the means to travel to academic research centers. Success in rare disease clinical trial enrollment and retention necessitates expanded access, more inclusive outreach strategies, and technology-driven solutions.
Join Lanya McKittrick - Chair of the Usher Syndrome Coalition and Founder, Hear See Hope Foundation; Steve Smith - President, Patient Advocacy, WCG; and Karmen Trzupek, M.S., CGC, Director of Clinical Trial Services, InformedDNA in a live webinar on Thursday, December 3, 2020 at 1:00PM EST.
For more information, or to register for this event, visit Engaging Diverse Patient Populations in Rare Genetic Disease Clinical Research.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss the use of digital tools in MS clinical research, as well as practical approaches to the selection of fit-for-purpose assessments and the development of endpoint strategies for MS clinical trials. Attendees will also hear about case studies in the application of cognitive and motor assessments.

TORONTO (PRWEB) NOVEMBER 16, 2020
Substantial progress has been made in the development of disease modifying therapeutics for Multiple Sclerosis (MS) in recent years. The array of next-generation compounds for this complicated disease have made great strides in increasing the time between relapse and delaying disease progression. Future treatment options must go beyond new routes of administration and dosing frequency to listen closely to the MS patient voice and address the additional—and often less visible—symptoms that impact health outcomes and quality of life.
Cognitive function and motor abilities have been noted by patients as being some of the most disabling aspects of the disease. Earlier, more precise identification of change or decline in motor abilities may shed light on aspects of therapeutic response or disease progression with relevance for patients and family members.
As pharmaceutical researchers develop new therapeutics targeting those symptoms that matter most to patients, they are faced with the challenge of how to measure these outcomes in clinical trials.
This webinar will present advances in validated tools and technologies to collect digital endpoints relevant to MS and other neuromuscular diseases that can improve signal detection and gather relevant data needed to measure treatment response. The speakers will review examples of how these technologies have provided high quality outcome measures via sensitive, reliable and objective assessments which fully characterize motor and cognitive impairment.
Join Fay Horak, PhD, Chief Scientist, Wearables & Digital Biomarkers, ERT; and Chris Edgar, PhD, Chief Science Officer, Cogstate in a live webinar on Tuesday, December 1, 2020 at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit Digital Technologies for Assessing Patient Functioning in Multiple Sclerosis Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

With the first major changes to E/M payment policies and documentation guidelines in over 20 years, healthcare organizations are looking for the latest education and regulatory information to reduce the risk of incorrect coding and help prevent subsequent denials and audits.

BRENTWOOD, TENN. (PRWEB) NOVEMBER 16, 2020
With major E/M code changes set to go live on January 1, 2021, healthcare organizations need to prepare their staff to prevent potential disruption to a key revenue stream. E/M office visits account for 20% of total physician fee schedule charges and approximately $15.6 billion in payments from Medicare (based on 2018 data for codes 99201-99215). The American Medical Association (AMA) projects that the impending E/M code changes will impact $25 billion in Medicare Part B spend.
The experts at HCPro and DecisionHealth are excited to announce the release of new E/M training programs and solutions to provide healthcare organizations with the education and regulatory information to reduce the risk of incorrect coding and help prevent subsequent denials and audits.
"Given the breadth of changes and potential impact on revenue, a comprehensive training plan is highly recommended to give your staff enough time to understand the new E/M billing policies and documentation guidelines. This includes using practical scenarios to help them fully comprehend the new complexities prior to 2021," says Richard Scott, Associate Content Manager for Part B News, among other DecisionHealth publications.
With E/M changes impacting personnel across the entire spectrum of a healthcare organization's revenue cycle, we have created specific E/M training programs for:

Coders and auditors who need to assign, verify, and act as a resource for interpreting the new and revised guidelines while optimizing E/M audits;

Compliance, documentation integrity (CDI), and finance education, zeroing in on specific need-to-know information to compliantly protect revenue;

Physicians tasked with selecting their own levels of E/M services and want to ensure minimal interruption to workflow processes; and

Payers who need to understand the implications on revenue cycle and compliance departments from medical policy and claims to data analysis, provider outreach educators, and more.

Scott adds, "It's more than just providing training for your coders. Clinicians need to understand how to document accurately, billing departments need to be able to keep your revenue on track, and managers must be ready to make high-level decisions, such as whether to use time or MDM for your patient encounters. They will all be impacted."
View a full suite of E/M training programs available at https://interactive.hcpro.com/evaluation-management-solutions.
And if your healthcare organization requires a more custom-designed training program, our E/M Solution Center allows you to browse featured offerings by category, including:

Instructor-led boot camps, virtual workshops, and eLearning course libraries for coders of every level basic, intermediate or advanced;

Online digital workflow coding tools, eNewsletters, and membership subscriptions providing instant access to the latest E/M news and updates;

Webinars on specialty practices, Medicare physician fee schedule, E/M new documentation guidelines, pay rates, and more available in both live and on-demand formats; and

2021 guides, books, and quick reference cards.

You can even download a complimentary copy of a 2021 E/M Prep Guide from our experts that contains critical information to ensure coding accuracy and secure proper payment.
Visit the E/M Solution Center at https://interactive.hcpro.com/solution-center/evaluation-management.
To discuss training recommendations that fit your specific needs or to receive additional information on E/M solutions, contact our compliance and education team at 1-800-650-6787.
About HCPro
HCPro provides the latest healthcare regulatory and compliance updates through industry-leading publications, continuing education, online coding platforms, instructor-led training, and consulting services. We focus on providing specialized solutions for every stage of the revenue cycle at healthcare facilities, including clinical documentation, coding, compliance, reimbursement, billing, denials, and more. Visit http://www.hcpro.com/.
About DecisionHealth
For over 30 years, DecisionHealth has served as the industry's leading source for home health agencies and medical practices to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, accreditation, benchmarks, payment, and HIPAA compliance. You also may know our flagship publications Part B News, Home Health Line, Medical Practice Compliance Alert, and Inside the Joint Commission, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com.

Given the breadth of changes and potential impact on revenue, a comprehensive training plan is highly recommended to give your staff enough time to understand the new E/M billing policies and documentation guidelines.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nymbl Science - a breakthrough fall prevention solution in the healthcare space - closes $4 million Series A funding round, led by Cobalt Ventures, LLC.

DENVER (PRWEB) NOVEMBER 16, 2020
Nymbl Science, the leader in digital, scalable fall prevention for older adults, is pleased to announce the closing of a $4 million Series A funding round. Cobalt Ventures, LLC, the investment arm of Blue Cross and Blue Shield of Kansas City, led the round with additional participation from other Nymbl investors. The proceeds will enable the expansion, support and technical needs of Nymbl's rapidly growing balance improvement system, thus furthering the company's ability to meet the needs of older adult populations through Medicare Advantage and Single-Payer insurance systems worldwide.
"We are thrilled by the support of successful investors who see Nymbl as a breakthrough solution in the healthcare space. This investment will help us accelerate our growth as we continue to deliver population-level fall prevention solutions through leading health insurers, both in the U.S. and worldwide," said Ed Likovich, chief executive officer of Nymbl. "The Cobalt investment gives us the ability to recruit top-notch talent and enhance our product development as we expand our balance improvement platform that has demonstrated a 35 percent reduction in injurious falls. We are also excited to have Phillip Linville, Principal of Cobalt Ventures, join Nymbl's Board of Directors. His financial and strategic industry knowledge will be valuable as we continue to grow and expand our impact."
Cobalt Ventures, LLC invests exclusively in high-growth healthcare companies with capabilities that can be scaled and leveraged nationally across the payer universe. Cobalt targets companies that increase the overall quality of healthcare services, improve outcomes and lower costs for customers and members.
"Nymbl is a company that aligns extremely well with Cobalt's investment strategy" said Phillip Linville. "They have demonstrated the ability to deliver their solution with excellent results through major Medicare Advantage payers and have only scratched the surface of this enormous market opportunity. We look forward to working with Nymbl to achieve and exceed their company mission of preventing one million falls."
The Series A financing builds on an exceptional year for Nymbl, which saw the launch of Nymbl's patented balance improvement system through two of the nation's largest Medicare Advantage Providers, as well as the Accident Compensation Corporation (ACC), New Zealand's single-payer injury prevention provider.
About Nymbl Science
Nymbl is the only company providing digital balance training that is scalable, insightful, and cost saving for our partners and effective and engaging for older adults. Our scientifically validated balance training program trains the brain and body to work together, known as dual-tasking. Using just a smart device, and in only 10 minutes a day, older adults are preserving and enhancing their freedom and enjoyment of life with Nymbl. We believe it is necessary to empower older adults to increase their confidence and ability to fully participate in life. Join us on our way to preventing 1 million falls. For more information, visit http://www.nymblscience.com.
About Cobalt Ventures, LLC
Cobalt Ventures, LLC is the captive investment subsidiary of Blue Cross and Blue Shield of Kansas City, the largest not-for-profit health insurer in Missouri and the only not-for-profit commercial health insurer in Kansas City. Cobalt owns, or is invested in, a portfolio of innovative companies in the healthcare services industry. Cobalt's goal is to be a strategic investment partner to help grow companies bringing new and innovative services to the healthcare universe. More information about Cobalt Ventures can be found at http://www.cobalt-ventures.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The General Richard B. Myers Program at Medisend College has trained veterans for technically advanced employment with leading healthcare organizations since 2013. Bank of America is committed to providing services and opportunities to service members, veterans and their families, and is a staunch supporter of programs that support veterans.

DALLAS (PRWEB) NOVEMBER 16, 2020
Bank of America has granted $30k to the General Richard B. Myers Veterans Program at Medisend College of Biomedical Engineering Technology. Veterans come from across the nation to attend the highly acclaimed program that has a proven record of helping to place graduates in well-paying jobs with healthcare organizations such as Siemens Healthineers, Henry Schein Dental, and GE.
"As one of the many organizations that Bank of America supports to benefit our US veterans, we are proud and grateful to be selected as recipients of their generosity. This funding will help enable Medisend College to expand the veterans program to serve even more young men and women endeavoring to successfully enter the civilian workplace," says General Richard B. Myers, 15th Chairman of the Joint Chiefs of Staff, current President of Kansas State University and Chairman of Medisend College Board of Trustees.
Through the intensive curriculum and state of the art laboratory experience, The General Richard B. Myers Veterans Program at Medisend College qualifies veterans to maximize the skills gained in service to their country. The program enables veterans to transition into civilian life with well-paying jobs in the rapidly growing healthcare industry. General Myers states it best, "Our mission is not complete until we have given our veterans and their families the opportunity for a secure future."
"Bank of America is committed to providing resources to veterans as they transition back to civilian life," said Emily Ledet, Dallas market executive for Bank of America. "Our partnership with Medisend College helps ensure our veterans have the skills needed to obtain a sustainable career that puts them on a path to greater economic mobility and will allow their families to thrive."

"As one of the many organizations that Bank of America supports to benefit our US veterans, we are proud and grateful to be selected as recipients of their generosity." General Richard B. Myers



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Periodontists Melanie Towe, DMD, MSD & Lisa Shoff, DMD, MS Now Offer LANAP Protocol, A Safe and Effective Treatment for the Most Common Medical Condition in the U.S.

FREDERICK, MD. (PRWEB) NOVEMBER 16, 2020
Advanced Implants & Periodontics now offers patients with periodontitis a quick and safe laser based treatment for gum disease. The LANAP protocol is minimally invasive treatment option that can help patients save their teeth.
Gum disease is a bacterial infection that can destroy the bone around your teeth if not treated properly. Without bone to support the teeth, they become loose and can fall out or be removed. The LANAP protocol is the only FDA cleared laser treatment that is scientifically proven to regenerate the bone, tissues and cementum destroyed by periodontal disease.
"Our practice goal is to provide exceptional service in a comfortable and caring environment. We are committed to preventative, minimally invasive and evidence-based treatment that helps save your teeth," states Dr. Melanie Towe. "Now, with the LANAP protocol, we have another approach to help more patients."
The impact of untreated gum disease goes well beyond the mouth. It has been linked to heart disease, diabetes, stroke, and certain cancers. Now patients in Frederick, MD have a safe and effective treatment option that is less invasive than traditional surgery with fewer post-operative effects.
"Offering LANAP to our patients aligns with our practice's core values of Integrity, Quality, Service and Compassion," sates Dr. Lisa Shoff. "LANAP treatment allows us to combine advanced technology with improving the patient experience and still provide long-term stable results."
The LANAP protocol uses the unique PerioLase MVP-7 dental laser to vaporize bacteria deep within the pockets of the gums while leaving healthy tissue intact. Patients choosing LANAP treatment enjoy fast healing times and more predictable results. Some of the primary benefits of LANAP laser surgery as compared to traditional cut-and-sew surgery are:

Less pain and very little downtime after treatment

Less sensitivity

Less gum loss

Promotes regeneration of supporting gum tissues and bone

The LANAP protocol is also safe for patients with health concerns. Patients taking medicine such as Plavix or aspirin can continue medications throughout treatment.
For information on the LANAP protocol, call Advanced Implants & Periodontics at (240) 651-5478 or visit https://frederickimplant.com.
ABOUT DR. TOWE:
Dr. Melanie Towe, DMD, MSD, DABP, DICOI
Ivy League Educated Board Certified Periodontist
Patients who meet with Dr. Towe immediately recognize both the passion she has for her work, and the professional manner in which she interacts with people. Dr. Towe's evaluations are highly based on the concerns and goals of the patient. You can be assured that you will be treated with compassion and integrity from the first phone call to your last appointment.
Dr. Melanie Towe grew up in Columbia, South Carolina and graduated Cum Laude from University of South Carolina. Dr. Towe received her dental degree from the University of Pennsylvania School of Dental Medicine, where she graduated at the top of her class with honors. After graduation, Dr. Towe spent 3 years at the Medical College of Virginia Advanced Graduate Periodontics program. Her training included traditional periodontal surgery, cosmetic soft tissue grafting, restoration of aesthetically challenging cases involving full mouth reconstructions using advance implant site preparation and placement protocols. Her surgical practice focuses on utilizing the most cutting-edge industry innovations, digital scanners and various CAD-CAM technologies.
Dr. Towe is currently on the faculties of the Virginia Commonwealth University as a Clinical Assistant Professor of Periodontics. Dr. Towe is a Diplomate of the American Board of Periodontology and the International Congress of Oral Implantologists. She maintains active memberships in many professional associations and lectures frequently at State Dental Associations and Study Clubs. (For full CV, please visit http://www.frederickimplant.com) She enjoys living in downtown Frederick, and spending time with her husband Wyatt and children Natalie and James.
ABOUT DR. SHOFF:
Dr. Lisa Shoff, DMD, MS, DABP
Ivy League Educated Board Certified Periodontist
Dr. Shoff was born and raised in York, PA and has returned to the area to be closer to family. Dr. Shoff completed her bachelors in Biology at the University of the Sciences in Philadelphia, PA where she was the valedictorian. Dr. Shoff received her dental degree and Masters from the University of Pennsylvania. After graduation, she entered the Air Force and completed a 1-year Advanced Education in General Dentistry residency in Northern California. Dr. Shoff served her country with the Air Force in Guam for 3 years, then entered the Periodontal residency at the University of Texas Health Science Center and Air Force Post Graduate Dental School. Dr. Shoff graduated top of her class from residency and was selected to teach an AEGD residency in Northern California. Dr. Shoff is a Diplomate of the American Board of Periodontists, and an active member of the American Academy of Periodontology. Dr. Shoff has lectured to local study clubs and presented her research at national meetings. Dr. Shoff continues to serve her country as a member of the Air National Guard.
Dr. Shoff and her husband, Eric, have been married for 14 years. In the past 3 years, they have grown to a family of 5 to include a corgi mix dog named Pliny, their son Samuel, and daughter Annie Joy. They love spending time together and love being outside. After living in Northern California near Napa/Sonoma for 4 years, they have really learned to appreciate great wine of all varietals. When Dr. Shoff is not busy keeping up with her kids, she loves to curl up with a good book. She also enjoys running, yoga, and Pilates. They are looking forward to settling down for good, exploring Frederick county, and getting involved in the community.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New study will reveal insights for COVID-19 vaccine adoption

PHILADELPHIA (PRWEB) NOVEMBER 16, 2020
The Behavior Change for Good Initiative (BCFG) at the Wharton School and School of Arts and Sciences of the University of Pennsylvania has partnered with Walmart to conduct the largest-ever communication research study aimed at increasing flu vaccinations during the Fall 2020 flu season. The results of the study will be well-timed to assist with encouraging COVID-19 vaccinations.
As Penn Professors Katy Milkman, Mitesh Patel, and Angela Duckworth noted in their recent USA Today op-ed about the American COVID-19 response, "In the war to establish herd immunity, developing a vaccine is only half the battle. We also need behavior change techniques to encourage an unprecedented number of Americans to choose vaccination when the time comes."
The BCFG-Walmart study focuses on closing what behavioral scientists call the intention-action gap.
"We focused on giving people an extra nudge to do something they already intended to do so it wouldn't slip through the cracks. Sometimes that's just a timely reminder, but it can also include a dose of encouragement when the task at hand feels arduous and easy to put off indefinitely. Past research suggests that we fail to act on anywhere from a third to two thirds of our intentions, particularly when it comes to our health," said Katy Milkman, Wharton professor and BCFG Co-Director.
The goal is to learn how scientifically-informed messages can help increase vaccinations at scale. When a COVID-19 vaccine becomes available, these learnings can then be deployed to help motivate people to receive the vaccine and combat the spread of the virus.
BCFG's interdisciplinary team of scientific experts designed 22 distinct text messaging strategies to encourage flu vaccination among hundreds of thousands of Walmart pharmacy customers who had agreed to receive messages from their pharmacy. These 22 communication strategies were then evaluated simultaneously in a massive A/B test in September 2020 to determine which were most effective at increasing flu shot uptake overall, as well as which were most effective among different sub-populations.
Some text messages prompted people to text "I will get a flu shot" to their pharmacy — a commitment to spur future action. Others took a more jovial approach to motivating vaccination by sharing a joke about flu season. Still other texts asked people to encourage others to get flu shots by passing along a motivational message that could easily be copied and pasted. This is just a small sample of the many messaging techniques evaluated, each designed to provide the last needed boost for getting vaccinated.
BCFG will rapidly analyze the results of this A/B test and share the most effective communication strategies in early 2021 to ensure healthcare providers around the world can benefit from these insights.
"I am incredibly excited about the potential of this project to advance knowledge and save lives," said Angela Duckworth, Penn and Wharton Professor and BCFG Co-Director.
"Walmart is well-prepared for flu season, and we want to better learn how to encourage our customers to get vaccines to keep themselves, their families and their communities safe," said Michelle Leclerc, Walmart Pharmacist. "Providing access to immunizations and effective communication of the importance of getting a flu shot is another way we can help people live better."
Walmart took many steps in 2020 to make it easier than ever for customers to get a flu shot. Walmart also launched a digital scheduler so customers could pre-book an appointment for a flu shot at any one of their 4,700+ pharmacies and hosted twice-weekly "fast flu" events to encourage customers to get flu shots during their regular shopping trips. Walmart has also ensured its 1.5 million associates have access to flu shots with no out-of-pocket costs, regardless of their insurance status.
About The Behavior Change for Good Initiative
The Behavior Change for Good Initiative (BCFG) at the Wharton School and School of Arts and Sciences of the University of Pennsylvania unites a world-class, interdisciplinary team of over 100 behavioral science experts (including two Nobel Laureates, five MacArthur Genius Award winners, and numerous members of the National Academy of Sciences) with leading organizational partners to help advance the science and practice of behavior change. BCFG identifies what works at scale by conducting mega-studies (massive random-assignment A/B tests), which simultaneously test the BCFG Scientific Team's best ideas for changing a target behavior. This approach gives BCFG the power to understand which strategies work best overall, what works best for whom, and how to most effectively use behavioral science to transform people's lives for the better. To learn more, visit https://bcfg.wharton.upenn.edu.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.

NEW YORK (PRWEB) NOVEMBER 16, 2020
A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.
These results are important because most cancer vaccine trials have failed to show clinical efficacy. These results show that adding two immune-boosting components can boost the immune response for not only melanoma patients but possibly also others whose cancers express a protein called the vaccine antigen, which is common in some cancers.
Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, working with colleagues at the National Cancer Institute-funded Cancer Immunotherapy Trials Network (CITN) based at the Fred Hutchinson Cancer Research Center, found that adding the small molecule Flt3L, which increases the number of dendritic cells, boosted the vaccine's effectiveness at producing antibodies and T cells that can later fight melanoma. Adding a second component, called poly-ICLC, also strengthened the dendritic cells' ability to promote antibodies as well as helper and killer T cells.
Sixty patients who had stage 2 or 3 melanoma, and whose cancer was successfully removed via surgery, received the vaccine. Half of the patients received the vaccine alone while the other half received the vaccine with Flt3L and poly-ICLC.
The vaccine is designed to target dendritic cells and is composed of an antigen found in melanoma bound to an antibody to increase the chances of binding with dendritic cells.
The cocktail of the vaccine, Flt3L, and poly-ICLC nearly doubled the vaccine's efficacy, according to analysis of the T cells detected in patients' blood samples after they received four doses over four months. That immune response was seen significantly earlier in the patients who received the cocktail and at much higher levels in many more patients compared to those who received only the vaccine. Researchers found antibodies were still present in blood samples tested 12 weeks after the last dose.
"This is the first randomized clinical trial to show that an immune response to a cancer vaccine can be potentiated by the addition of Flt3L," says Nina Bhardwaj, MD, PhD, Director of the Immunotherapy Program at The Tisch Cancer Institute, and first author and a corresponding author on the study. "The response was achieved because Flt3L mobilized dendritic cells, which are the gold standard in promoting cancer immunity, and improved the overall immunogenicity of the vaccine. This may change the approach of increasing efficacy in other cancer vaccines in the future."
"These positive results are significant not only for improving cancer vaccines, but also potentially for application to other vaccine platforms," reported the study's co-corresponding and senior author Steven Fling, PhD, Director of the CITN Laboratory and Senior Staff Scientist in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center, "and we are extremely grateful and indebted to the patients whose unwavering participation made this demanding clinical protocol a success."
These findings also provide a basis for adding immunotherapies called checkpoint inhibitors, which have been successful in treating metastatic melanoma, to vaccines in order to further increase the success in fending off melanoma recurrence. Researchers also plan to follow trial participants over time and measure how many have cancer recurrence to further study the vaccine's efficacy in each group.
"Immunotherapy has already shown great promise for patients with metastatic melanoma who would normally have a difficult, sometimes grave, prognosis," said Philip Friedlander, MD, PhD, Director of the Melanoma Medical Oncology Program at The Tisch Cancer Institute at Mount Sinai and site investigator of the trial. "It's important to work toward developing effective cancer vaccines that can prevent cancer on their own or in addition to the drugs already available."
This research was funded by the National Cancer Institute and Celldex. Celldex also manufactured the vaccine and Oncovir manufactured the poly-ICLC.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Physician peers select SGF's Stephanie Beall, M.D., Ph.D., and Howard McClamrock, M.D., among the region's best in reproductive endocrinology and infertility.

BALTIMORE (PRWEB) NOVEMBER 16, 2020
Shady Grove Fertility (SGF) physicians Stephanie Beall, M.D., Ph.D., and Howard McClamrock, M.D., are recognized as 2020 Top Doctors for infertility in the region by Baltimore magazine. Rounding the corner on its 34th year, the Baltimore Top Doctors honor is bestowed upon by physicians representing dozens of specialties. Physician peers voted and chose Drs. Beall and McClamrock among the estimated 14,000 physicians licensed to practice in the magazine's readership area.
Get to Know Dr. Stephanie Beall
Dr. Beall, who sees patients at SGF's Towson location, was the 29th physician to join SGF back in 2013. She has a keen clinical interest in treating patients with diminished ovarian function and fertility preservation. Dr. Beall is passionate about working with women coping with the stress of infertility, which she has rightfully been recognized for as the recipient of a Compassionate Doctor Award on Vitals.com.
She emphasizes a personalized approach to care, bearing in mind the couple's medical and emotional needs. Dr. Beall seeks to make fertility care accessible for women in the Baltimore region, motivating her to help pass the Maryland fertility preservation bill.
"I'm honored to be recognized by Baltimore magazine as a Top Doctor in the region, and it's my patients who are at the top of my priorities," shares Dr. Beall. "Fertility is a precious gift that's all too often taken for granted until it's hard to obtain or taken away prematurely. For me, it is incredibly satisfying to help build families."
A patient of Dr. Beall's shared, "Shady Grove Fertility was the third reproductive clinic my husband and I went to, and we desperately wish it had been the first! Dr. Beall was fantastic – she always made herself available for questions and concerns and never hesitated to give us her honest opinion...We never felt pressured and always felt as though we were in great hands."
Get to Know Dr. Howard McClamrock
A Baltimore magazine Top Doctor veteran, Dr. McClamrock has made an impression on the state of Maryland's when it comes to advancing reproductive care. Dr. McClamrock was the first reproductive endocrinologist in the state to perform a frozen embryo transfer (FET) that resulted in a live birth. He also co-founded the in vitro fertilization (IVF) program at the University of Maryland along with Dr. Eugene Katz of SGF's Towson office – where he played an integral role in training the next generation of top doctors in reproductive endocrinology.
Dr. McClamrock sees patients at SGF's Baltimore – Harbor East office and specializes in IVF treatment, male-factor infertility, and egg freezing.
Upon receiving the Top Doctor honor, Dr. McClamrock shared, "Part of what makes Shady Grove Fertility a world-class fertility practice is the bond we are able to create with our patients. To the Baltimore community, thank you for trusting me and my fellow physicians to be a part of one of life's most sensitive journeys."
"I cannot thank Dr. McClamrock enough for his kind and compassionate care," expressed a recent patient. "With him I felt a sense of hope that I had not previously felt such that no matter what our outcome...I truly feel blessed to have had the opportunity to be a patient of Shady Grove Fertility's in one of life's most stressful circumstances. Thank you from the bottom of my heart."
A Leader in Reproductive Treatment and Care
SGF extends its congratulations to all physicians who are honored by Baltimore magazine. Additionally, SGF celebrates its referral network of 4,000-strong physicians annually who help make it possible for SGF to fulfill patients' dreams of having a baby.
For people struggling to conceive, it may be time to consult a fertility specialist. Contact the SGF New Patient Center at 1-888-761-1967 or complete a brief online request form to schedule a virtual consult with an SGF physician. A virtual physician consult is the first step toward pursuing a pregnancy with the help of SGF.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nixxi's PopNatal offers the earliest and most cost-effective identification of women at risk for premature delivery

PHOENIX (PRWEB) NOVEMBER 16, 2020
Nixxi, a women's health company with a mission to improve pregnancies and pregnancy outcomes, announces the launch of PopNatal, a proprietary digital assessment of a woman's risk for preterm birth. The current standard of care, which largely consists of history-based screening, misses 93% of women who will have a preterm delivery. Based on advanced technology developed by leading maternal-fetal medicine physicians and data scientists, PopNatal identifies nearly ten times more women at risk for preterm birth than current screening methods in early pregnancy. Early identification provides health care providers and women with the best opportunities to take proactive steps to reduce preterm birth risk. PopNatal is a clinical decision support tool that provides actionable intelligence to health care providers for patient management. PopNatal is immediately available to women, clinicians, and healthcare payors.
How it Works
A woman who is planning for a pregnancy, or upon learning she is pregnant, may register on the Nixxi website (http://www.nixxihealth.com) for access to PopNatal. She will be asked to provide information about herself and her health history within the secure and HIPAA-compliant portal. Nixxi then analyzes hundreds of data points using a proprietary algorithm in order to produce a risk assessment. Within 72 hours, Nixxi reports the results to the woman's health care provider. The results allow the woman and her doctor to work together to develop a care plan tailored to her pregnancy.
Unlike other tests, which require a blood sample and can't be taken until the second half of pregnancy, the PopNatal preterm birth risk assessment offers an earlier, equally accurate, more convenient, and more affordable way to determine a woman's risk of premature delivery. The PopNatal process takes less than 15 minutes for most women to complete on their mobile phone when and where they choose -- whether in the comfort of their own home or on the go between activities.
PopNatal uses an advanced artificial intelligence algorithm to predict the risk of delivery prior to 37 weeks in all women, including first-time pregnancies and women without a prior history of preterm delivery. The test is 75% sensitive and 60% specific, which is similar to commercially available blood-based preterm birth prognostic testing. The individual's results will either fall in the high-risk group (she has a 4-fold increased risk for preterm birth before 37 weeks gestation) or low-risk group (she has a 96% chance of not delivering prematurely). Results from PopNatal are intended to inform the clinical decisions of healthcare providers, and do not replace the benefits of adequate prenatal care under the supervision of a qualified healthcare provider.
"History-based screening, the current standard of care for risk assessment in early pregnancy, only identifies 7% of women who will deliver preterm. PopNatal fills a significant unmet need and accurately identifies at-risk women early in pregnancy," said Avi Patil, MD, Nixxi's founder, chief executive officer, and a maternal-fetal medicine physician. "Our team was determined to provide an easy-to-use, non-invasive and affordable tool to help arm clinicians and women with actionable information early in pregnancy. The early implementation of PopNatal is particularly useful to allow time to create a tailored and meaningful care plan for each woman."
About Preterm Birth
Preterm birth is defined as delivery of a baby before 37 completed weeks of pregnancy. A full-term pregnancy lasts between 37-40 weeks or about nine months. Preterm babies tend to have more health problems and stay in the hospital longer than babies born full-term. The earlier in pregnancy a baby is born, the greater the chance of serious health problems, both immediate and long-term, including slower growth, cerebral palsy, sudden infant death syndrome (SIDS), diseases of the ears and eyes and even blindness.
Preterm birth affects one in 10 pregnancies in the U.S.. The overall rate has continued to increase for the past four consecutive years. Preterm birth and related complications are the largest contributors to infant death in the U.S. and globally. In the U.S. alone, the annual economic burden associated with preterm birth exceeds $26.2 billion. The majority of these costs stem from those babies born before 32 weeks.
Common causes of preterm birth include a woman having had multiple pregnancies, infections, and chronic conditions such as diabetes and high blood pressure. There could also be shared genetic factors among family members that affect risk. Women who live in poverty, both in low-income countries and more developed nations, also have a much higher risk. Often, however, no cause will be identified.
Other known risk factors for preterm birth include having had a prior preterm birth, pregnancy with twins or other multiples, a short interval between pregnancies, fertility treatments, and problems with the major organs involved in the pregnancy. Smoking, drug use, inability in maintaining a healthy weight and stress can all contribute to preterm birth risk as well. Lifestyle choices and decision-making play a critical role in eliminating some of these risk factors and give women a better chance of having a healthy pregnancy and baby.
About Nixxi
Nixxi, based in Phoenix, AZ, is a women's health company with a mission to improve pregnancies and pregnancy outcomes. The company is led by a group of experienced, determined professionals with a variety of healthcare backgrounds.
Nixxi's focus is to reduce pregnancy risk and enhance neonatal outcomes through early and cost-effective testing paired with actionable insights for providers and women. PopNatal is one of several Nixxi products. Others include PopNatal Insights, a report for health care providers with curated evidence-based guidelines that can soon accompany PopNatal, and DocNatal, a forthcoming blood test to pinpoint the highest risk pregnant women, those likely to deliver before 32 weeks' gestation.
For more information or to take the PopNatal preterm birth risk assessment, please go to http://www.nixxihealth.com.
# # #



START your own Wordpress site, business or personal website, or online store at www.siteground.com

ConcertAI will present at the Stifel 2020 Virtual Healthcare Conference

BOSTON (PRWEB) NOVEMBER 16, 2020
ConcertAI will present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020, at 8:40 a.m. Eastern Time. The conference will be held virtually.
Jeff Elton, PhD, Chief Executive Officer at ConcertAI, will talk about the significant pausing of clinical studies, declines in new starts, and drops in clinical trial patient accruals during the COVID-19 pandemic. ConcertAI will further report on novel digital oncology clinical research initiatives it is accelerating with biopharma partners in response.
ABOUT CONCERTAI
ConcertAI is a technology leader in Definitive Real-world Data (RWD) and AI solutions for precision oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. ConcertAI is a SymphonyAI company. eurekaHealth is a trademark of ConcertAI. For more information, visit us at http://www.concertai.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The high cost of diagnosing and treating cancer—in addition to the prescription drugs and therapies associated with the disease—is bankrupting hard-working Americans, who cannot afford the expensive deductibles, copays, and increasing monthly premiums. The study and treatment of cancer must evolve, says Paul J. Crowe, CEO of NuView Life Sciences, a Utah clinical-stage oncology firm.

PARK CITY, UTAH (PRWEB) NOVEMBER 16, 2020
Cancer costs in the United States for 2020 could reach approximately $150 billion, while the out-of-pocket expenses for the average American worker could take up to 70% or more of their monthly income. To put those numbers in perspective, the average gross pay in the US is $3,600 a month. Furthermore, 20% of cancer patients report spending as much as $20,000 out of pocket during the course of their care for drugs like chemotherapeutic agents and treatments like radiation therapy, etc.(1) "The high cost of cancer, from diagnostic procedures like biopsies to various treatments and prescription cancer medicines, has become unbearable for patients. There needs to be a change," says Paul J. Crowe, CEO of NuView Life Sciences, a clinical-stage oncology firm in Utah.
Biopsies are one of most common methods used to diagnose cancer. This procedure, which involves the removal of a small sample of suspect tissue for further testing, varies greatly in cost—some procedures, like skin biopsies, may cost as little as $150. But for major organ biopsies, patients without health insurance may be on the hook for as much as $10,000 or more.(2) For patients covered by health insurance, copays generally range from 10 to 40 percent of the total cost. And while most simple biopsies generally do not require hospitalization, major organ biopsies usually do, which adds additional expense on top of the already pricey biopsy copayment—not to mention the possibility of infections, bleeding and other complications that would add to the costs
According to a 2019 study in the American Journal of Public Health, 66.5% of all bankruptcies in the US result from the inability to pay medical expenses—regardless of health insurance, the high deductibles, copays, increasing monthly premiums, loss of income, and high cost of prescription cancer drugs contribute to this impact.(3)
Another factor that has to be taken into consideration is the cost of cancer treatment itself. On average, chemotherapy costs between $1,000 and $12,000 per session (depending on the drugs used and the severity of the cancer).(4) According to the American Cancer Society, in 2014, Americans spent roughly $4 billion out of their own pockets for cancer treatments. And since there are over 200 identified forms of cancer, it is impossible to predict just how many prescription cancer drugs or other treatments, like radiation therapy, a single person may need. (5)
The Future of Cancer Diagnoses and Treatment
New imaging technologies in radiology, such as biochemical positron emission tomography (PET) imaging combined with magnetic resonance imaging (MRI) or computed tomography (CT) anatomical imaging have made great strides in detecting cancer. Now, NuView Life Sciences has developed a unique and proprietary binary test that would more accurately diagnose cancer by targeting only cancer cells.
As a first-of-its-kind technology, NuView Life Sciences combined their proprietary NV-VPAC1(TM) peptide construct with the radionucleotide Copper-64 [(64)Cu] for diagnostics and Cu for treatment. Research shows that malignant cells accumulate (64)Cu in much greater quantities compared to normal, healthy cells.(6) As a result, the NV-VPAC1 peptide construct targets cancer cells, binding to specific receptors, called VPAC1 receptors, which are overexpressed on the surface of cancer cells.
Healthcare providers can easily view this accumulation using PET diagnostic imaging, eliminating the need for more expensive—and invasive—diagnostic tests like biopsies. NV-VPAC1 also identifies cancerous cells shed from the body in biofluids like urine, thus offering diagnosis without radiation.
NV-VPAC1 also helps transform cancer treatment into a more precision-based and personalized process. In addition to (64)Cu, the peptide construct also carries Copper-67 [(67)Cu], another radioisotope that contains enough radioactivity to destroy cancer cells. Another factor to consider, (67)Cu also has a half-life of 2.5 days, which limits exposure to unnecessary radioactivity during the course of treatment.(7)
After pausing the investigative process due to the COVID-19 pandemic, NuView plans to resume clinical trials at several major medical institutions. The company, which hopes to go public within the next three years, is confident that NV-VPAC1 will outperform other cancer diagnostic and treatment methods, saving patients and the healthcare system as a whole a substantial amount of money.
"NV-VPAC1 is a unique binary molecular tool, with the ability to diagnose cancer in vivo and in vitro, to treat primary and metastatic lesions, and to allow one to determine the efficacy of therapeutic interventions," says Dr. Mathew Thakur, who invented NV-VPAC1 along with a team of colleagues at Thomas Jefferson University in Philadelphia, PA.
"When you take into consideration that diagnosing and treating cancer may be accomplished without the expensive and invasive tests currently available, we at NuView Life Sciences are confident NV-VPAC1(TM) will revolutionize and transform the field of oncology," said Crowe.
About NuView Life Sciences
Founded in 2005, NuView Life Sciences is a clinical-stage oncology company located in Park City, Utah, influencing the way cancer is diagnosed and treated in our modern healthcare system. NuView is focused on creating precision binary cancer diagnostics and Theranostic applications. The development and clinical implementation of NuView's exclusive peptide analog technology, NV-VPAC1(TM) provides clinicians more choices to improve patient outcomes while reducing healthcare costs. Led by a team of industry experts with decades of multidisciplinary experience in healthcare, NuView is poised to introduce a new cancer diagnostic technology and subsequently deliver a Theranostics approach for effectively observing and treating a variety of cancers. To learn more, visit http://www.nuviewlifesciences.com.
1. McGrail, Samantha; "Cost of Cancer Reaches Nearly $150B Nationally"; 15 January 2020; Health Payer Intelligence; healthpayerintelligence.com/news/cost-of-cancer-care-reaches-nearly-150b-nationally.
2. Cost Helper; health.costhelper.com/biopsy.html; accessed 28 October 2020.
3. Cussen, Mark P.; "Top 5 Reasons Why People Go Bankrupt"; Updated 24 February 2020; Investopedia; investopedia.com/financial-edge/0310/top-5-reasons-people-go-bankrupt.aspx.
4. Asbestos.com; "High Cost of Cancer Treatment"; asbestos.com/featured-stories/high-cost-of-cancer-treatment/.
5. The Costs of Cancer: Addressing Patient Costs. American Cancer Society Cancer Action Network, Apr. 2017, fightcancer.org/sites/default/files/Costs%20of%20Cancer%20-%20Final%20Web.pdf.
6. Gutfilen, Bianca, et al. "Copper-64: A Real Theranostic Agent." Drug Design, Development and Therapy, Dove Medical Press, 2 Oct. 2018, ncbi.nlm.nih.gov/pmc/articles/PMC6173185/.
7. "Clarity Pharmaceuticals Signs Copper-67 Supply Agreement with ISU Idaho Accelerator Center." Idaho State University, 2020, isu.edu/news/2020-spring/clarity-pharmaceuticals-signs-copper-67-supply-agreement-with-isu-idaho-accelerator-center.html.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Working together to bring hope and healing to places where it was previously out of reach

MAHWAH, N.J. (PRWEB) NOVEMBER 16, 2020
Mindray North America renewed its longtime support of Mercy Ships as the non-profit organization announced a first look at the construction of the world's largest NGO hospital ship, Global Mercy, earlier this month. Mercy Ships, a faith-based global organization powered by charitable donors and volunteers, has been providing world-class surgical care to those in need for more than 40 years, free of charge.
"The Global Mercy will be a true modern marvel— a fully custom-built hospital ship with customized instruments, state-of-the-art technology and highly-trained talent of a modern hospital," said Rosa Whitaker, president of Mercy Ships. "It also represents a unique call-to-action for anyone called to serve, and it presents the opportunity for people to use their skill set to positively impact global healthcare."
In addition to providing surgeries, the Global Mercy will be outfitted with state-of-the-art training spaces including a simulation lab with virtual and augmented reality, mannequins and other training tools and simulated post-op care space, which allow trainers to simulate local conditions and limitations in order to teach best practices in low-resource environments.
The 174-meter, 37,000-ton ship will have six operating rooms and house over 600 volunteers from around the globe representing many disciplines including surgeons, maritime crew, cooks, teachers, electricians, the host staff and more. The ship will also feature a 682-seat auditorium, student academy, gymnasium, pool, café, shop and library – all of which have been designed to accommodate up to 950 crew onboard when docked in port. The Global Mercy will join the current flagship Africa Mercy, more than doubling the impact of volunteers and services provided by the charity.
"We are steadfast in our desire to extend the benefits of our solutions and technologies to those around the world who do not have access to state-of-the-art medical interventions and care, "stated Bill Dwyer, Vice President, Corporate and Strategic Accounts, Mindray North America. "Our long-term partnership with Mercy Ships is in direct alignment with our mission to advance medical technologies to make high-quality healthcare more accessible to all. We are grateful for the opportunity to support this wonderful organization as they continue improving the lives of so many around the globe."
About Mindray
Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.
About Mercy Ships
Mercy Ships uses hospital ships to deliver free, world-class healthcare services, capacity building, and sustainable development to those with little access in the developing world. Founded in 1978 by Don and Deyon Stephens, Mercy Ships has worked in more than 55 developing countries, providing services valued at more than $1.7 billion and directly benefitting more than 2.8 million people. Its ships are crewed by volunteers from over 50 nations, with an average of over 2,000 volunteers each year. Professionals including surgeons, dentists, nurses, healthcare trainers, teachers, cooks, seamen, engineers, and agriculturalists donate their time and skills. With 16 national offices and an Africa Bureau, Mercy Ships seeks to transform individuals and serve nations. For more information, please visit http://www.mercyships.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Community Leaders in Government, Law Enforcement and Healthcare Join Forces to go Beyond the Stigma

INDIANAPOLIS (PRWEB) NOVEMBER 16, 2020
The HeroZona Foundation is excited to announce a special segment of the Bridge Forum, "Mental Health," during which a panel of Indiana leaders, including a keynote from U.S. Surgeon General (VADM) Jerome M. Adams, will discuss mental health issues plaguing the state and what actions can be taken to help community members struggling to access the resources they need. The event will take place on Thursday, November 19 from 9 to 12 p.m. at the Hyatt Regency Indianapolis (1 S. Capitol Ave). The invitation-only event is supported by the State of Indiana Attorney General's Office, Greater Indianapolis NAACP Branch #3053, Indianapolis Urban League, the Indiana Drug Enforcement Association, National Newspaper Publishers Association and Vitanya Brain Performance, a company revolutionizing modern neuroscience to maximize brain function. The forum will also be livestreamed to the public at Facebook.com/HeroZonaOrg/Live.
"The pandemic has caused a wave of negative repercussions, mental health being one of them," says Ron Williams, president of the HeroZona Foundation. "The uncertainty, stress and tension across the nation has shown us that now, more than ever, it is crucial to find solutions for depression, anxiety and other mental health issues in our underserved communities that lack access to proper support. We are thankful to these distinguished leaders for supporting our cause and helping us take action to help Americans in need."
Event panelists include Marion County Public Health Department Director Dr. Virginia A. Caine, Marion County Superior Court Judge David Certo, Elkhart Police Department Senior Chaplain Jim Bontrager and Marion County Prosecutor Ryan Mears. Special guests of the forum include Indianapolis NAACP President Chrystal Ratcliffe and Indianapolis Urban League President & CEO Anthony "Tony" Mason. The opening remarks of the event will be delivered by Indiana Attorney General Curtis Hill, followed by the keynote from U.S. Surgeon General (VADM) Jerome M. Adams M.D., M.P.H.
"Mental and emotional health is a topic that HeroZona continues to work very closely on with veteran and first responder communities, both disproportionately affected by issues like depression, PTSD and suicide," says Alan "AP" Powell, Chairman of AP & Associates - Strategic Alliances, U.S. Army Desert-Storm Veteran and founder of HeroZona. "While the forum may have started in Arizona, these issues plague the entire world, and we are working diligently to find solutions."
"Police work by its very nature involves carrying out difficult duties that challenge the psychological well-being of even the strongest individuals," Attorney General Hill says. "Every day, officers deal with community members facing their own serious mental-health issues, often in situations fraught with extreme stress and tension. One key to helping de-escalate potentially explosive interactions is to help connect all individuals — both police and civilians — with resources that help nurture and protect mental health. That is one important objective of this forum. Let us move beyond the stigma and make progress together."
"As a community, we must remove the stigma associated with mental illness and advocate strongly for better training for police officers who find themselves serving as mental health intervenors," says Chrystal Ratcliffe, president of the Greater Indianapolis Branch of the NAACP. "The NAACP, in frequent conversations with law enforcement agencies and lawmakers, has urged more allocation of resources to better prepare officers on how to interact with the mentally ill. On a national level the NAACP has further suggested the U.S. Department of Justice develop national training standards and provide mental health toolkits to departments. We feel with these steps, the number of police-community confrontations will decrease, and we can foster an environment toward de-escalation rather than deadly outcomes."
The special edition of the Bridge Forum will be moderated by the President & CEO of the National Newspaper Publishers Association, National Director of the Million Man March, and Assistant to Rev. Martin Luther King Jr., Dr. Benjamin F. Chavis Jr. Dr. Chavis first received international recognition in 1971 as the leader of the Wilmington Ten, when he was wrongfully convicted of committing arson and received the longest sentence before winning his appeal in 1980. He recently kicked-off his brand-new public television show called "The Chavis Chronicles" on PBS, which is seen as a combination of "Meet the Press" and "Fareed Zakaria GPS," but with an urban American flare.
The Bridge Forum first came to Indianapolis on October 6, where Indiana leaders in government and law enforcement discussed systemic racism in America and what actions can be taken to achieve equality. The panel included Lake County Prosecutor Bernard A. Carter, Indianapolis Metropolitan Police Department Chief of Police Randal Taylor, Indiana State Fraternal Order of Police President William Owensby, Lake County Sheriff Oscar Martinez Jr. and National Organization of Black Law Enforcement Executives President Lynda R. Williams. Also in attendance were City of Indianapolis Mayor Joe Hogsett, Indiana State Representative for District 95 John L. Bartlett, Fort Wayne United Director Iric Headley and Indiana Attorney General Curtis Hill.
In January 2018, the Scottsdale Police Department in Arizona implemented 29 new initiatives from the Scottsdale Bridge Forum 2017, which included establishing sufficient resources for police personnel dealing with trauma, establishing dialogue opportunities with under-served communities, enhancing engagement with the community's youth and identifying ways to address the needs of the community related to behavioral health.
For more information about the Bridge Forum and to stream its upcoming event on Thursday, November 19, visit Facebook.com/HeroZonaOrg.
About the HeroZona Foundation
The HeroZona Foundation is a non-profit organization that empowers Heroes in the community through entrepreneurship, employment, and education. The group works with veterans, first responders and those that bring social good to future generations and under-served communities. The foundation's mission is to create opportunities for the brave men and women who serve their country, and community, every day. For more information, please visit HeroZona.org.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

It was one year ago when UofL Health acquired the former KentuckyOne Health assets, taking on a struggling system with hospitals on the brink of closing, jeopardizing our community's access to health care. Today, UofL Health supports more than 700 physicians and providers, 12,000 team members, and revenues of more than $1.8 billion. The acquisition preserved and expanded health care access, which has shown to be more critical than ever during the COVID-19 pandemic.

LOUISVILLE, KY. (PRWEB) NOVEMBER 16, 2020
It was one year ago when UofL Health acquired the former KentuckyOne Health assets, taking on a struggling system with hospitals on the brink of closing, jeopardizing our community's access to health care. Today, UofL Health supports more than 700 physicians and providers, 12,000 team members, and revenues of more than $1.8 billion. The acquisition preserved and expanded health care access, which has shown to be more critical than ever during the COVID-19 pandemic.
"In any other year, turning around struggling facilities and successfully building a health system would be noteworthy, but for 2020 it's remarkable," said Tom Miller, CEO of UofL Health. "We pivoted to handle COVID-19, but our team never lost sight of the future. We succeed by recruiting more bedside nurses, adding physicians, investing in technology and increasing access points in underserved areas."
Drawing patients from each of Kentucky's 120 counties, plus neighboring states, UofL Health doubled in size and is now the Commonwealth's largest academic health system. To meet the needs of an increasing number of patients, almost 300 new positions were created and 500 nurses recruited in the last 12 months, along with more than 40 new physicians.
In specific response to COVID, UofL Health opened Kentucky's first drive-thru testing site, expanding to four additional locations and screening nearly 50,000 people, so far. A telemedicine platform was launched with 600 providers to ensure continuity of care during social distancing guidelines. Bedside teams implemented additional safety protocols, COVID treatments, and were called on to step in as surrogate family members during increased visitor restrictions. In advance of the potential "twin-demic," COVID and seasonal flu, 10,000 free flu vaccines were made available across the community.
"We formed UofL Health to address the significant needs of our community and our Commonwealth," said University of Louisville President Neeli Bendapudi. "But its impact has been even more substantial than we could have predicted, particularly in helping address the COVID pandemic. Our entire team – from support staff, to nurses, to providers and physicians – deserves credit for this success in building an organization of which Kentucky can be proud."
The formation of UofL Health preserved thousands of jobs once in jeopardy. From acquired facilities, more than 5,800 jobs were saved, as well as 60 residency positions with the University of Louisville School of Medicine. Now, medical education opportunities are poised for growth with additional rotations at UofL Health – Mary & Elizabeth Hospital and UofL Health – Peace Hospital for future physicians, advanced level providers and nurses.
Improvements at UofL Health – Jewish Hospital represent the biggest turnaround success. Previously targeted for closure, the hospital is now seeing dramatic growth in patient volume including a 54% increase in organ transplants. $6 million invested in surgical robotics is expected to bring similar increases in cardiovascular procedures.
A renewed focus on serving community needs has led to similar growth at Mary & Elizabeth Hospital. In September, a voluntary medical detox unit opened with 12 private rooms. The service is a partnership with Peace Hospital and has a dedicated team specifically trained to treat behavioral health issues and addiction. Patients in south Louisville also have now have access to improved early breast cancer detection with 3D Mammography, installed at Mary & Elizabeth Hospital in October.
System-wide capital investments during the first year totaled $60 million with a focus of strengthening UofL Health's ability to meet community needs and prepare for future growth. Additional notable projects include:

System wide IT upgrades with improved patient portal and electronic medical records

3D mammography installed - 3 locations: Shelbyville Hospital, Medical Center South, Mary & Elizabeth Hospital

daVinci Xi surgical robot - Jewish Hospital

Monarch Platform - Jewish Hospital

Catheterization lab renovations – Jewish Hospital, Mary & Elizabeth Hospital

Operating room expansion – UofL Hospital

UofL Health was formed on November 1, 2019 through the leadership of the University of Louisville and financial support from the Commonwealth of Kentucky, Jewish Heritage Fund for Excellence and the KentuckyOne Health Foundation.
####
NOTE: Video B-Roll available here
About UofL Health
UofL Health is a fully integrated regional academic health system with five hospitals, four medical centers, nearly 200 physician practice locations, more than 700 providers, the Frazier Rehab Institute and James Graham Brown Cancer Center. With more than 12,000 team members – physicians, surgeons, nurses, pharmacists and other highly skilled health care professionals, UofL Health is focused on one mission—one purpose—delivering patient-centered care to each and every patient—each and every day.
With our vast network of community and academic physicians, we are in communities throughout western Kentucky bringing the expertise, care and compassion that is at the core of our mission to every patient we serve.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Learn how to meticulously pursue tasks in a streamlined flow like water with a quiet Zen mindset.

NEW YORK (PRWEB) NOVEMBER 16, 2020
World Teacher and Happy Science CEO Ryuho Okawa has released a new publication, "The Power of Basics: Introduction to the Modern Zen Life of Calm, Spirituality and Success." This timely publication explores the principles of Zen Buddhism in a manner that can be applied to contemporary lifestyles. Unlike many other recent books about Zen Buddhism, "The Power of Basics" focuses primarily upon practical guidance that may be put into use immediately; rather than presenting itself in a grandiose fashion, it is instead a highly constructive and accessible work to the layman and spiritual practitioner alike.
Two concepts explored at length in this work are "the power of basics and the time of silence." The essential concept behind the power of basics is that mastery in any area of life, be it work, business, meditation or otherwise, is achieved by mastering the basic tasks that form the foundation for said area. It can be difficult, especially in a contemporary society that often encourages instant gratification, to maintain the discipline necessary to master the basics. However, if such discipline can be maintained, mastery is the inevitable consequence. Throughout the book myriad examples are provided in order to explain this concept thoroughly and provide methods of putting it into practice.
The time of silence is a concept that has become lost to many people in contemporary civilization. One form of taking time for silence involves allowing oneself time for religious practice and devotion, as well as, and importantly, self-reflection. Another form of taking time for silence involves setting aside some time each day to study and learn something new. It is easy and fast to read concise information on the internet, but the extent to which this alone can produce genuine knowledge and wisdom is ultimately limited.
It is easy to become caught up in the fast-paced lifestyle of the modern world, but, as Okawa explains, it is nonetheless very possible to find time for silence. The key to this often exists in willfully reducing the distractions that one engages in. Excessive use of the internet, for example, can easily become a distraction, and one that few contemporary people can proclaim to be free of. The same can be said of watching television shows and movies. There is nothing inherently wrong with those things, but Okawa provides unique methods for how their use can be tempered so as to allow more time for personal development, even in the midst of a very busy schedule. Such applies even to those who may work several jobs and have a family; no situation is too busy that a time for silence cannot be found within it.
The latter half of "The Power of Basics" addresses matters such as remaining relevant in a competitive world and methods for developing an executive mindset. Okawa explains that even, and especially, the most successful people struggle daily to maintain their place in society, and provides methods that assist the reader in doing precisely this. Okawa uses examples from his own organization, Happy Science, to illustrate what positive and negative management styles may look like, and likewise provides advice as concerns how businesses can maintain a highly functional standard of order and operational success.
"The Power of Basics" is a truly unique contribution to the world of Zen Buddhist literature in that it is targeted towards regular people who experience regular difficulties in life. This work is appealing to a broad variety of readers, and can be very beneficial for those who feel overwhelmed or "burnt out" by the pressures of contemporary life. Pick up a copy of "The Power of Basics" today and learn how to live a calm and focused life that balances spiritual truth with material success.
"The Power of Basics" is available at all major bookstores nationwide and online retailers, including Barnes & Noble and Amazon.
For in-depth commentary on the works of Ryuho Okawa, please listen to the Okawa Book Club podcast now streaming on Spotify, Apple Podcasts, and Amazon Music.
IRH Press USA



START your own Wordpress site, business or personal website, or online store at www.siteground.com

MedShift reaches its five year milestone since its original establishment in 2015

CHARLOTTE, N.C. (PRWEB) NOVEMBER 16, 2020
MedShift is proud to announce its five year anniversary as a successful MedTech company located in Charlotte, North Carolina. Founded in 2015, MedShift has experienced immeasurable amounts of growth, development, and victories when reflecting on the past five years. While the original business plan was cultivated in 2015, MedShift has enjoyed strong market adoption, exemplified by its recognition on the 2020 Inc. 5000 list. This list displays America's fastest-growing private companies, with MedShift earning a notable ranking of 185. The employee count consisted of only four team members. Since then, the company has expanded its Charlotte operations to include 28 employees, all of whom offer a multitude of skill sets to help service clients and continue to build market leading offerings.
MedShift's prominent goals are to provide medical professionals with the latest aesthetic medical devices, develop and deliver highly secure and compliant cloud based SaaS platforms, and deliver prime communication and marketing assistance. To successfully implement and meet its goals, MedShift offers various services to aid in each practices' or manufacturers success, including an embedded IoT compute platform, Ecommerce platform, MedBox subscription platform, and MedShift TV services.
Although MedShift's core values have remained unchanged since its founding, the company's device lineup and marketing services have certainly evolved. In total, MedShift now offers over 25 leading aesthetic medical devices, tripling its initial device portfolio count. Additionally, MedShift has also increased its clientele, partnering with over 330 medical practices to date. The increase in devices, software platforms, and partnerships directly resulted in catapulting revenues beyond $10 million annually.
Another significant addition to the company throughout the last few years is the establishment of MedShift Connect, MedShift's in-house communications and marketing agency. MedShift Connect works to amplify its offerings to manufacturers and practices through providing paramount communication, marketing, and public relations services. As the world continues to utilize social media, MedShift Connect has adjusted its strategy to adapt to the latest trends and methods of marketing in the business sector. MedShift Connect creates an added value of marketing that is tailored for each client, setting them apart from competitors.
The past five years have allowed MedShift to grow and remain unique in its involved industries, allowing the company to continue delivering highly-demanded devices, software, and services to its customers. Every business must learn, grow, and adapt in its market in order to progress, and every past milestone has provided copious lessons for MedShift for future applications.
About MedShift
MedShift, founded in 2015 in Charlotte, NC delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally, MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 330 doctors in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.
MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians, and their business. MedShift's broad portfolio of services for practices includes a portfolio of 25 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers, MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real-time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Fresh-Aire UV's residential, commercial and healthcare UV equipment designed for HVAC, duct systems and surfaces inactivates the coronavirus in less than two seconds.

JUPITER, FLA. (PRWEB) NOVEMBER 16, 2020
Fresh-Aire UV, a leading global manufacturer of HVAC ultraviolet (UV) disinfection systems, announced that third-party lab tests successfully proved its residential and commercial UVC disinfection equipment for HVAC systems are >99.99-percent effective in inactivating SARS-CoV-2, the virus which causes the COVID-19 disease.
The "SARS-CoV-2 Neutralization by Germicidal UVC Light Systems" study conducted by independent laboratory Innovative Bioanalysis, Costa Mesa, Calif., validated a 4-log, >99.99-percent coronavirus inactivation in less than two seconds of exposure to Fresh-Aire UV's germicidal UVC 254-nanometer light systems. The exposure time is comparable to a moving airstream model within a facility's HVAC or ventilation system. The lab used Fresh-Aire UV's ADS airstream and TUVC/BlueTube XL coil and airstream disinfection systems designed for healthcare, education, office and other commercial facility applications. The residential and commercial APCO-X coil and air disinfection system also exhibited the same positive results.
The study is one of the first successful SARS CoV-2 inactivation tests in the HVAC industry and is available at http://www.freshaireuv.com.
"Consulting engineers, contractors, facility managers and directors can now confidently specify, install and use our UV equipment, knowing they are being proactive in improving the building's indoor air quality," said Aaron Engel, Vice-President–Business Development, Fresh-Aire UV. "Dosage is critical for effectiveness; however, our Blue-Calc, a powerful UVC disinfection design and analysis software, can accurately help the HVAC, design and engineering and healthcare community, specify UV equipment for any disinfection application," said Engel.
Since the early 2020 onset of the COVID-19 pandemic, Fresh-Aire UV has helped provide recommendations for both residential and commercial UV systems. In the FDA-sponsored test published in the American Journal of Infection Control, Fresh-Aire UV systems were used to show the efficacy of UVC light in disinfecting and extending the life of N95 respirators.
Now with a proven study validating Fresh-Aire UV's equipment effectiveness against SARS-CoV-2, Innovative Bioanalysis, a CAP, CLIA and AABB-certified laboratory, is now executing the next phase of Fresh-Aire UV testing. "We are excited to continue our testing to gauge effectiveness against different HVAC, airstream and surface applications," said Engel.
For more information, please visit http://www.freshaireuv.com, call 1-(800) 741-1195 or email: sales@freshaireuv.com.
About Fresh-Aire UV: Fresh-Aire UV is a leading North American manufacturer and developer of germicidal UV light & carbon ceramic systems designed for residential, commercial, industrial, agriculture, healthcare, and other specialized markets. Fresh-Aire UV systems are designed to improve Indoor Air Quality by addressing biological contaminants such as viruses, bacteria and mold as well as odors and volatile organic compounds (VOCs). Systems are designed for airstream and surface disinfection as well as specialized products for ice-machines and other unique applications. Fresh-Aire UV has been the recipient of numerous industry awards including the 2011 and 2020 AHR Innovation Award in IAQ. Visit our Facebook page, LinkedIn, or YouTube Channel.
*DISCLAIMER: Fresh-Aire UV systems are not intended to diagnose, treat, prevent, or cure any disease. Fresh-Aire UV systems have been tested on SARS-CoV-2, isolate USA-WA1/2020.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SynDevRx has submitted to the FDA results from a Phase 1 dose escalation study in patients with metastatic and progressing solid tumors to assess the safety and tolerability of SDX-7320. Additional outcome measures suggest that SDX-7320 may slow the rate of disease progression and formation of new metastases. Exploratory endpoints suggest that SDX-7320 may induce favorable changes to insulin and insulin resistance and other key metabolic hormones (leptin, adiponectin) as well as to multiple angiogenic biomarkers.

CAMBRIDGE, MASS. (PRWEB) NOVEMBER 16, 2020
SynDevRx, Inc., a clinical-stage oncology company, has submitted results of its Phase 1 dose escalation safety study in late-stage cancer patients with progressive, metastatic solid tumors to the United States Food and Drug Administration (FDA) [1]. The study's primary endpoint was to establish the maximum tolerated dose and dosing schedule and the recommended Phase 2 dose for SDX-7320, the company's lead drug candidate for the treatment of metabolically sensitive cancers [2]. Secondary and exploratory endpoints included analysis of anti-tumor efficacy and changes in key angiogenic and metabolic biomarkers.
The study evaluated data from 32 patients, whose disease progression and new lesion formation were measured at intervals of every 2 months from the initiation of treatment. Exploratory changes from baseline to metabolic hormones were measured, including leptin and adiponectin, as well as changes to insulin levels and insulin sensitivity (HOMA-IR). Exploratory changes from baseline to angiogenesis biomarkers bFGF, VEGF, and IGF-1 were also evaluated. A total of 28 patients had at least one tumor burden assessment performed, of whom 21 (75%) had at least one stable disease determination before leaving the study or experiencing progressive disease. Of these 21 patients, the period of measurable stable disease averaged 85 days. There were no objective partial or complete responses.
"The results of our Phase 1 trial suggest that SDX-7320 may have potent anti-angiogenic activity, appears to induce favorable changes to insulin, leptin and adiponectin, and has a safety profile that supports future combination studies. These data provide us with the scientific rationale for future clinical studies in tumors that are sensitive to metabolic hormones, i.e., metabo-oncology," said Brad Carver, President and CEO of SynDevRx. "Animal data we previously presented at the San Antonio Breast Cancer Symposium in 2019 showed that SDX-7320 attenuated the hyperglycemia and hyperinsulinemia caused by the PI3K inhibitor alpelisib, and showed synergistic tumor growth inhibition in mice. Considering the aforementioned data together with this clinical data, we believe SDX-7320 could provide real benefit to breast cancer patients taking a PI3K inhibitor. We expect to open enrollment for our upcoming clinical trial in metastatic ER+/Her2- breast cancer patients with a mutation in the PIK3CA gene early next year, followed by additional trials focused on triple-negative breast cancer and prostate cancer, tumor types that are highly sensitive to systemic metabolic dysfunction."
About the Study:
SynDevRx's Phase 1 dose escalation study was designed to assess the safety and tolerability of SDX-7320 in patients with advanced refractory or late-stage solid tumors (lung, colon, breast, rectal, pancreatic, appendiceal, carcinoid, cholangiocarcinoma, cervical, endometrial, hepatocellular, and urothelial cancers). [3] Patients were a mean age of 66 years old and had progressed following five prior lines of treatment for their metastatic disease, on average.
SDX-7320 was administered subcutaneously at doses ranging from 1.7–65 mg/m2 and induced primarily mild side effects including fatigue, GI symptoms (nausea, abdominal pain, diarrhea), and anemia. The dose-limiting toxicity event, thrombocytopenia, was generally reversible without intervention and was observed only at the highest doses tested. Results of the study suggest that the dose of SDX-7320 at 49 mg/m2 on a once every two weeks (i.e., Q14D) schedule may be appropriate for future studies. [3]
SDX-7320 acts by inhibiting MetAP2, a clinically validated target that appears to play a key role in tumor growth, metastasis, angiogenesis, and metabolic dysfunction. "Many solid tumor types are highly sensitive to dysregulated metabolic hormones, such as insulin, leptin, or adiponectin. These hormones signal through known oncogenic pathways, like PI3K/Akt/mTOR or STAT3. Given the epidemic of metabolic syndrome in the world plus the frequency of tumors that are sensitive to metabolic hormones (e.g., breast and prostate cancers), we believe that SDX-7320 could help clinical oncologists treat their cancer patients with concomitant, systemic metabolic dysfunction in combination with standard-of-care therapies," said James Shanahan, Co-Founder and Chief Business Officer of SynDevRx.
About SDX-7320:
SynDevRx believes that SDX-7320 is the first drug being developed specifically for cancer patients with metabolic complications, such as obesity, diabetes, high blood glucose or HbA1c, pre-diabetes or insulin resistance. For certain tumor types, metabolic hormones stimulate oncogenic pathways, making the cancer more aggressive and deadlier. SDX-7320 acts by binding irreversibly to the target enzyme MetAP2, triggering improvements in the metabolic hormones, insulin, leptin and adiponectin. Additionally, SDX-7320 inhibits the important angiogenic proteins bFGF and VEGF, and in preclinical studies, inhibited multiple cell cycle signaling pathways and reversed immune suppression within the tumor micro-environment. SDX-7320 is being developed for use in combination with clinically indicated standard-of-care cancer therapies.
SynDevRx and Metabo-oncology:
SynDevRx is pursuing the research and development of therapeutic interventions for cancer patients that also have background metabolic dysfunction. Metabo-oncology is the emerging field of research into, and treatments for cancer patients with tumors that are sensitive to metabolic hormones. Many common cancers are highly sensitive to dysregulated metabolic hormones stemming from overweight/obesity, pre-diabetes (hyperinsulinemia), type 2 diabetes and metabolic syndrome. An estimated 600,000+ patients in the United States alone are diagnosed each year with tumors that fit this category, yet little attention is given to the influence of systemic metabolic dysfunction on cancer progression. While diet and exercise can be effective at mitigating these effects, patients undergoing cancer treatment often find it difficult to adhere to these regimens. Therapeutic interventions are needed.
SynDevRx expects to commence enrollment for clinical studies in breast and prostate cancers that will test whether SDX-7320, when added to standard-of-care treatment, will help these patients more than standard-of-care treatments alone. The first study is in 2nd line metastatic ER+/Her2- breast cancer patients with a PIK3CA mutation, in combination with the PI3Kα inhibitor Piqray (Novartis). To learn more about SynDevRx upcoming clinical trials, visit: http://www.syndevrx.com/
References:
1. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2016 Apr 19 - . Identifier NCT02743637, A Dose Escalation Study of SDX-7320 in Patients with Advanced Refractory or Late-Stage Solid Tumors (SDX-0101); 2020 Jan 27 [cited 2020 Oct 21]; Available from: https://clinicaltrials.gov/ct2/show/study/NCT02743637?term=syndevrx&draw=2&rank=1
2. Uzunlulu M, Telci Caklili O, Oguz A. Association between Metabolic Syndrome and Cancer. Ann Nutr Metab. 2016;68(3):173-9. doi: 10.1159/000443743. Epub 2016 Feb 20. PMID: 26895247.
3. Abstract CT153: SDX-7320 elicits improvements in tumor-related and metabolic biomarkers: Results of a phase 1 dose-escalation study in patients with advanced refractory or late-stage solid tumors. Mita M, Bendell J, Mita AC, Gordon M, Sachdev J, Carver BJ, Shanahan J, Mayes B, Awerkamp K, Browning D, Salomon N, Sullivan K, Anderson-Villaluz A, Johnson J, Petersen JS, Turnquist DJ, Cornelius P. J Cancer Res 2020 (80) (16 Supplement). DOI: 10.1158/1538-7445.AM2020-CT153
About SynDevRx:
SynDevRx is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts focused on the research and development of treatments that address the underserved needs of cancer patients with systemic metabolic dysfunction – i.e., metabo-oncology. Obesity, pre-diabetes and type 2 diabetes are known to worsen certain cancer patients' prognosis, but oncologists have no specific tools to treat systemic metabolic complications, except for diet and exercise. SynDevRx intends to initiate a series of clinical studies of its drug candidate SDX-7320 to address this major, unmet medical need. Preclinical studies have shown that SDX-7320 reduces tumor growth and angiogenesis, helps to control aberrant metabolic hormone signaling, and reduces treatment resistance to certain standard cancer therapies in metabolically sensitive cancers. SDX-7320 is being developed for use in combination with standard of care therapies for a variety of solid tumors.

The results of our Phase 1 trial suggest that SDX-7320 has a safety profile that supports future combination studies. These data provide us with the scientific rationale for clinical studies in tumors that are sensitive to metabolic hormones, i.e., metabo-oncology.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Spaulding Academy & Family Services (formerly Spaulding Youth Center) has appointed Todd Emmons of New London as President and CEO. Emmons joined the organization in 2017 as Chief Financial Officer and has served as Interim CEO since the end of September.

NORTHFIELD, N.H. (PRWEB) NOVEMBER 16, 2020
Spaulding Academy & Family Services (formerly Spaulding Youth Center) has appointed Todd Emmons of New London as President and CEO. Emmons joined the organization in 2017 as Chief Financial Officer and has served as Interim CEO since the end of September.
"In the weeks since Todd stepped in as Interim CEO, he has been a constant and steadying force on campus, bringing his knowledge of Spaulding as well as his collaborative and open style to the role," said Michael Ventura, Chair, Spaulding Academy & Family Services Board of Directors. "He is deeply committed to the mission of Spaulding and the children we serve. Todd's actions are informed by his integrity, compassion, and humility, and he will keep Spaulding focused on the future as we move into 2021 and the years to come."
Emmons has more than 30 years of executive experience in financial management and operations for education institutions, including Quinsigamond Community College, Elms College, Daniel Webster College, and Saint Anselm College. Prior to joining Spaulding Academy & Family Services, he was Vice President of Finance and Operations and Treasurer of Colby-Sawyer College.
He currently serves as a member of the Board of Directors for both the New Hampshire Health and Education Facilities Authority (NH HEFA) and the Community College System of New Hampshire. He holds an MBA in Finance from the Stern School of Business at New York University and an MSc. in Economics from the London School of Economics & Political Science.
"I'm grateful to be continuing my work with the families and staff of Spaulding Academy & Family Services in this important role," Emmons said. "The past several years have been among the most rewarding of my career, and I look forward to advancing Spaulding's mission in partnership with its exceptional team of educators, clinical, and residential staff."
For more information about Spaulding Academy & Family Services and its comprehensive special education services, visit SpauldingServices.org. Details about its Board of Directors and Management team are available at SpauldingServices.org/leadership.
ABOUT SPAULDING ACADEMY & FAMILY SERVICES
Spaulding Academy & Family Services is a leading provider of educational, residential, therapeutic and community based programs and services for families, and children and youth with neurological, emotional, behavioral, learning or developmental challenges, including Autism Spectrum Disorder and those who have experienced significant trauma, abuse or neglect. Established in 1871, Spaulding Academy & Family Services is a tax-exempt 501(c)(3) nonprofit that was formerly known as Spaulding Youth Center since 1958. Our scenic hilltop campus is located on nearly 500 acres in Northfield, NH and welcomes boys and girls from ages 4 to 21 from around the state of New Hampshire and beyond. In addition to programs provided on our Northfield campus, Spaulding's community based programs include foster family licensing, Individual Service Option (ISO) foster care, ISO in-home services, child health support services, and more for children ages 0 to 20 and their family. For information about Spaulding Academy & Family Services, visit http://www.spauldingservices.org



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Can one's data integrity controls withstand FDA scrutiny? Here's how to stay compliant and avoid 483s or warning letters. Register today.

FALLS CHURCH, VA. (PRWEB) NOVEMBER 16, 2020
Data Integrity for GMP/Postmarket Professionals:
Core Requirements, Expectations and Challenges
A Virtual Workshop Presented FDAnews and Cerulean Associates LLC
Tuesday, Dec. 8 and Thursday, Dec. 10, 2020, 10:00 a.m.-4:30 p.m. EST
https://www.fdanews.com/dataintegrityforgmppmpros
Is the FDA's increasing scrutiny on data integrity giving causing a data migraine? One must establish internal competency and assessment programs; otherwise, a Form 483 or warning letter can be expected.
With FDA data integrity requirements among the most stringent within regulated industries, compliance is challenging for drug and device manufacturers. This interactive virtual workshop makes it infinitely easier.
Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges will give attendees the tools needed to ensure electronic records are trustworthy and reliable across their entire data lifecycle, from initial data creation through long-term archives.
It will be led by award-winning FDA compliance expert, author and Cerulean Associates founder, John Avellanet. He can explain complex FDA data integrity regulations in simple "what to do, how to do it" language using real-world examples and offering practical advice you can follow. A former FDA and Department of Justice prosecutor calls Mr. Avellanet, "The best in the business. Period." Confirm this for oneself when he shares:

How to apply the elements of data integrity characteristics — attributable, legible, contemporaneous, original and accurate (ALCOA+)

An exploration of overlooked guidance documents that can help define expectations (including what the FDA and the European Medicines Agency inspect for and why)

How to address recall handling and reporting and product complaint trending

How to deal with suppliers, including the typical supply chain red flags that FDA and other regulatory health agencies look for

What to take away from recent, relevant GMP and QSR data integrity enforcement examples

Considerations for both on-site and remote inspections, with questions and tactics one must be prepared to handle

The modern, risk-based validation techniques one needs to know, along with the FDA's view of sampling, test cases and supplier-provided validations

The record-keeping "musts" to consider: which records to retain to prove good data integrity controls, incorporating quality audits and sampling techniques and developing a media migration strategy

The risks and realities of true and certified copies with digital records, from the basics of true/certified copy and legal admissibility to putting together a scanning process for manufacturing records and the true copy requirements from submission guidances

No more data migraines. By attending this virtual workshop attendees will be equipped to help the entire company stay compliant.
Multi-attendee discounts available!
Significant tuition discounts are available for teams of two or more from the same company.
Virtual Workshop Details:
Data Integrity for GMP/Postmarket Professionals:
Core Requirements, Expectations and Challenges
A Virtual Workshop Presented FDAnews and Cerulean Associates LLC
Tuesday, Dec. 8 and Thursday, Dec. 10, 2020, 10:00 a.m.-4:30 p.m. EST
https://www.fdanews.com/dataintegrityforgmppmpros
Tuition:
$597
Multiple attendee discount available
Easy Ways to Register:
Online: https://www.fdanews.com/dataintegrityforgmppmpros
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New Jersey, Connecticut, Massachusetts, and New Hampshire, has expanded in Westchester, NY with a brand new, state-of-the-art clinic in The Bronx.

MELVILLE, N.Y. (PRWEB) NOVEMBER 16, 2020
Professional's latest clinic is their second in The Bronx, located at 1200 Waters Place, in Suite M113. Open November 16th, the new clinic allows for more space to continue see new and existing patients as an essential business.
Regional Director of Operation Mike Camperlengo remarks, "This clinic is unique in that we will have the space, equipment and clinical expertise to provide patients a continuum of care to meet their therapy needs, from orthopedic rehabilitation, specialty spine care or return to work services. We look forward to providing our patients individualized programs to promote a positive patient experience and active recovery. With a wall of windows overlooking a courtyard, free parking and ground floor location, it is a distinctly large and accessible clinic in Waters Place."
Professional Physical Therapy CEO Dan Dourney adds, "Professional is prioritizing our development strategy around providing safe, exceptional care, centered on our core values. We will continue to seek and evaluate all opportunities that serve that commitment. This is a community we have served for a long time and we look forward to serving for many more years to come."
Clinical Director and treating therapist Sean Altman, DPT, PT, CPT, states, "I am truly excited to bring more high quality physical therapy care to the Bronx community. In the wake of COVID-19, there is an even greater need for skilled physical therapy services provided with all of the appropriate social distancing guidelines. I am looking forward to helping patients receive the treatment that they need while maintaining their safety."
After completing his undergraduate education studies in Molecular Biology at Colgate University, Dr. Altman then went on to complete his Doctorate in Physical Therapy at Stony Brook University where he graduated Summa Cum Laude. While he is proficient in McKenzie, Maitland, Mulligan, Graston, and Cyriax manual therapy techniques, Sean is also certified in Spinal and Peripheral Joint Manipulation, Dry Needling, FMS, and SFMA. He also trained at the Titleist Performance Institute in order to better perform golf swing analysis and golf rehabilitation services.
Altman has extensive experience in the outpatient setting with patients including post-op, orthopedic injuries, prenatal patients, spine disorders, chronic pain disorders, neurologic population, semi-professional and professional athletes, with advanced training in Kinesio Taping and McConnell taping for orthopedic patients, athletes, and post-operative care. Sean is also certified in Personal Training (ACE-CPT), CPR, and BLS (Basic Life Support).
Professional Physical Therapy currently operates widely across five of the Northeast states. For more information and a list of all Professional Physical Therapy locations and services, please visit http://www.professionalpt.com
###
About Professional Physical Therapy
Professional Physical Therapy, headquartered in Melville, New York, is a leading provider of outpatient physical and hand therapy and rehabilitation services throughout the New York Metropolitan area, New Jersey, Connecticut, Massachusetts and New Hampshire.
Professional's patient-centric treatment philosophy is focused on providing exceptional, compassionate care to the entire person, and not just their injury. Their licensed Physical Therapists design customized treatment plans, using the most innovative therapeutics, to help patients achieve and exceed their goals. Service offerings include telehealth, in-home physical therapy, and outpatient physical therapy, hand, and occupational therapy in over 180 clinics throughout the Northeast.

Professional is prioritizing our development strategy around providing safe, exceptional care, centered on our core values. We will continue to seek and evaluate all opportunities that serve that commitment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

ISO 14971:2019 is changing risk management for devicemakers. Prepare for the updates one needs to make. Register today.

FALLS CHURCH, VA. (PRWEB) NOVEMBER 16, 2020
Medical Device Risk Management:
Implementing ISO 14971:2019
A Virtual Workshop Presented by FDAnews and Ombu Enterprises
Tuesday, Dec. 1, 2020, 10:00 a.m. – 4:30 p.m. EST
https://www.fdanews.com/mdriskmanagement
ISO 14971:2019 is changing the standards around risk management — and the introduction of the EU-MDR is only making things more complicated. This process has never been simple but having to adjust clause numbers, documentation and risk-management systems while successfully merging the two new sets of expectations adds extra challenges.
How does one prepare for these changes? Has the team worked on risk analysis and evaluation? Are the risk management files and plans up-to-date?
This Medical Device Risk Management virtual workshop on Dec. 1 will cover everything needed to implement an efficient and effective risk management system. Through expert advice, attendees will gain a basic understanding of medical device regulations, discover how ISO 14971:2019 will impact procedures and work to identify gaps in implementation plans.
The risk management guide is Dan O'Leary, a favorite presenter at dozens of FDAnews-sponsored workshops. Dan will share tips on how to define acceptable risk, create a risk management plan, and complete an overall residual risk evaluation. He'll also share how these requirements connect to the EU-MDR and what organizations need to do to match the two standards.
During this virtual workshop, attendees will cover:

Basic medical device regulations and standards

Risk management files and plans

Acceptable risk definitions and the risk matrix

Risk analysis, evaluation and control

Residual risk evaluation

Risk management review

Production and post-production requirements

EU-MDR adjustments and expectations

ISO 14971:2019 implementation and process standards

Annex I risk-specific requirements

Implementing ISO-14971:2019 will require a careful look at one's current risk management systems and a deep understanding of where they need to go. This virtual workshop can make that process simpler and more successful.
Want to share this experience with your colleagues?
Ask us about our tiered discounts for multiple participants!
Virtual Workshop Details:
Medical Device Risk Management:
Implementing ISO 14971:2019
A Virtual Workshop Presented by FDAnews and Ombu Enterprises
Tuesday, Dec. 1, 2020, 10:00 a.m. – 4:30 p.m. EST
https://www.fdanews.com/mdriskmanagement
Tuition:
$597 per person
Multiple attendee discounts are available
Easy Ways to Register:
Online: https://www.fdanews.com/mdriskmanagement
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CHOP, an acronym for Covid Home Oximetry Program, enables patients to monitor their oxygen levels and be alerted to a drop below the 92% threshold that would signal the onset of respiratory distress for patients with the coronavirus.

HOLLYWOOD, FLA. (PRWEB) NOVEMBER 16, 2020
47-year-old Sam Nehme has been a professional athlete that still trains regularly. He eats right, takes care of his body, and has no underlying medical conditions. In short, he's what many would consider the picture of good health.
That wasn't; however, the way he felt upon arrival at Memorial Regional Hospital's Emergency Department. With symptoms consistent with COVID-19, he expected to be admitted for observation while medical teams monitored if and how the disease progressed. Instead, he was sent home to self-quarantine, but with equipment and a support system created to help patients monitor themselves and avoid unnecessary hospital stays.
"For lower-risk patients in the early stages of the coronavirus, we'd rather they be in places they feel safe and comfortable," said Dr. Eric Bassan, a physician specializing in emergency medicine at Memorial Regional Hospital. "For many, that's in the privacy of their own home, surrounded by all that's familiar to them. With enrollment in our CHOP program, that's a viable option."
CHOP, an acronym for Covid Home Oximetry Program, enables patients to monitor their oxygen levels and be alerted to a drop below the 92% threshold that would signal the onset of respiratory distress for patients with the virus. Individuals can update their status online through Memorial's MyChart application and have regular contact with medical teams monitoring their situation from the hospital. Patients return to the ER if their circumstances warrant, but have peace of mind in the meantime if their symptoms aren't out of the ordinary. "I spoke with nurses every morning, so I knew what to expect and what medications would help," said Nehme. "Documenting my condition was huge because it kept my primary care physician and nurses informed and gave me the opportunity to ask pertinent questions. When I returned to the hospital, it was because I needed to be there, not because I was scared of something I didn't understand."
Nehme is one of more than 120 patients that have been enrolled in CHOP. Nearly half completed their quarantines at home, 24 were admitted to Memorial facilities, and, most importantly, no one has passed away. During surge periods, the program enabled beds within hospitals to be used by the sickest COVID-19 patients and doctors to focus on the most critically ill.
"We've had great feedback from our patients about the program," said Monica Puga, Memorial Healthcare System's vice president of population health. "Connecting the clinical technical, and human elements, and keeping individuals out of hospitals whenever possible, has decreased patient anxiety while still delivering a superior level of care."
While CHOP was created in response to factors associated with the coronavirus, Dr. Bassan says it can expand to help monitor patients with other conditions, including chronic obstructive pulmonary disease (COPD), asthma, and congestive heart failure. Fluctuations in weight and peak air flow measurement are two other indicators of potentially serious problems in those with chronic conditions.
Meanwhile, it has been more than two months since Nehme's oxygen saturation dropped to dangerously low levels and his pulse oximeter and medical team alerted him it was necessary to return to the ER. "I felt like I was going to die that day, but my post-COVID chest x-rays have been good and I'm back to being healthy again."
Memorial Healthcare System is one of the largest public healthcare systems in the U.S. and a national leader in quality care and patient satisfaction. It is highly regarded for a patient and family-centered approach at facilities that include Memorial Regional Hospital, Joe DiMaggio Children's Hospital, Memorial Regional Hospital South, Memorial Hospital West, Memorial Hospital Miramar, Memorial Hospital Pembroke, Joe DiMaggio Children's Health Specialty Center in Wellington, and Memorial Manor nursing home.
Among its many awards and recognition are Modern Healthcare magazine's "Best Place to Work in Healthcare," Florida Trend's "Florida's Best Companies to Work For," and Becker's Hospital Review's "150 Great Places to Work in Healthcare." In a recent report ("Humanizing Brand Experience"), the Denver-based consulting firm Monigle named Memorial the top health system brand in America, based on consumer surveys.
To learn more, visit mhs.net.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Upgrade the efficiency and effectiveness of quality management system's with simple statistical techniques one can learn in a day.

FALLS CHURCH, VA. (PRWEB) NOVEMBER 16, 2020
Statistical Techniques for Medical Device Manufacturers
A Virtual Workshop Presented by FDAnews and Ombu Enterprises
Tuesday, Dec. 15, 2020, 10:00 a.m.-4:30 p.m. EST
https://www.fdanews.com/stattechmdworkshop
Want to upgrade the efficiency of quality management system's (QMS) and make it more effective? The answer is statistics — and one doesn't need to be a statistician to benefit.
While regulations don't require the use of statistical techniques, devicemakers with the most robust QMS employ them regularly. Without statistics bolstering QMS, the likelihood of getting FDA approval or a CE Mark for devices is significantly reduced.
Come away from this virtual workshop understanding the core statistical techniques most commonly required for QMS, why they apply, choosing the technique and common applications, how they work (without too much math!) and how to implement them in Microsoft Excel — no fancy statistical software packages required. In fact, the focus will not be on calculation, but on correct application, data integrity and understanding the results.
Dan O'Leary, President of Ombu Enterprises, chose the techniques based on ISO/TR 10017:2003, which describes statistical techniques for a QMS, and touches on other methods available, so attendees will get the guidance needed to make QMS work to its best advantage. He'll include the regulatory requirements from both QSR and ISO 13485:2016, and he'll share real-life warning letters to illustrate problems encountered by devicemakers.
Just have a basic understanding of Excel formulas and medical device regulations. It would be helpful to bring a set of descriptive statistics, too. Dan will provide the rest, sharing:

Introduction and Basic Statistics

Summarizing Data with Statistics

        - Probability Distributions
        - Graphical Methods

Understanding Data Over Time

        - Run Charts
        - Time Series Analysis
        - Statistical Process Control Charts

Data Modeling

        - Regression Analysis
        - Predictive Analysis
        - Shelf Life Estimation

Measurement Analysis

     - Measurement Uncertainty
     - Measurement System Assessment

Acceptance Sampling

     - Attribute Methods
     - Variables Methods

Hypothesis Testing

Move QMS ahead with these statistical techniques.
Multi-attendee discounts available!
Significant tuition discounts are available for teams of two or more from the same company.
Virtual Conference Details:
Statistical Techniques for Medical Device Manufacturers
A Virtual Workshop Presented by FDAnews and Ombu Enterprises
Tuesday, Dec. 15, 2020, 10:00 a.m.-4:30 p.m. EST
https://www.fdanews.com/stattechmdworkshop
Tuition:
Pricing: $597
Easy Ways to Register:
Online: https://www.fdanews.com/stattechmdworkshop
By phone: 888.838.5578 or 703.538.7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Digital agency develops and launches mobile app to help major university track building occupancy safely

SANTA BARBARA, CALIF. (PRWEB) NOVEMBER 17, 2020
Visus LLC, a digital agency, has created and launched a new iOS and Android mobile app for monitoring building occupancy and access. Designed for a major California university in response to the COVID-19 pandemic, the app allows users to ensure facility use remains at a safe level and potential contact tracing, if necessary.
As the university works together with its professors and researchers to continue to operate safely, monitoring occupancy levels in shared spaces is essential to promote a healthy environment. Each building and room have a predetermined maximum occupancy threshold, and the mobile app monitors and records data on the number of entries and exits to make sure safety precautions are followed.
Using the app is simple. Those who need to access the university's buildings and rooms download the mobile app, login, and then use it to scan QR codes each time they enter and exit. The data collected by the app is secured and made available to university personnel to let them know which facilities have been accessed and the number of people in each space at any given time. Using this data, the university can enforce social distancing policies and adjust its operations as necessary to promote safety.
Visus created and deployed the app within just four weeks, and it is now available on both the Apple App Store and the Google Play store.
About Visus LLC:
Visus LLC, a digital agency is a Progress Sitefinity Partner, Sitefinity MVP and Microsoft Partner, exceling at developing digital solutions using web and mobile technology. Corporations and public sector organizations rely on Visus for well-thought-out and designed solutions that work right the first time. Visus fills the gap between a company's vision and its technical implementation, creating an architected solution focused on the user experience while solving the business problem and delivering ongoing ROI.
Media Contact: Keith Butler, VP of Marketing
Phone: (805) 452-7744
Email: kbutler@visusllc.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology CEOs of Asia for 2020

NEW YORK (PRWEB) NOVEMBER 17, 2020
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology CEOs of Asia for 2020. The healthcare technology industry is facing more pressure than ever before as the demand for new treatments, devices, and digital solutions reaches new heights. Strong and inventive leadership is needed in order for companies to keep up with this evolving market, and the CEOs represented on this year's list exemplify both of those qualities and more. They have successfully guided their companies to become leaders in their fields, in both Asia and the global healthcare technology sector while fostering growth and innovation within their workforces.
Among this year's notable achievements, Dharmil Sheth has seen his company PharmEasy double its business each year to become one of the largest pharmaceutical technology platforms in the industry. Similarly, DXY has seen four successful funding rounds under the guidance of CEO Jin Zhang, totaling $182 million in funding raised to date. These accomplishments demonstrate the expert strategy employed by these leaders in developing products and services that are not only financially promising, but also widely beneficial to the health of populations around the world.
Through their dedication to improving global health, their ability to build and guide their organizations, and their specific domains of expertise, these individuals have made their mark. The Healthcare Technology Report team celebrates the achievements of this year's Top 25 Healthcare Technology CEOs of Asia for 2020.
Congratulations to each of this year's awardees.
David Chang (WuXi AppTec), Peter DeYoung (Piramal Group), John Oyler (BeiGene), Sanjiv Navangul (Bharat Serums and Vaccines), Shashank ND (Practo), Alex Li (United Imaging Healthcare), Dharmil Sheth (PharmEasy), Jonathan Sudharta (Halodoc), Tushar Vashisht (HealthifyMe), Vedam Ramprasad (MedGenome), Deepak Sahni (Healthians), Prashant Jhaveri (MediBuddy), Jin Zhang (DXY), Toru Nishikawa (Preferred Networks), Michelle Xia (Akeso Biopharma), Mukesh Parmar (Docplexus), Avi Lasarow (Prenetics), Silviu Itescu (Mesoblast), Minhong Jang (Lunit), Jingsong Wang (Harbour BioMed), Colin Denver (SpeeDx), Shailesh Prithani (Doxper), Li Chen (Hua Medicine), Daniel Carraway (RWDC Industries), and Sudhir Srivastava (SS Innovations).
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Clinical Advisors to Guide Development of Glint Drug Delivery contact lens technology

SOMERVILLE, MASS. (PRWEB) NOVEMBER 17, 2020
Glint Pharmaceuticals announces the formation of a clinical advisory board composed of notable and experienced clinicians in ophthalmology and optometry.
The clinicians on the advisory board include: Dr. Mark Abelson, Founder ORA, Inc., Dr. Cynthia Matossian, Medical Director, Matossian Eye Associates, an affiliate of Prism Vision Group, Dr. James Thimons, Medical Director, Ophthalmic Consultants of Connecticut, Dr. Mark Blecher, Professor Ophthalmology, Wills Eye Hospital and Dr. Paul Karpecki, Director, Kentucky Eye Institute,
"We are grateful to have such an experienced and knowledgeable group of clinicians join our advisory board to guide the development of our drug delivery technology to treat significant medical eye disease," says Chris Adams CEO.
About Glint
Glint Pharmaceuticals, a Massachusetts company, is developing proprietary drug delivery technology for the treatment and prevention of ocular infections and diseases. Examples of diseases to be treated include, Covid-19 infection, glaucoma, ocular inflammation, conjunctivitis, allergic rhinitis, and dry eye. Over 40 million Americans suffer from ocular surface disease. The technology has the potential to increase drug efficacy and patient compliance.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The bill, which is supported by the AAAAI, directs the CDC to expand data collection of information related to food allergies and specific allergens, and revises the definition of major allergen to specifically include sesame.

MILWAUKEE (PRWEB) NOVEMBER 17, 2020
The Food Allergy Safety, Treatment, Education, and Research (FASTER) Act (H.R. 2117), a bill supported by the AAAAI, passed the House of Representatives today with a unanimous voice vote. The FASTER Act directs the Centers for Disease Control and Prevention (CDC) to expand data collection of information related to food allergies and specific allergens, and revises the definition of major allergen to specifically include sesame. House Energy and Commerce Committee Chairman Frank Pallone (D-NJ), Ranking Member Greg Walden (R-OR), and Representative Doris Matsui (D-CA) spoke in support of the bill.
"The AAAAI joins with our Patient Advocacy Organization partners in celebrating the news that H.R. 2117 has successfully passed the House of Representatives," said AAAAI President Mary Beth Fasano, MD, MSPH, FAAAAI. "While it still needs to pass the Senate before it can be signed into law, this bill will do several things to improve the health and safety of Americans living with food allergies, including revising the definition of major allergens to include sesame, which is tremendously significant."
H.R. 2117 is sponsored by Representative Doris Matsui, who was joined by more than 90 bipartisan cosponsors. "Food allergies impact the daily lives of so many Americans, including our friends and family members," said Congresswoman Matsui. "Some of these food allergies can be serious and potentially be life-threatening diseases, and it's become abundantly clear to me that we need more research and evidence-based solutions to help understand, treat, and maybe one day prevent food allergies. I hope this legislation will provide progress treating allergies and improving the lives of those suffering from them."
The AAAAI continues to advocate for congressional adoption of H.R. 2117 which would advance recommendations from the National Academy of Medicine report "Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management, and Public Policy," including strengthening data collection on the prevalence of food allergies, and adding sesame to the list of allergens required to be listed on food labels, as well as providing flexibility for the Secretary of Health and Human Services to add any other food ingredients determined by regulation to be a major food allergen. The AAAAI joins its stakeholder partner FARE in support of this important legislation.
Passage of the FASTER Act comes after the Food and Drug Administration (FDA) recently issued a draft guidance titled "Voluntary Disclosure of Sesame as an Allergen". The document encourages food manufacturers to voluntarily declare sesame in the ingredient list on food labels. Comments on the draft guidance are due January 11, 2021. Additionally, the recently released Senate appropriations bill included a statement about allergen labeling expressing concern that the FDA has failed to take further action to require labeling for sesame and urging the agency to act swiftly to address this risk by requiring the same labeling for sesame as other major food allergens. Also included was report language requested by the AAAAI and other stakeholders which recognizes the prevalence of food allergy in the pediatric and adult communities, commends the ongoing work of the National Institute of Allergy and Infectious Diseases (NIAID) and the Consortium of Food Allergy Research (CoFAR), and encourages the NIAID to expand its clinical research network to add new centers of excellence in food allergy clinical care and to select such centers from those with a proven expertise in food allergy research.
AAAAI's professional governmental relations team and physician leadership continue to make a priority of encouraging federal research support for food allergies and related advocacy activities.
You can learn more about food allergies on the American Academy of Allergy, Asthma & Immunology website, aaaai.org.
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Lachman Consultant Services, Inc. (Lachman Consultants), a provider of compliance, regulatory, and technical consulting services to the global pharmaceutical and related industries, was recently named a "Top-Ten Medical Device Consulting Company" by highly-regarded, industry publication MedTech Outlook.

WESTBURY, NY (PRWEB) NOVEMBER 17, 2020
In making the announcement in its September issue, the monthly periodical outlined that its goals in creating the list was to identify "...prominent consulting companies in the industry that solve medical device manufacturing challenges" and to "...help the medical device manufacturing fraternity strengthen their infrastructure and enable growth."
Lachman Consultants was also prominently featured in the recent September 2020 awards issue of MedTech Outlook. In the extensive article, the magazine detailed the areas of distinction and excellence which earned Lachman Consultants the coveted designation. Of particular interest was the organization's experience and expertise in the areas of compliance and regulatory requirements. MedTech points out in the article, that "while other consulting companies have been continually moving in and out of the regulatory compliance landscape, Lachman Consultants stayed true to its core offering since its inception and have evolved according to clients' business requirements."
Featured prominently in the article are Lachman Consultants' industry-acknowledged experts: Executive Director, Ricki Chase, and V.P. & Chief of Staff, Linda Evans O'Connor.
Ms. Evans O'Connor states, "Over the last four decades, we've been helping these sectors in many ways, such as preparing and responding to inspections, filling applications, remediating unforeseen challenges and proactively building systems to address the regulatory requirements."
Noted for its comprehensive, holistic approach, Lachman Consultants serves its clients through three service groups; the Compliance Group, comprised of a group of former FDA veterans and experts from the medical device industry; a Regulatory Affairs Group, which features former FDA senior-level managers and FDA reviewers and; the Science and Technology Group, which holds a deep and expansive understanding of the technical challenges to address the myriad of compliance issues that clients may encounter.
Lachman Consultants is consistently expanding its menu of services to assist its clients in eliminating compliance roadblocks. One example is expanded compliance guidance in ground-breaking areas of products like auto-injectors, pre-filled syringes, and patch delivery systems.
In addition to the numerical accolade, the number "10" is of further significance in that all consultants working as part of Lachman Consultants three practice groups have a minimum of ten years' experience in the industry or related regulatory agencies. Ricki Chase concludes, "Over the years, we have gained a comprehensive knowledge of the regulatory nuances. We leverage it to enable our clients to jump through complex regulatory hoops."
# # # #
ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver highly effective and proven solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which have been shown to consistently exceed client requirements and expectations.
For additional press information, please contact:
Ilena Della Ventura
Delia Associates
T. 908-534-9044
W. delianet.com

"Over the last four decades, we've been helping these sectors in many ways, such as preparing and responding to inspections, filling applications, remediating unforeseen challenges and proactively building systems to address the regulatory requirements." - V.P. & Chief of Staff, Linda Evans O'Connor



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Online guide highlights senior living communities with quality programs and top features

CHICAGO (PRWEB) NOVEMBER 17, 2020
MemoryCare.com, a comprehensive resource for caregivers and older adults living with memory impairment, has announced the Best Memory Care Facilities in Chicago, IL. The guide identifies 6 memory care communities based on location, access to experts, facility features and amenities.
According to the Alzheimer's Association, 5.6 million people age 65 and older are living with Alzheimer's dementia. In Chicago, the number of senior deaths related to Alzheimer's increased by 30 percent between 2013 and 2017. Memory care facilities offer activities and therapies to help delay or halt cognitive decline. They also give family members and caregivers peace of mind by providing a safe environment for loved ones.
There's a high demand for quality memory care all across our nation; specifically, in cities like Chicago, which experienced a rapid increase in Alzheimer's related deaths, says Joyce Collins. MemoryCare.com provides free resources to help families find the best facilities.
Through hours of research and an intensive selection process, MemoryCare.com was designed to help caregivers find effective solutions for their loved ones. The website not only highlights the best facilities in the city, it also shares information about cost, reviews from residents, type of care offered and more. For a detailed listing of the Best Memory Care Facilities in Chicago, IL, please visit https://www.memorycare.com/chicago-il-facilities
2020 Best Memory Care Facilities in Chicago, IL (in alphabetical order)
Belmont Village Oak Park
Phone: 708-848-7200
Address: 1035 Madison St., Oak Park, IL 60302
Web: belmontvillage.com
Hartwell Place
Phone: 773-596-2215
Address: 5520 N. Paulina St., Chicago, IL 60640
Web: cmsschicago.org
Norwood Crossing
Phone: 773-631-4856
Address: 6016 N. Nina Ave., Chicago, IL 60631
Web: norwoodcrossing.org
St. Joseph Village of Chicago
Phone: 773-245-1031
Address: 4021 West Belmont Ave., Chicago, IL 60641
Web: franciscanministries.org
Sunrise of Lincoln Park
Phone: 847-686-3720
Address: 2710 N. Clark St., Chicago, IL 60614
Web: sunriseseniorliving.com
The Clare
Phone: 312-784-8100
Address: 55 East Pearson St., Chicago, IL 60611
Web: theclare.com
ABOUT MEMORYCARE.COM
MemoryCare.com provides tools and resources to help adults living with memory impairment and their families. The online guide uses data-driven research and expert evaluations to identify the best facilities across the nation. The MemoryCare.com team includes medical and elder care professionals as well as board of directors. For more information, visit https://www.memorycare.com/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Byers Recognized for Third Straight Year for Commitment to Improving Healthcare

JUNO BEACH, FLA. (PRWEB) NOVEMBER 17, 2020
Document Storage Systems, Inc. (DSS), a leading provider of health information technology (HIT) solutions for federal, private and public healthcare organizations, today announced that Mark Byers, president of DSS, has been named a 2021 FedHealthIT100 awardee for a third straight year.
Nominated and chosen by his peers, Byers was again selected for his commitment to improve healthcare delivery. In 2020, DSS launched a number of innovative clinician decision support (CDS) solutions that harness the power of software and data visualization to empower caregivers and improve patient outcomes. The company also made key updates to many of its products to fight the spread of the COVID-19 virus.
"It is a great honor to again be recognized by FedHealthIT," said Byers. "It's a privilege to work within the dedicated community of government and industry professionals who are transforming federal health innovation. Of course, the entire team at DSS deserve a great deal of credit, especially for when our tools helped the VA address the sudden COVID-19 pandemic. We'll continue to support our customers on that front and with any other healthcare delivery challenges that emerge in 2021."
The FedHealthIT100 honors those individuals recognized for driving change and advancement in the Federal Health IT and consulting marketplaces. The award spotlights those who challenge conventional wisdom and go above and beyond to drive health IT innovation.
Byers is a Service Disabled Veteran (United States Air Force), and co-founder of DSS. His professional software development experience spans almost 45 years in the data processing industry and development of electronic document management software.
During his illustrious career Mr. Byers has been dedicated to leveraging new technologies and finding ideal solutions that reduce care costs, streamline workflows, and provide higher quality of care for patients. Byers' leadership has resulted in health IT solutions that have delivered billions of dollars in proven savings annually for medical centers across the country.
Byers and the other award recipients will be honored at the "7th Annual FedHealthIT100 Awards and A Peek at The Year Ahead Celebration," a virtual event being held on November 17th.
Click here to view the full 2021 FedHealthIT100 listing.
About Document Storage Systems, Inc. (DSS, Inc.)
With over 25 years of experience, DSS knows what works. We are a health information software development and systems integration company, providing services and solutions used daily by thousands of clinicians and administrative staff nationwide, to reduce costs, streamline workflows and improve patient care. For more information about DSS, visit http://www.dssinc.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

His deep healthcare experience and genuine interest in promoting wellness for all populations adds great depth to the PEAR team

NEWPORT BEACH, CALIF. (PRWEB) NOVEMBER 17, 2020
PEAR Sports announced today that it has appointed Robert C. Falkenberg, CEO UnitedHealthcare of California, to its board of directors effective October 20, 2020. This brings PEAR's total board membership to 8.
"We are very excited to welcome Rob to our board of directors. He brings decades of leadership in key areas, including health care, public-private partnerships, strategy implementation, and technology acquisition, that are vital to PEAR's future direction as a growing health and wellness SAAS platform provider," said Bob Allison, PEAR Sports Co-Founder and CEO. "Rob's expertise and counsel will bring energy to our board and strengthen PEAR's commitment to making a positive impact on our health, fitness and wellness initiatives."
Mr. Falkenberg said, "Eighty percent of what influences a person's health happens outside the doctor's office. I'm looking forward to working with the innovative group at PEAR to help deliver effective, world-class digital fitness and wellness solutions to create positive health outcomes for all. Exercise has clear implications on the health of people and their communities, and with PEAR's technology we have a great opportunity to influence that."
About Robert C. Falkenberg
Falkenberg, 57, is a 35-year healthcare industry expert, with deep knowledge and experience working within the managed care sector. Rob has spent the past 20 years at the UnitedHealthcare Group in various leadership positions across the country. Entrepreneurial-minded, he has a strong record building and leading successful teams, developing talent, and growing sustainable business models. Rob received a BS in Business Administration from Towson University where he graduated Magna Cum Laude, and he earned an MBA from Loyola College. He is passionate about outdoor activities, especially mountain and road biking, hiking, tennis and golf.
About PEAR Sports
PEAR Sports is perfecting the personalized delivery of digital health, wellness and fitness programs. Our platform and solutions deliver on-demand customized coaching that creates great experiences for customers and enterprises. To learn more about how PEAR's digital coaching and wellness solutions can increase user engagement for your business, please visit http://www.pearsports.com.
Contacts
PEAR Sports
Anita Habeich, anita@pearsports.com
Share This
PEAR Sports
https://twitter.com/PEARsports
https://www.facebook.com/PearSports/
https://www.instagram.com/pearsports
https://www.linkedin.com/company/pear-sports-llc
https://pearsports.com/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Smile Brands Announces new Affiliate Partnership

IRVINE, CALIF. (PRWEB) NOVEMBER 17, 2020
Smile Brands Inc., one of the nation's leading dental support organizations (DSO) providing business support services to more than 440 affiliated offices across 18 states, is pleased to announce its new partnership with seven Southern Dental Associates locations in Houston, Texas. This marks the company's eighth new affiliate partnership since the start of the pandemic.
Southern Dental Associates has more than 60 years of experience, providing full-service dental care at its locations throughout Houston. The group's 13 general dentists and specialists work together as a team to provide high quality, comprehensive patient care.
Smile Brands will provide full-service administrative support to the practice, including purchasing, payroll, accounting, IT, billing, facilities management, and marketing. The existing staff will remain in place and the offices will continue to operate under the Southern Dental Associates name.
Southern Dental Associates' Regional Clinical Director, Dr. Tiffany White, is looking forward to a strong partnership with Smile Brands. "I have loved the experience that I have received from working with a company that has been in business since 1957. Southern Dental has provided excellent comprehensive care to patients. We have provided services from routine cleaning, preventive care, to dramatic smile makeovers," explains White. "This integration with Smile Brands has me full of excitement. This will allow our staff members to go the extra mile to ensure a comfortable and enjoyable dental experience for the patient. I am extremely honored to join such a reputable company. The BEST is sure to come!"
Steve Bilt, CEO of Smile Brands, stated, "Houston has long been an important market for Smile Brands and we are proud to be expanding our presence through this partnership with Southern Dental Associates. Our two teams share similar values including a commitment to improving lives by making dental care more convenient and affordable. We look forward to helping Southern Dental Associates achieve their goals in the coming months and years."
About Smile Brands Inc.
Based in Irvine California, Smile Brands Inc. is one of the largest providers of support services to dental groups in the United States. The organization's award-winning culture has made it the only dental support organization on Glassdoor's Best Places to Work for the past three years. Smile Brands' affiliated dentists benefit from industry-leading business support services, so they can spend more time caring for patients and less time on the administrative, marketing, and financial aspects of operating a dental practice. The organization supports over 440 affiliated practices and 60 brands across 18 states, including Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Maryland, Ohio, Oregon, Nevada, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, and Wisconsin. Smile Brands is a portfolio company of Gryphon Investors, a leading middle-market private equity firm based in San Francisco, CA. For more information, visit http://www.smilebrands.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

National Diabetes Month Emphasizes Dangers of Added Sugars in the Diet. SweetLeaf Sweetener delivers sweet taste without calories, carbs, or added sugars.

GILBERT, ARIZ. (PRWEB) NOVEMBER 17, 2020
November is National Diabetes Month, and SweetLeaf Sweetener, maker of plant-based, zero-sugar/carbs/calories sweeteners, continues to give consumers the tools to reduce sugars in their foods, beverages and recipes.
Of all foods and beverages, sugar-laden drinks including soda, fruit juice, sweet tea, and energy drinks probably add more sugar to our diets than anything else Americans consume. According to Harvard's T.H. Chan School of Public Health, a typical 20-ounce soda contains 15-18 teaspoons of sugar and more than 240 calories. The American Heart Association recommends a daily added sugar limit of no more than 9 teaspoons/36 grams/150 calories for men, and 6 teaspoons/25 grams/100 calories for women. All children 5 and younger should avoid drinking flavored milks, toddler formulas, plant-based non-dairy milk, caffeinated beverages and sugar- and low-calorie sweetened beverages.
"SweetLeaf Sweetener offers a deliciously satisfying, plant-based alternative. SweetLeaf products are a great alternative to sugar because they deliver sweet taste without the calories, sugar, carbohydrates and artificial ingredients. Our products are made from natural stevia leaf extract," said Carol May, CEO of Wisdom Natural Brands, maker of the SweetLeaf family of products. "Because SweetLeaf contains zero calories, zero carbs, and a non-glycemic response, consumers can sweeten food, beverages, and recipes without impacting blood sugar. Switching to great-tasting SweetLeaf will reduce daily added dietary sugar intake."
Added sugar is a major contributor to obesity and diabetes, according to the American Diabetes Association. During November particularly, Americans are urged to watch consumption of added sugar and be aware of the warning signs for diabetes.
Diabetes is the seventh leading cause of death in the United States, so it's important to know as much as possible about this silent killer. Here are a few diabetes statistics from the Centers for Disease Control and Prevention (CDC) and the American Diabetes Association (ADA):

1 out of 10 people have diabetes

1 out of 4 people don't realize they have diabetes

1 out of 3 people has prediabetes

9 out of 10 people don't realize they are pre-diabetic

85.2% of people with type 2 diabetes are overweight or obese

The prevalence of diabetes in the U.S. increased by 382% from 1988 to 2014

Diabetes is a disease that occurs when blood glucose, also called blood sugar, is too high. When one's body is working properly, much of the food we eat is turned into blood glucose. Insulin, a hormone produced by the pancreas, helps the glucose from the food we eat to get into cells where it's used as energy.
When the body doesn't make enough insulin, or the insulin is not being used efficiently, the glucose stays in the blood and never gets to the cells. The buildup of sugar in the blood can cause many health issues including cardiovascular risk.
There are two types of diabetes, type 1 and type 2. Those with type 1 diabetes are unable to make enough insulin. Type 1 diabetes is caused by an inherited genetic variant, is usually first discovered in children, and cannot be prevented.
Type 2 diabetes occurs when the body produces insulin but is unable to use it properly. In adults, 95% of all diagnosed cases of diabetes is type 2. Those most at risk of getting type 2 diabetes are those that are overweight, have a family history of diabetes, are physically inactive, and are over 45 years old. Doctors agree that the most important factor in prevention and management is maintaining the proper weight.
Obesity results when more calories are consumed than are burned. And what is the main cause of that imbalance? Sugar. Sugar is prevalent in everything we eat and drink but is cleverly disguised on food labels with so many other names, most of us don't even realize we're consuming it.
SweetLeaf products have a non-glycemic response, and that means they won't affect blood sugar. Plus, the entire SweetLeaf family of sweeteners is gluten free with zero sugars/calories and no artificial sweeteners. Enjoy SweetLeaf Stevia Sweetener or Organic SweetLeaf Stevia Sweetener in packets or shaker jar, Liquid Stevia Sweet Drops, in 2-ounce or convenient 50ml bottles, or SweetLeaf Water Drops water enhancer in six delicious fruit blends, or SweetLeaf's two newest products, Better Than Sugar, a powder or granular one-to-one plant-based sweetener that replaces sugar in foods, recipes, and beverages, and award-winning SweetLeaf Organic Monk Fruit in granular bags and packets, 50ml squeezable organic liquids, and 2-oz organic liquid drops. Local retailers for all SweetLeaf products can be found on SweetLeaf's Store Locator page, or Shop.SweetLeaf.com
SweetLeaf makes it easy to switch from sugars to SweetLeaf with their Stevia Conversion Chart or interactive Stevia Conversion Calculator. SweetLeaf also has hundreds of easy-to-make low- or no-sugar recipes.
For interviews with company leadership, please call the number at the bottom of this release.
###
About WISDOM NATURAL BRANDS, maker of SweetLeaf Sweetener and
SweetLeaf Organic Monk Fruit Sweeteners
Wisdom Natural Brands, based in Gilbert, Ariz., has been the leading stevia expert and industry pioneer with its plant-based SweetLeaf Sweetener brand for 38 years. SweetLeaf is the only stevia brand winning 37 awards for taste and innovation. SweetLeaf Organic Monk Fruit is a 1:1 sugar replacement and available in granular, packets, squeezable, and liquid drops, totalling 18 products. SweetLeaf Sweeteners have zero calories, zero sugars, a non-glycemic response, and no artificial ingredients. SweetLeaf Stevia is sold in boxes containing 35 or 70 packets and shaker jars (organic or natural) for easy home use. SweetLeaf Liquid Stevia Sweet Drops add flavor without calories, zero sugars, or artificial sweeteners to foods, beverages, and recipes. Organic Sweet Drops are available in three popular flavors: English Toffee, Vanilla Crème, and SteviaClear. SweetLeaf Stevia Water Drops add delicious flavor to still or sparkling water. New Better than Sugar! powdered and granular, natural and organic, is a sugar replacement measuring 1:1 like sugar—without any of the calories or carbs and zero sugars. SweetLeaf Zero-Sugar Stevia Syrup, in three popular flavors, brings the incredible sweetness of stevia and monk fruit, with only 70 calories per serving. Wisdom introduced herbal blends made from Yerba Maté through its Wisdom of the Ancients brand, one of the most respected herbal lines in the natural industry. Wisdom of the Ancients herbal blends are available in bags and loose leaves and come in a variety of beneficial flavors. And new zero-sugar, zero-calorie Yerba Maté Energy Shots, available in regular and orange flavors, provide energy with 200 nutrients and 100% naturally occurring caffeine. SweetLeaf Sweeteners and Wisdom of the Ancients' products are available at: Shop.SweetLeaf.com, health food stores, natural groceries, supermarkets, and online retailers.
MEDIA CONTACT:
Barbara McFadden    
McFadden/Gavender
M: (520) 990-6040
barbara@mcfaddengavender.com
Website:
SweetLeaf.com
WisdomNaturalBrands.com

Sugar is prevalent in everything we eat and drink but is cleverly disguised on food labels with so many other names, most of us don't even realize we're consuming it.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Hemp extractor/processor receives vegan certification from nonprofit organization dedicated to educating the public about veganism and assisting vegan-friendly businesses.

TAMPA, FLA (PRWEB) NOVEMBER 17, 2020
Eagle Hemp recently had three of their ultra-pure full spectrum cannabinoid oil products certified by Vegan Action. Vegan Action is a nonprofit organization that guarantees a fully vegan product when they give their stamp of approval.
The Vegan Certification covers Eagle Hemp's CBD+, CBDa+, and CBD4Pets products. Vegan Certification goes beyond just the ingredients of a product. This certification ensures the absence of cross-contamination through shared machinery and product testing on animals.
Elliot Taylor, Laboratory and Process Manager at Eagle Hemp, spearheaded the efforts to achieve Vegan Certification on the aforementioned products.
"At Eagle Hemp, we strive to provide the purest and most effective products on the market. Our products are formulated to meet as many dietary demands as possible, so that we can deliver the highest-quality products to all customers," said Taylor. "We are actively working to achieve more certifications to ensure quality, safety and peace-of-mind for our customers."
Eagle Hemp's FDA registered facility located in Lakeland, Florida uses state-of-the-art CO2 extractors and proprietary processing to create its own ultra-pure full spectrum cannabinoid oil. Eagle Hemp processes four tons of hemp biomass per hour, now with 3 products ensured to have no animal products, testing or GMOs used in manufacturing. Eagle Hemp is working towards certifying more vegan products as well as other certifications to ensure their products meet every customer need.
Eagle Hemp offers each product in various sizes and concentrations depending on consumer needs. Bulk products and white label are also available on their website.
About Eagle Hemp:
Eagle Hemp has crafted a manufacturing process whose goal is to be rigidly consistent and maintain the highest level of quality and purity on the market. The hemp market is flooded with suspect formulations and products that lack consistency, so Eagle Hemp strives to provide the highest quality product with the fastest delivery times for their customers every single day. For more information, visit eaglehempcbd.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated solely to cancer immunotherapy, has published a clinical practice guideline specific to the use of immunotherapy for acute leukemia, a type of blood cancer.

MILWAUKEE (PRWEB) NOVEMBER 17, 2020
The Society for Immunotherapy of Cancer (SITC), the world's leading member-driven organization dedicated solely to cancer immunotherapy, has published a clinical practice guideline specific to the use of immunotherapy for acute leukemia, a type of blood cancer.
"The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia," was developed by an expert panel of leaders in the fields of hematology, oncology, hematopathology, oncology nursing and cancer patient advocacy from across the United States. This immunotherapy-specific guideline provides hematologists, oncologists, and other advanced practice providers a clinical roadmap to provide optimal care for patients who have acute leukemia.
"Immunotherapies including blinatumomab and tisagenlecleucel have demonstrated deep and durable responses for the treatment of acute lymphoid leukemia and a number of emerging options are showing encouraging results in clinical trials for patients with acute myeloid leukemia as well," said Martin Tallman, MD, co-chair of the SITC Acute leukemia Immunotherapy Guideline Expert Panel. "Now that more immunotherapies are FDA-approved and becoming available for broader populations of patients, our SITC expert panel developed this manuscript to help address the challenging questions that medical hematologists and oncologists sometime face when incorporating various immunotherapy agents and regimens into their practice."
Published in the Journal for ImmunoTherapy of Cancer (JITC), the society's open access, peer-reviewed online journal, this guideline is an update to the society's previous 2016 manuscript on hematologic malignancies, which also included lymphoma and multiple myeloma. SITC published a standalone guideline on multiple myeloma on July 12, 2020, and a manuscript devoted to lymphoma is forthcoming.
The SITC Cancer Immunotherapy Guidelines are a collection of clinical practice guidelines (CPGs) developed by leading experts to help hematologists and oncologists determine when and how to best use immunotherapy to treat their patients. The guidelines cover immunotherapy treatment recommendations, toxicity management and considerations for optimizing patient quality of life. SITC has published CPGs for bladder carcinoma, cutaneous melanoma, head and neck squamous cell carcinoma, multiple myeloma, non-small cell lung cancer, prostate cancer and renal cell carcinoma. Additional guidelines are in development covering acute leukemia and lymphoma, breast cancer, hepatocellular carcinoma, non-melanoma skin cancer and immune-related adverse events.
"Advances in cancer immunotherapy are occurring rapidly across the spectrum of malignancies, and as treatment options and complexity increase, so does the need to disseminate information on best practices. SITC is committed to providing resources for clinicians that lead to the best possible outcomes for patients," said SITC President Mario Sznol, MD. "Our society's Cancer Immunotherapy Guidelines are developed by experts in the treatment of the respective malignancies and I believe are an invaluable resource for clinicians. I look forward to our continued expansion of this important series."
In addition to the published manuscript, SITC is also offering several different opportunities to help clinicians understand and implement the guidelines into their practice, including live webinars and on-demand modules hosted on the SITC website. SITC will host a live, free webinar during which attendees will be able to learn more about the treatment recommendations within the acute leukemia guidelines and ask questions of expert faculty. A date and registration information will be announced in the coming weeks. Click here to view on-demand SITC Cancer Immunotherapy Guidelines webinars.
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word "cure" a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.
About JITC
Journal for ImmunoTherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of the Society for Immunotherapy of Cancer featuring an impact factor of 10.252. The journal publishes high-quality articles on all aspects of tumor immunology and cancer immunotherapy, on subjects across the basic science-translational-clinical spectrum. JITC publishes original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal editors. These articles, freely accessible at jitc.bmj.com, make JITC the leading forum for tumor immunology and cancer immunotherapy research. Follow JITC on Twitter @jitcancer.
# # #




START your own Wordpress site, business or personal website, or online store at www.siteground.com

The collaboration improves CGT manufacturing through a standardized, scalable platform

COLLEGE STATION, TEXAS AND WOODCLIFF LAKE, N.J. (PRWEB) NOVEMBER 17, 2020
G-CON Manufacturing, Inc. (G-CON), a leader in prefabricated flexible cleanroom solutions, and Ori Biotech Ltd. (Ori), an innovator in cell and gene therapy (CGT) manufacturing, announced today their global collaboration to offer a predesigned platform for flexible manufacturing of cell therapies. The non-exclusive collaboration integrates Ori's proprietary, flexible CGT manufacturing platform with the highly innovative prefabricated cleanroom that is the G-CON POD. The combination of the two technologies will provide standardized CGT manufacturing in a closed platform that can be seamlessly scaled for clinical through commercial scale manufacturing.
Ori's ability to increase throughput, improve quality and decrease cost coupled with G-CON's extensive experience in building cGMP manufacturing facilities for various modalities will combine to achieve the ultimate goal to help therapy developers bring lifesaving therapies to patients more quickly and cost effectively.
"G-CON is a leader in flexible cell and gene therapy manufacturing and, with this collaboration, Ori continues to partner with best-in-class, expert suppliers across the CGT ecosystem. This partnership will help enable our vision for a fully integrated, automated, closed system manufacturing platform supporting the cell and gene therapy industry," said Farlan Veraitch, Co-Founder and CSO, Ori Biotech. "Innovation that reduces the significant size and cost of cell and gene therapy manufacturing facilities to enable scalable capacity, distributed manufacturing and marks another step toward enabling our partners to bring their life saving treatments to patients at scale."
"A significant, upfront investment of $50M-$150M is often required to develop manufacturing capacity and building large bricks and mortar manufacturing facilities presents major challenges for CGT developers. An Ori powered G-CON POD can provide a flexible model with rapid scalability to manufacture thousands of doses of advanced therapies in a much smaller footprint, reducing the required facility investment by up to 75%" added Jason C. Foster, CEO, Ori Biotech.
"Ori is a pioneer in the cell therapy field with a truly disruptive technology in development," said Peter Makowenskyj, Director of Sales Engineering for G-CON. "Enhancing automation and closing the process really eliminates a lot of the high cost elements and manual interventions currently required in making cell therapies. Our collaboration aligns well with Pharma 4.0 initiatives along with distributed manufacturing and will ultimately bring these treatments to patients more quickly and cost effectively."
About G-CON Manufacturing
G-CON Manufacturing designs, builds and installs prefabricated G-CON POD cleanrooms. G-CON's POD portfolio provides cleanrooms in a number of dimensions for a variety of uses, from laboratory environments to personalized medicine and production process platforms. G-CON POD cleanroom units surpass traditional cleanroom structures in scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end. For more information, please visit G-CON's website at http://www.gconbio.com.
About Ori Biotech
Ori is a London and New Jersey based cell and gene therapy (CGT) manufacturing technology company. Ori has developed a proprietary, flexible manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to further develop and bring their products to market at commercial scale. The promise of the full stack Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining hardware, software and data services.
Ori was founded by Professor Chris Mason (AVRO) and Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and executive management team with over 100 years of pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CBO Jason Jones (Miltenyi Biotec), VP Tom Heathman (HCATS) alongside expert advisers like Bruce Levine, Anthony Davies and Bob Preti. For more information, visit http://www.oribiotech.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Allegheny Health Network (AHN) today announced that it has selected one of the region's and nation's foremost cardiac surgeons to serve as System Chair of the Network's Department of Thoracic and Cardiovascular Surgery. Stephen H. Bailey, MD, currently Director of Cardiac Surgery at AHN and a leading specialist in heart transplantation, heart valve disease and mechanical heart assistance, is the first recipient of the Magovern Chair at AHN, recognizing his many accomplishments and innovations in advancing the field of cardiac surgery.

PITTSBURGH (PRWEB) NOVEMBER 17, 2020
Allegheny Health Network (AHN) today announced that it has selected one of the region's and nation's foremost cardiac surgeons to serve as System Chair of the Network's Department of Thoracic and Cardiovascular Surgery. Stephen H. Bailey, MD, currently Director of Cardiac Surgery at AHN and a leading specialist in heart transplantation, heart valve disease and mechanical heart assistance, is the first recipient of the Magovern Chair at AHN, recognizing his many accomplishments and innovations in advancing the field of cardiac surgery.
In his new role, Dr. Bailey will direct all cardiovascular and thoracic related surgical services across AHN, leading day-to-day operations, overseeing programmatic growth, and facilitating clinical research efforts that bring innovative, state-of-the-art care to cardiac patients.
A graduate of Williams College in Massachusetts, Dr. Bailey received his medical degree from Vanderbilt University, and completed residencies at New York-Presbyterian/Columbia hospital in cardiothoracic surgery and the University of Utah in general surgery.
"Dr. Bailey is an exceptional clinical leader and a visionary pioneer in the surgical treatment of complex cardiovascular diseases. Our Cardiovascular Institute and the Department of Thoracic and Cardiovascular Surgery will be well-served by his expanded leadership role with our organization," said Donald Whiting, MD, AHN's Chief Medical Officer.
During his tenure at AHN, Dr. Bailey has risen to distinction as one of the nations' leading heart surgeons in the areas of minimally invasive heart valve surgery, heart transplantation, mechanical heart assistance technologies and other complex surgical interventions.
In addition to serving as Director of Cardiac Surgery at AHN, Dr. Bailey, Associate Professor of Cardiothoracic Surgery, Drexel University College of Medicine, has also served as surgical director of both AHN's Cardiac Transplantation/Ventricular Assist Device Program and its Structural Heart Program. His research has been widely published, focusing broadly on optimizing clinical, technological and economic outcomes of complex cardiac surgical procedures.
"Under Dr. Bailey's leadership, the Division of Cardiac Surgery at Allegheny General Hospital has flourished, providing nationally recognized, high-quality care and leading the region in the development of new and innovative surgical options for complex diseases of the heart and vascular system," said Dr. Whiting. "His leadership has helped further elevate our longstanding reputation as a premiere referral center for advanced cardiovascular care."
AGH's VAD program was the first in the region to receive Joint Commission Certification. The hospital is also routinely ranked among the nation's top medical centers for three-year survival rates among heart transplant patients. In 2019, the heart transplantation program had the best three-year survival rate in Pennsylvania and seventh-best in the U.S. Most recently, Healthgrades listed AGH as one of the country's top hospitals for overall cardiac care and cardiac surgery, and the Society of Thoracic Surgeons recognized AGH as a 3 Star TAVR program.
Dr. Bailey succeeds George Magovern Jr., MD who recently stepped down as Chair. Dr. Magovern, however, will continue to have a role with the Cardiovascular Institute. The Magovern name has been synonymous with pioneering heart surgery and cardiovascular research at AGH for decades.
"It's been an honor to work alongside some of the world's foremost medical and surgical leaders in this field and caregivers who truly exemplify what it means to practice innovative, compassionate and patient-centered medicine. I'm thrilled to work with everyone in this new capacity to further expand the reach of our program's expertise across the many communities AHN serves," said Dr. Bailey. "It's also been a particularly rewarding experience to work with and learn from Dr. Magovern. We look forward to him being a continuing source of knowledge, guidance and inspiration to our team and the future generations of cardiovascular clinicians who train within our programs."
###
About the Allegheny Health Network:
Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 13 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss the incorporation of digital options for dermatology trials and how to increase the speed and quality of data. They will discuss how a decentralized trial design benefits each stakeholder, and also highlight strategies to compete for eligible and diverse patient populations.

TORONTO (PRWEB) NOVEMBER 17, 2020
An important trend in the dermatology clinical space is the increasing use of technology for virtual visits, remote electronic consent and other applications. With the COVID-19 pandemic as a driver for uptake, teledermatology has gained more widespread use across the world for clinical consultation, patient assessment and follow-up. Virtual visits are of increasing interest in dermatology clinical trials as a way to reduce the study visit burden for both patients and trial sites.
To be most successful, dermatology clinical trials should not only be digitally enabled, but accessible to a diverse array of qualified patients and designed to encourage patient participation. The digital options available today reduce patient and investigator site burden, accelerate startup and enrollment timelines, and ensure consistent, high-quality assessments and data collection.
Join PPD experts Rose Blackburne, MD, MBA, Executive Medical Director, Global Product Development; Norma Cantu, Senior Director, Project Management; and John Manns, Senior Director, Innovation and Digital Operations, for a live webinar on Friday, December 4, 2020 at 10 a.m. EST (3 p.m. GMT/UK).
For more information, or to register for this event, visit Developing a Digital Protocol for Dermatology Trials: A Step-by-Step Guide to Optimizing Research for Patients and Clinicians.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/




START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will provide an overview of the current sesame market. They will discuss the agronomic and financial benefits of adding Smarter Sesame to a farming operation, how to grow Smarter Sesame and the benefits of Equinom's varieties across the supply chain.

TORONTO (PRWEB) NOVEMBER 17, 2020
Equinom is bringing about a sea of change in the food and agricultural industries, introducing newly designed non-GMO "Smarter Sesame" with high-value health, function and cultivation characteristics.
With huge value packed into a tiny superfood, sesame has become one of the world's most prominent oilseed crops and an essential part of a nutritious diet. Equinom's breakthrough Smarter Sesame varieties are abundant in qualities targeted to food industry specifications, making these high oil- and protein-content seeds highly profitable across regional economies.
In addition to many nutritional trait upgrades, Equinom's IP-protected sesame varieties offer a myriad of benefits to growers, including:

Boosting crop yields up to 2,200 lbs/acre (compared to the industry standard of 500 lbs/acre)

Durability in a range of growing conditions, with heat tolerance and drought resistance

Requiring less fertilizer and water (compared to sorghum, cotton and corn)

Reducing the use of pesticides due to naturally high levels of disease and insect tolerance compared to other crops

Fitting in multiple-row cropping systems and conforming to most planting and irrigation methods

Improving soil tilth leading to higher yields on the following crops

Equinom is introducing Smarter Sesame to optimize cultivation in many new and existing geographical areas: The United States, South America, Western Europe, Southern Europe, the Middle East and Australia. In the US, Smarter Sesame has been grown commercially across 50,000 acres in Texas and Oklahoma over the last three years.
Join experts from Equinom, Rick Mignella, EVP and Managing Director; and Chris Schupp, Director of Business Development, in a live webinar on Friday, December 4, 2020 at 11am EST (4pm GMT/UK).
In the webinar, attendees will learn how to increase farm potential and profitability with Equinom's Smarter Sesame. Topics of discussion will include a current market overview, the agronomic and financial benefits of Smarter Sesame, how to grow Smarter Sesame and the benefits of Equinom's sesame varieties across the supply chain.
For more information, or to register for this event, visit Making Cultivation Financially Profitable and Optimizing Farm Potential with 'Smarter Sesame'.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com